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ABSTRACT 
Bovid herpesvirus 1 (BHV1) causes a variety of disease syndromes in 
cattle world -wide. The biology of the virus is reviewed with 
emphasis on clinical disease, epidemiology and the role of viral 
latency, the physical, genetic and antigenic make -up of the virus, 
experimental respiratory disease (infectious bovine rhinotracheitis 
- IBR), the immune response of cattle and its exploitation in 
diagnostic tests. An analysis was made of the epidemiology of 
BHV1 infection in Great Britain, using diagnostic data from Veter- 
inary Investigation Centres and the Central Veterinary Laboratory. 
There was a marked seasonal incidence, with IBR occurring mainly 
in winter and fetopathy in summer. There was a dramatic increase 
in IBR incidence in the late 1970s. Estimates of the prevalence of 
seropositive cattle showed a rising trend over the period 1970 -1986. 
Restriction endonuclease fingerprinting of the DNA of BHV1 showed 
that early British isolates (from both IBR and genital disease) 
were all of genotype 2 along with the prototype American genital 
strain. More recent isolates, since 1977, are predominantly of 
genotype 1 resembling the prototype IBR strains from America. This 
supports the view that genotype 1 viruses were imported to Britain 
during the 1970s. 
Four British isolates of genotype 1 virus and two of genotype 2 were 
used in a series of experimental calf inoculations. All six strains 
produced a febrile upper respiratory and ocular disease. A score 
system was used to quantify the clinical responses. Statistical 
analysis indicated that genotype 1 viruses were more virulent than 
genotype 2, and calves inoculated with genotype 1 excreted signific- 
antly more virus. For both genotypes of virus, the calves showed 
clinical resistance to subsequent challenge with the opposite 
genotype. In the primary infections, an early serological IgM 
response peaked on days 12 -14 after inoculation. IgG1 and IgG2 
were first detected on days 9 or 10 with a marked rise in IgG1 
between days 10 and 15. Secondary rises in IgG antibodies occurred 
following challenge exposure and also after reactivation of latent 
virus by the administration of dexamethasone. 
Comparisons were made of the diagnostic tests for BHV1 infection. 
Antigen- detection methods were specific and sensitive although they 
could not equal the sensitivity of virus isolation. Direct immuno- 
fluorescent labelling of cells extracted from the nasal mucus or 
the use of reverse passive haemagglutination to detect soluble 
antigen in secretions, were the simplest techniques which offered 
high sensitivity. A. number of enzyme immunossays for cytological 
labelling or the detection of soluble antigen were evaluated but 
their technical complexity led to increased opportunities for test 
error. In contrast, enzyme linked immunosorbent assay proved a 
flexible and reliable tool for serological diagnosis. The para- 
meters of an IgG assay were determined so as to enable its use in a 
variety of diagnostic applications. Preliminary studies suggested 
that an IgM capture assay using monoclonal antibodies was of potent- 
ial diagnostic value as an indicator of recent infection. 
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Chapter 1 
THE BIOLOGY OF BOVID HERPESVIRUS 1: A LITERATURE REVIEW. 
INTRODUCTION 
This review will focus on those diseases of cattle in which bovid 
herpesvirus type 1 (BHV1) has been assigned a major causal role. It 
will extend into the epidemiology, diagnosis and control of the 
diseases, as well as introducing the molecular biology of the virus, 
in so far as it relates to the disease epidemiology. 
The subject was comprehensively reviewed by Gibbs and Rweyemamu 
(1977). Clinical aspects were also reviewed by Kahrs (1977). For 
this reason, the earlier literature will be quoted only selectively 
in order to present a cohesive view of the virus and its associated 
diseases in a historical context. Developments in the decade since 
1977 will be reviewed in more detail, notably in the areas of immuno- 
assays and the molecular biology of the virus. An introductory 
review of the latter was given by Ludwig (1982), and summarized by 
Ludwig and Gregersen (1986). 
CLINICAL DISEASES 
1. Historical 
The earliest reports are found in Germany, in the nineteenth and 
early twentieth centuries, (summarized by Witte, 1933) of a condition 
called Bläschenausschlag or coital exanthema. Zwick and Gminder 
(1913, quoted by Ludwig, 1982) proposed a viral aetiology and this 
was proved by Reisinger & Reimann (1928) who showed its transmis- 
sibility to cattle by filtrates of infected secretions. 
Kendrick and others (1958) isolated a virus from genital lesions in 
-1- 
cows in the USA. They recognized the similarity of the disease to 
Bläschenausschlag and referred to it as infectious pustular vulvo- 
vaginitis (IPV). 
Meanwhile, also in the USA, an upper respiratory disease of cattle in 
beef feedlots had been recognized in Colorado since 1950 (Miller, 
1955). Its incidence was increasing and it subsequently emerged as a 
syndrome of considerable economic importance (Schroeder & Moys, 1954; 
McKercher and others, 1954). In 1955 the term infectious bovine 
rhinotracheitis (IBR) was first used (McKercher and others, 1955) and 
the acronym has since come into widespread use to describe both the 
disease and its causal virus, which was first isolated by Madin and 
others (1956). Subsequently it was shown, by cross -neutralization 
tests in vitro and cross -protection tests in cattle, that the viruses 
isolated from Bläschenausschlag, IPV and IBR were serologically 
indistinguishable (Gillespie and others, 1959; McKercher, 1963). 
2. Infectious Bovine Rhinotracheitis 
Darbyshire and others (1962) first isolated the virus in Britain from 
an outbreak among store cattle in Oxfordshire in 1961 of a disease of 
high morbidity characterised by conjunctivitis and lachrymation, 
together with rhinitis and nasal discharge in some animals. The 
virus was shown to be indistinguishable from the American IBR isolate, 
and it has since been recognised as the UK prototype strain, des- 
ignated "Oxford ". Dawson and others (1962) described the outbreak in 
more detail. There was an intense conjunctivitis, uni- or bilateral, 
with oedema, punctate haemorrhages and profuse lachrymation. Kera- 
titis and photophobia were not seen in uncomplicated cases. Conges- 
tion of the nasal mucous membranes was particularly obvious in the 
-2- 
white -faced Hereford cross -bred animals. It was accompanied by a 
serous to mucopurulent nasal discharge, with areas of necrosis of the 
nasal mucous membranes. Several animals had slight diarrhoea and 
occasional animals a moist cough. Uneventful recovery occurred after 
10 days' clinical illness. These clinical features resembled those 
of IBR, described in the USA (Schroeder & Moys, 1954; McKercher and 
others, 1954; Miller, 1955) although appeared to be relatively mild. 
A number of outbreaks have been reported in America (Abinanti and 
Plumer, 1961; Hughes and others, 1964), Ireland (Timoney and 
O'Connor, 1971) and Britain (Veterinary Investigation Service, 
personal communications) where conjunctivitis and ocular discharge 
were the only presenting signs. 
When outbreaks of a severe type of IBR were first reported in Britain 
(Wiseman and others, 1978), clinical features similar to those 
described above were present, together with pyrexia, dullness, fre- 
quent coughing and tachypnoea. The clinical features of 15 incidents 
of severe IBR in northern Britain were described by Wiseman and 
others (1980). There was a reduction in appetite, dullness, pyrexia, 
soft coughing, ocular discharge, initially serous and later purulent 
nasal discharge, and nasal mucosal congestion followed by the develop- 
ment of diphtheritic plaques. Drooling of saliva was frequently 
observed but was not associated with oral lesions. Halitosis, res- 
piratory stertor and slight to moderate tachypnoea were recorded, but 
clinical pneumonia was rarely a feature even though extensive lung 
lesions were found in all cases examined pathologically (Allan and 
others, 1980). The morbidity varied from 10% upwards but was over 
90% in ten of the 15 incidents, while the mortality ranged from zero 
-3- 
in five of the incidents up to 7% in the most severe outbreak. 
Impaired production was noted in that beef cattle showed a reduced 
rate of weight gain and dairy cows' milk yield fell. Abortions 
occurred in four of the 15 outbreaks. 
Allan and others (1980) described in detail the pathology of 25 
natural cases of severe IBR, of which eight had died and the remainder 
were slaughtered during the acute clinical phase. There were severe 
acute necrotising rhinitis, pharyngitis, and laryngotracheobronchitis 
in most of the cases, with pseudomembrane formation and obstruction 
of the larynx with necrotic debris. The ciliated epithelium of the 
airways was extensively denuded. Neutrophil infiltration of the 
epithelia was extensive; macrophages and lymphocytes were also num- 
erous. The pneumonia was of an exudative type, often accompanied 
by emphysema or pleurisy. Congestion and oedema of the conjunctiva 
were present in 80 per cent of the cases. Renal infarction was noted 
in 48 per cent of the cases. No pathological lesions were found in 
the brains. Although BHV1 was isolated from the 14 cases examined 
microbiologically, a variety of other pathogens were also found 
including Pasteurella spp (4 cases) and Mycoplasma bovis (7 cases). 
The pathology described must therefore be regarded as complicated 
BHV1 infection. It has been claimed by Wiseman and others (1984) that 
the severe form of IBR recognised in northern Britain in the late 
1970s was "identical in almost every respect to the disease described 
originally in North America" in the 1950s. 
3. Infectious pustular vulvovaginitis and balanoposthitis. 
Although, as mentioned above, IPV had long been recognised in female 
cattle, it was only with the development of artificial insemination 
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techniques that attention focussed on the role of the bull as a virus 
carrier and the potential risk of dissemination of the virus through 
semen from infected bulls. Bouters and others (1960) isolated BHV1 
from bulls with ulcerative infectious pustular balanoposthitis (IPB) 
and showed that it could induce IPV in heifers. The genital disease 
was often accompanied by nasal ulceration and discharge from which 
virus could also be isolated. In Germany (Knoblauch, 1962; Straub 
and Mackle, 1965) and subsequently in Britain (Huck and others, 1971) 
outbreaks of IPB were described in bull studs. Saxegaard (1966) 
described the isolation of BHV1 from 23 out of 24 bulls at an arti- 
ficial insemination centre, 20 of them being clinically normal. 
Spradbrow (1968) isolated the virus from frozen semen from a healthy 
bull. It has also been shown that infected bulls can shed BHV1 
intermittently for prolonged periods in excess of one year (Snowdon, 
1965; Bitsch, 1973). These findings led to the establishment of BHV1 
control programmes for artificial insemination centres in a number of 
countries, including Britain (Lucas, 1986). 
Bulls with IPB may or may not have a visible discharge (mucopurulent 
or even haemorrhagic) from the preputial orifice (Huck and others, 
1971). Lesions were only evident after extrusion of the penis and 
varied from papules through haemorrhages and pustules to frank 
ulceration. Ocular and /or nasal signs were also present in some 
bulls. Concurrent IBR, IPV and IPB in a dairy herd were also des- 
cribed by Collings and others (1972). The principal genital signs in 
the females were tail swishing, frequent micturition, oedema and 
erythema of the vulvo -vaginal mucosa, and purulent vaginal discharge 
which could persist for weeks. Focal pustular lesions were found in 
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the vaginal mucosa during the acute stage of the disease. The dis- 
ease in many animals was mild (Kendrick and others, 1958) and was not 
always apparent on external examination. The effects on appetite and 
milk yield were minimal. A more severe form of BHV1 genital infec- 
tion has been described in Africa (Kaminjolo and others, 1975), 
associated with epididymitis and vaginitis. 
4. Infertility and Abortion 
The role of BHV1 in infertility remains uncertain. Witte (1933) 
challenged earlier views that IPV and infertility were associated, 
and the controversy continues in the literature to the present. The 
early literature was reviewed by Saxegaard (1970) who found some 
evidence for impaired semen quality in acutely infected bulls. In 
females he concluded that natural mating with infected bulls did not 
affect the conception rate, but artificial insemination with infected 
semen may cause endometritis and hence prevent conception. This view 
was supported by the experimental work of Parsonson and Snowdon 
(1975) who found that natural mating of susceptible females with 
preputially infected bulls produced lesions of IPV, but did not 
significantly affect the conception rate or the number of services 
per conception compared with the same bulls before they were infected. 
In contrast, the inoculation of BHV1 into the uterus at the time of 
first insemination led to a greatly reduced pregnancy rate and in- 
creased services per conception (4.5) compared with non -infected 
controls (1.7 services per conception). In this case the infected 
group suffered endometritis, salpingitis and vaginitis, and had a 
high proportion of shortened oestrous cycles (<18 days). Detailed 
studies of the pathogenesis of this phenomenon (Miller and Van der 
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Maaten, 1984 and 1985; Van der Maaten and Miller, 1985; Van der 
Maaten and others, 1985) have shown that the adrenal glands and the 
corpus luteum of dioestrus are highly susceptible to infection with 
BHV1 (including attenuated vaccine strains). Necrotic lesions were 
produced in these organs, and plasma progesterone concentrations were 
abnormally low, following intramuscular, intravenous or intra- uterine 
inoculation of the virus at, or 1 day after, oestrus. Ovarian infec- 
tions did not develop following nasal aerosol inoculation. This was 
thought to be because such animals did not develop viraemia. 
Bowen and others (1985) showed that recently hatched embryos were 
highly susceptible to in vitro exposure to BHV1. Viral replication 
led to embryonic death. Bielanski and others (1987) showed a simi- 
lar susceptibility in early embryos from which the zona pellucida 
had been artificially removed. Miller and Van der Maaten (1986) 
extended these observations to in vivo studies by inoculating BHV1 
intravenously into pregnant heifers 7, 14, 21 or 28 days after mat- 
ing. Necrotic corpora lutea were found in the 7 and 14 day inocula- 
tions, and necrotic follicles in the 21 and 28 day heifers, all the 
ovarian lesions being associated with viral antigen. Of the two 
animals inoculated at seven days after mating, one had a normal 
conceptus and the other a dead, virus -infected embryo. 
It may be concluded therefore that infertility associated with BHV1 
could be caused by: 
(a) Reluctance of bulls to mate due to painful IPB. 
(b) Impaired semen quality in infected bulls. 
(c) Abnormal hormonal events in females due to infection of the 
corpora lutea and adrenal glands. 
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(d) Failure of implantation due to viral endometritis. 
(e) Early embryonic death due to viral infection of the embryo. 
Whilst infertility is considered as a sequel to viral infection at 
mating or insemination, abortion (which has long been associated with 
BHV1 - Owen and others, 1964) is regarded as a sporadic sequel to the 
respiratory disease (IBR). The received dogma on the pathogenesis of 
abortion by BHV1 is taken from Kendrick (1973 and 1980). He claims 
that the virus spreads by the haematogenous route, during the acute 
phase of IBR, to reach the placenta where a chronic infection is 
established. Some time, possibly many weeks later, an unknown trigger 
mechanism allows the virus to cross the placenta and reach the fetus. 
BHV1 viraemia during acute infection is not readily demonstrated and 
usually requires cocultivation of blood leukocytes with susceptible 
cell monolayers. Peripheral blood monocytes support replication of 
the virus and are probably the vehicle of haematogenous spread (Nyaga 
and McKercher, 1980). Once infected, fetuses undergo a fulminating 
infection and die within a few days with extensive focal necrotic 
lesions throughout the body, notably in the liver, kidney and spleen. 
Experiments in our laboratory (S. Edwards and C. Richardson, unpub- 
lished work) have confirmed that 100 day bovine fetuses are dead by 5 
days after direct intrafetal inoculation of BHV1. Nevertheless most 
natural abortions due to BHV1 occur during the second half of gesta- 
tion. Kendrick and Osburn (1973) showed that fetuses of between 3 
and 8 months gestation could respond serologically to inactivated 
BHV1 antigen. It is therefore presumed that the absence of BHV1 
antibody in aborted fetuses (Lucas and others, 1986) is because fetal 
death supervenes before seroconversion can occur. The incidence of 
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BHV1 abortion appears to vary widely. Kirkbride and others (1973) in 
the USA found it was the commonest diagnosed cause of abortion (16% 
of cases) and epizootics in the absence of respiratory disease have 
been reported in Germany (Straub and others, 1982) and Hungary (Tanyi 
and others, 1983). Although sporadic cases have occurred in Britain 
in the past decade (Wiseman and others, 1980; Stubbings and Cameron, 
1981; Nettleton and others, 1981), usually in association with IBR 
outbreaks, BHV1 abortion does not appear to have given any great 
cause for concern here (Lucas and others 1986). 
5. Acute Systemic Disease of Newborn Calves. 
Some time in the last month of gestation the fetus undergoes a change 
which enables it to survive an acute BHV1 infection and mount an 
immune response (Kendrick, 1973). There is evidence that such a late 
gestationally infected fetus could be born alive as a virus carrier 
(Pospisil and others, 1979). The finding that calves born to sero- 
positive dams could be reared free of BHV1 infection (Barth and 
others, 1983; Bradley, 1985) suggests that this late gestational in 
utero transmission is an uncommon event. The change over to relative 
resistance to BHV1 appears to be variable in onset; there are a 
number of reports of an acute fatal systemic disease of newborn 
calves, in which the lesions resemble those of BHV1 infected aborted 
fetuses (Reed and others, 1973; Higgins and Edwards, 1986). Mechor 
and others (1987) reproduced the disease experimentally by aerosol 
exposure of two day old calves to BHV1, and also demonstrated clini- 
cal protection by prior feeding of seropositive colostrum. Others 
have found typical, but severe, signs of the respiratory form of IBR 
in young calves (Thiry and others, 1984), or an ulcerative alimentary 
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tract disease (Ross and others, 1983). The latter disease (in the 
absence of bovine virus diarrhoea infection - which it resembles) has 
also been recorded in older cattle (Rogers and others, 1978). 
Msolla and others (1983a) reported evidence from experimental infec- 
tions in calves that the susceptibility to IBR continued to decline 
for some months after birth, and suggested that the ability to resist 
infection was related to the maturation of the cell- mediated immune 
system. 
6. Other Diseases. 
Alimentary tract disease has been mentioned above. BHV1 has also 
been isolated from udder lesions (Guy and others, 1984) and from 
cows' milk (Probst and others, 1985). The other major disease syn- 
drome associated with BHV1 is encephalitis (French, 1962; Carrillo, 
1983). This has not been reported in Britain, although histological 
evidence of a viral encephalitis was reported by Higgins and Edwards 
(1986). 
7. Other Species 
Viruses antigenically related to BHV1 have been isolated from pigs, 
buffalo, goats, sheep and deer, and antibodies to BHV1 have been 
found in these and other ruminant species (reviewed by Gibbs and 
Rweyemamu, 1977; also Doyle and Heuschele, 1983; Rosadio and others, 
1984; Inglis and others, 1983; Brake and Studdert, 1985). Recent 
advances in virus typing must cast doubt on whether serological 
reactions, or even virus isolations, reported earlier were associated 
with BHV1 itself or with related strains such as bovid herpesvirus 6 
(BHV6) from goats (Saito and others, 1974; Engels and others, 1983; 
Hasler and Engels, 1986) or cervid herpesvirus 1 (CHV1) (Reid and 
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others, 1986) from deer. 
Experimentally, rabbits are readily infected (Lupton and others, 
1980) and can be used as a laboratory model; mice are relatively 
refractory although have been infected with some difficulty (Geder 
and others, 1981). 
8. Mixed Infections 
Although BHV1 is an established primary pathogen, several disease 
outbreaks have been described where bovine virus diarrhoea virus 
(BVDV) has also been isolated (Gratzek and others, 1966; Eugster and 
others, 1975; Greig and others, 1981). Clinically the outbreaks 
presented as complex diseases with both respiratory and alimentary 
signs. Experimental studies indicated that infection with BVDV (a 
known immunosuppressive agent) allows BHV1, given by aerosol, to in- 
vade a much wider range of tissues than it does when given alone 
(Potgieter and others, 1984). BHV1 has also been isolated from a 
rinderpest case (Hassan and El Tom, 1985). In interpreting such 
reports, the possibility should be considered of consequential react- 
ivation of a latent BHV1 infection due to immunosuppression by the 
primary infectious agent, although an attempt to demonstrate such an 
effect experimentally with BVDV was unsuccessful (Edwards & Roeder, 
1983). BHV1 itself has immunosuppressive effects (Briggs and others, 
1988) which may predispose to secondary infection with other agents. 
BHV1 infections of the eye do not induce a keratitis per se, but can 
predispose to Moraxella bonis infection leading to infectious kerato- 
conjunctivitis (Pugh and others, 1970). Another interaction with 
bacteria, Pasteurella haemolytica, has been extensively exploited by 
workers in Canada as a reproducible model of calf pneumonia (Yates 
and others, 1983a; Jericho, 1983). The combined infection with BHV1 
and, four days later, P. haemolytica produced more severe lesions 
than either agent alone. The response was dose dependent for both 
the virus (Yates and others, 1983b) and the bacteria (Yates and 
others, 1983c). 
EPIDEMIOLOGY AND THE ROLE OF VIRAL LATENCY 
Evidence of BHV1 infections in cattle has been reported from all the 
inhabited continents and the virus is considered to have a worldwide 
distribution (Odend'hal, 1983). Specific national eradication pro- 
grammes are in operation in Switzerland (Riggenbach, 1985) and Denmark 
(Danish Veterinary Service, 1985). The seropositive prevalence in 
cattle varies widely between and within countries, for example 12% in 
Scotland (Msolla and others, 1981), 40% in Italy (Allegri and others, 
1985), 57% in New Zealand (Durham and Sillars, 1986), 63% in Morocco 
(Mahin and others, 1985) and 7 to 69% in Egypt (Hafez and Frey, 1973). 
The widespread practice of vaccination against BHV1 in North America 
(Kahrs, 1977) confounds any attempts to estimate the natural sero- 
prevalence there. 
It has been proposed that BHV1 originated as a venereally transmitted 
genital infection of cattle (McKercher, 1959) in which the virus and 
host had evolved to an epidemiologically stable relationship. Increa- 
sing intensivism of cattle husbandry gave opportunity for other means 
of transmission, and there is evidence for non -venereal spread in 
some outbreaks of IPV /IPB (Kendrick and others, 1958; Straub and 
Bohm, 1963; Huck and others, 1971) even though venereal transmission 
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by natural or artificial insemination remains an important factor 
in the genital disease (Collings and others, 1972; Loretu and others, 
1974). Hyne and Johnston (1964) and Collings and others (1972) 
speculated on the possible role of flies in BHV1 transmission in the 
outbreaks they described. Conclusive evidence to implicate arthopods 
in the biology of BHV1 was produced by Taylor and others (1982) who 
isolated the virus from soft ticks (Ornithodoros coriaeeus) in the 
Western USA, although any role for the ticks in transmission to cat- 
tle remains to be demonstrated. 
McKercher (1963) suggested that the virus must have entered the USA 
with infected cattle before 1930 (when cattle importation from Europe 
ceased) and became established there in the form of a low prevalence, 
relatively mild genital infection (Kendrick and others, 1958) similar 
to the European situation. IBR was considered to be a new disease, 
not recognised before about 1950 (Miller, 1955). McKercher (1959) 
concluded that it arose as a result of BHV1 evolving to exploit the 
opportunity for rapid transmission by the respiratory route, in the 
intensive conditions of the American feedlot system. Outbreaks of 
IBR typically occurred following the introduction of cattle to a 
herd. There was moderately slow spread over a period of weeks until 
most cattle in the herd had been affected. This evolutionary theory 
was supported by the work of Gillespie and others (1959) who showed 
that whilst IBR and IPV virus isolates were serologically identical, 
and both could infect cattle by either vaginal or nasal routes, the 
amount of virus shed in the nasal secretions was 100 -fold more for 
the IBR isolate than for the IPV strain. 
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In the 1970s, reports of IBR in Europe in a new, severe form (Van 
Bekkum and Strayer, 1975; Wellemans, 1975; Martel and others, 1976; 
Wiseman and others, 1978) bore close resemblance to the 1950s ac- 
counts from the USA (McKercher and others, 1955; Wiseman and others, 
1984). Circumstantial evidence suggested that this wave of new 
disease was associated initially with herds which had imported Hol- 
stein cattle from North America (Dannacher and Fedida, 1978; Msolla 
and others, 1981). This would support the view that certain European 
countries, including mainland Britain, had imported cattle infected 
with the IBR strain of BHV1 which evolved in the USA in the 1950s 
(Ludwig and Gregersen, 1986). 
There is general agreement in the literature that outbreaks of IBR in 
epidemic form usually occur following the introduction of new cattle 
to a herd (McKercher, 1959; Wiseman and others, 1980). Once estab- 
lished in a herd the virus may circulate intermittently, with long 
periods (2 to 3 years) of quiescence (Van Nieuwstadt and Verhoeff, 
1983). In such herds resurgence of infection may be associated with 
clinical disease in young non -immune cattle; nevertheless most BHV1 
infections pass unnoticed. All the available evidence points to 
carrier cattle as the main reservoir of BHV1 infection, and BHV1 
survives in nature by an interplay of short cycle and latent infec- 
tions (Gibbs and Rweyemamu, 1977). While other species may become 
infected there is no evidence that they have any role in perpetuation 
of the virus (Ackermann and others, 1986; Hasler and Engels, 1986). 
The ability to establish latent (ie persistent but non -productive) 
infections is a characteristic of the family Herpesviridae (Rapp and 
Jerkofsky, 1973). Latent infection of cattle by BHV1 was implied by 
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observations of intermittent virus shedding over long periods (Snow- 
don, 1965). Sheffy and Davies (1972) were the first of many authors 
to report the consistent recrudescence of latent BHV1 in seropositive 
cattle from 3 days after the administration of corticosteroid hor- 
mones. Other events which can induce reactivation of latent BHV1 
include other viral infections (parainfluenza type 3 - Mensik and 
others, 1976), parasitic infections (DictyocauZus viviparus - Msolla 
and others, 1983b), 3- methylindole toxicity (Espinasse and others, 
1983), parturition (Thiry and others, 1985a) and transport of the 
animals (Thiry and others, 1985b and 1987). The pathogenesis of BHV1 
latency and its role in the epidemiology of the virus have been 
reviewed by Pastoret and others (1982 and 1984). A theoretical model 
for BHV1 latency, based on binary logic, has been proposed by Pas - 
toret and others (1986). 
Davies and Duncan (1974) showed that the local sensory nerves 
(trigeminal for the respiratory tract and sacral for the genital 
tract) were closely related to the persistence and latency of BHV1 
in experimentally infected calves. Further studies have implicated 
the trigeminal and sacral nerve ganglia as the major site of viral 
latency, using the techniques of ganglion explant culture (Homan and 
Easterday, 1980) or in situ DNA hybridization (Ackermann and others, 
1982; Homan and Easterday, 1983; Ackermann and Wyler, 1984). The 
latter technique has shown the latent viral DNA to be located in the 
nuclei of the ganglionic neurons. At the time of recrudescence, 
ganglionitis could be demonstrated histopathologically, associated 
with demonstrable viral antigen (Narita and others, 1978a, 1979a and 
1981). During the quiescent (latent) phase viral antigen could not 
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be detected but the presence of viral RNA in the neuronal nuclei 
(Rock and others, 1986 and 1987) suggested that the BHV1 genome was 
transcriptionally active at a restricted level during latent infec- 
tion. The nature and sites of herpesvirus latency and the mechanisms 
involved in reactivation and recrudescence remain uncertain despite 
considerable reserch efforts (Wildy and others, 1982). The ganglia 
may not be the only site of BHV1 latency: Pastoret and others (1979) 
have speculated on the possible role of latently infected nasal 
epithelial cells, particularly in relationship to reactivation by 
dexamethasone. This hormone may exert a direct pharmacological 
effect on the latently infected cells and this, as well the drug's 
role as an immunosuppressant (Babiuk and Rouse, 1979), may be in- 
volved in the reactivation of latent virus (Pastoret and others, 
1982). 
Whatever the mechanisms of latency and reactivation, the epidemio- 
logically important facts for BHV1 are that: all cattle are con- 
sidered latently infected after recovery from acute infection (Pas - 
toret and others, 1984); the virus is readily reactivated and repeated 
reactivations can be induced in a single animal (Narita and others, 
1979a; Pastoret and others, 1979); reactivated virus is shed at high 
infectious titre in the nasal and /or genital secretions, whatever the 
original site of infection (Davies and Duncan, 1974); vaccination 
either before or after exposure to wild -type virus neither prevents 
nor abolishes latent infection (Straub, 1979; Nettleton and Sharp, 
1980; Zuffa and others, 1985) while live vaccine strains, including 
temperature sensitive mutants, can themselves establish latent 
infections and be reactivated artificially or spontaneously (Pastoret 
and others, 1980a; Gregersen and Wagner, 1985); and the biological 
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characteristics of recrudescent BHV1 isolates do not appear to differ 
from the original infecting strain (Castrucci and others, 1984; 
Rodriguez and others, 1984). 
THE VIRUS 
The IBR isolate of Madin and others (1956) was shown to be a herpes - 
virus, with properties similar to herpes simplex virus, by Armstrong 
and others (1961). It has a double stranded DNA genome, an 
icosahedral capsid with 162 capsomeres and a surrounding envelope of 
approximately 200 nm diameter (Fig. 1.1). The virus is sensitive to 
ether, acid and heat. Its buoyant density is in the range 1.22- 
1.25 g /cm3. Haemagglutination of mouse erythrocytes has been demon- 
strated (Trépanier and others, 1985). The physical and chemical 
properties of the virion were reviewed by Gibbs and Rweyemamu (1977). 
There is no consensus in the literature on the most appropriate 
nomenclature for this virus. The vernacular names IBR virus or IBR - 
IPV virus continue to be commonly used. The Herpesvirus Study 
Group (chairman Roizman, 1973) of the International Committee for the 
Nomenclature of Viruses classified herpesviruses according to the 
taxonomic family of the vertebrate host, with arabic numerals to 
distinguish different viruses of the same host group. Thus IBR virus 
became bovid herpesvirus 1. This system has been perpetuated by 
Ludwig (1982 and 1984) and is used in the present account, although 
the Herpesvirus Study Group had by then decided (Roizman and others, 
1981) that it was useful to distinguish sheep and goat herpesviruses 
from those of cattle, and that classification should therefore be by 
host subfamily. BHV1 would then be bovine herpesvirus 1. The 
differences between the two systems are summarised in table 1.1. 
-17- 
(a) magnification x 190 000 (b) magnification x 230 000 
(c) magnification x 230 000 
Fig. 1.1 Electron micrographs of negatively stained bovid herpes - 
virus 1 (strain ED1) showing (a) intact virion (b) virion 
with ruptured envelope, revealing detail of nucleocapsid 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































They are of little consequence when considering BHV1, but have caused 
considerable confusion over the nomenclature of malignant catarrhal 
fever virus, the Movar 33/63 group and the caprine /ovine herpes - 
viruses (Bartha and others, 1987). BHV1 has the characteristics of 
the subfamily Alphaherpesvirinae, within the family Herpesviridae, 
namely a short replicative cycle, a lytic type of cytopathic effect 
in culture, and latency in neural ganglia of the host species (Roizman 
and others, 1981). 
The DNA of BHV1 is double stranded with guanine plus cytosine content 
of 71% (Russell and Crawford, 1964). These authors estimated the 
molecular weight as 54 mega daltons (MD), but more recent estimates 
are in the range 84 -88 MD (Mayfield and others, 1983; Seal and others, 
1985). Skare and others (1975) used BHV1 (the IPV strain - K22) as a 
heterologous control for their studies of herpes simplex virus, and 
in doing so published the first restriction endonuclease (RE) finger- 
print of BHV1 DNA using the enzyme Eco RI. Restriction endonucleases 
(type II) are bacterial enzymes which cleave double stranded DNA 
molecules only at specific base sequences, typically from 4 to 6 base 
pairs. Their function is to protect the bacteria against foreign 
DNA, the bacterial DNA itself being protected from digestion by 
specific methylation at the equivalent base sequences. The enzymes 
are extensively exploited in genetic manipulation procedures (Malcolm, 
1981). They have also been used with a variety of DNA viruses, 
including herpesviruses (Skare and others, 1975; Paul and others, 
1982) to fingerprint strains and isolates by digesting the viral DNA 
at the specific cleavage loci, then separating the resultant fragments 
on the basis of molecular weight, by electrophoresis in agarose gels. 
The technique allows a much more precise definition of virus strains 
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than is possible by antigenic analysis, and it thus allows very 
detailed epidemiological tracing operations to be carried out (Buch- 
man and others, 1979; Allen and others, 1983). 
The BHV1 DNA molecule (Fig. 1.2) consists of a long unique sequence 
of base pairs, joined to a short sequence composed of two 11.4 -12.2 
kilobase repeat sequences inverted with respect to each other and 
flanking a 10.7 kilobase short unique sequence (Farley and others, 
1981; Mayfield and others, 1983). Because of the inverted repeat 
sequences the short sequence can have two orientations with respect 
to the long sequence, giving two isomeric forms of the DNA. Recent 
work has shown some heterogeneity in a tandem repeat sequence at the 
5' terminal of the unique long sequence (Hammerschmidt and others, 
1986). Hammerschmidt and others (1988) sequenced the BHV1 DNA at 
the genomic termini and at the junction between short and long seg- 
ments. They proposed functional relationships between the genomic 
structures, the cleavage of replicative circularized forms of the 
DNA, and the production of the two isomeric forms of the molecule. 
Mayfield and others (1983) identified the cleavage loci on the mole- 
cule for four restriction enzymes (Hind III, EcoR I, Hpa I, and Bam 
HI) with the American IBR strain "Cooper" and compared the results 
with those for the IPV strain "K22 ". This indicated an overall 
difference in base sequence of about 5% between the two strains. 
This was confirmed by Seal and others (1985) who used DNA liquid 
hybridization to establish that there was at least 95% sequence 
homology between different isolates of BHV1 despite detectable differ- 
ences in their RE fingerprints. A preliminary study by Engels and 
others (1981) indicated that there were at least two patterns of RE 
-21- 










Hind III cleavage sites 
(showing the short region in both orientations, 
with fragment sizes in kilobases) 
DNA type 1 (Cooper) 
I 't 
DNA type 2 (K22) 
Hpa I cleavage sites 
DNA type 1 
DNA type 2 
Fig 1.2 Structure of the BHV1 DNA molecule (after Mayfield 
and others, 1983) 
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fingerprint which they equated with IBR and IPV isolates. A close 
inspection of the sources of their isolates does not support such a 
distinction in that some of their so- called IPV strains were iso- 
lated from respiratory disease cases. Thiry and others (1983) found 
that a number of Belgian field isolates of BHV1 were indistinguish- 
able by RE fingerprinting from the IBR Los Angeles strain, but did 
differ from one vaccine strain which was originally from an IPV case. 
A more comprehensive review of RE types of the virus was carried out 
in Canada (Misra and others, 1983). They identified four major RE 
types by combining the results of digestions with Eco RI, Hind III, 
Hpa I and Bam HI. The patterns were designated by Roman numbers 
I -IV. There was some heterogeneity within these types, although it 
remains to be clarified whether their designation of nine "sub- types" 
is of general validity. The majority of Canadian isolates were 
classed as type I while fewer were type III. Only one isolate was 
classed as type IV, while the two type II isolates may have been 
vaccine strains. European isolates tested were either type I or III, 
including the Oxford and Aberdeen strains from the UK which were both 
type III. 
European reports all support the view that BHV1 isolates fall into 
two major DNA types distinguishable by RE fingerprinting (Ludwig, 
1984; Nettleton and others, 1984; Pauli and others, 1984; Metzler and 
others, 1985). A simpler, more pragmatic, classification has been 
proposed (Metzler and others, 1985) by which they are designated RE 
type 1 (equivalent to type I of Misra and others (1983), "Cooper - 
like" or "IBR- like ") and type 2 (types II and III of Misra and others 
(1983), "K22- like" or "IPV- like "). This scheme will be followed in 
the present account. 
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Recent reports have identified a type 3 virus from cases of encepha- 
litis in cattle in Australia and Argentina (Metzler and others, 
1986; Engels and others, 1986), and have also shown that antigenically 
related herpesviruses from other species (goat, buffalo, deer) are 
quite distinct from bovine isolates by RE fingerprinting (Brake and 
Studdert, 1985; Ronsholt and others, 1987). All the bovine respira- 
tory and genital isolates from Australia were of type 2, suggesting 
that type 1 virus is absent from that continent (Brake and Studdert, 
1985). 
Our knowledge of the protein structure of the BHV1 virion has expan- 
ded considerably in the 1980s, and is likely to continue to do so, 
with the application of sodium dodecyl sulphate (SDS)- polyacrylamide 
gel electrophoresis (PAGE) techniques, combined with immunoprecipi- 
tation, immunoblotting, and the use of monoclonal antibodies for 
precise epitope definition. Pastoret and others (1980b) identified 
21 viral proteins by SDS -PAGE, of molecular weights from 31 to 275 
kilodaltons (KD), and further showed that ten of them were glyco- 
sylated. Subsequent work has identified more structural polypeptides 
- initially 25 (11 glycosylated) (Misra and others, 1981; Metzler and 
Wyler, 1983) and more recently 33 (Bolton and others, 1983; Chang and 
others, 1986). Of the 11 glycoproteins, 10 are expressed on the 
surface envelope of the virion (Chang and others, 1986). A further 
15 non -structural viral proteins have been found in BHV1 infected 
cells (Misra and others, 1981) but are absent from purified virions. 
Virus -specific thymidine kinase activity has been shown in infected 
cells (Weinmaster and others, 1982; Kit and Qavi, 1983) and thymidine 
kinase negative mutants were avirulent for calves (Kit and others, 
1985). The location in the viral genome of the thymidine kinase gene 
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has been mapped (Bello and others, 1987) as has the putative DNA poly - 
merase gene, which hybridized specifically to the equivalent herpes 
simplex gene (Owen and Field, 1988). 
Various authors do not agree on the precise molecular weights of the 
BHV1 proteins but, this apart, a reasonably consistent picture is 
now emerging of the envelope glycoproteins and their role in antibody 
mediated virus neutralization. The seven major immunogenic envelope 
glycoproteins (gp) comprise three antigenic sets: 
(a) *180KD: a dimer of a 90-97 KD gp (neutralizing and haemagglut- 
inating activity and attachment to cells). 
(b) 150KD: a dimer of a 74 -77 KD gp (the major site for neutra- 
lizing activity). 
(c) 130KD: a heterodimer of a 33KD and a 74KD gp (involved in com- 
plement dependent neutralization). 
Ludwig and Letchworth (1987) termed these gIII, gIV and gI glycopro- 
teins respectively and showed that gI and gIV were early (beta) pro- 
teins wheras gIII was expressed later (gamma) in the cycle of infec- 
tion, after the synthesis of virion DNA. 
The BHV1 viral proteins have also been used to investigate relation- 
ships of the virus with other herpesviruses and to compare isolates 
*Molecular weights all approximate; data collated and summarized from 
Gregersen and others, 1983 and 1985; Collins and others, 1984; Pauli 
and others, 1984; Van Drunen Littel Van Den Hurk and others, 1984 and 
1985; Van Drunen Littel Van Den Hurk and Babiuk, 1985 and 1986a; Lum 
and Reed, 1986; Marshall and others, 1986; Okazaki and others, 1986; 
Trépanier and others, 1986; Trudel and others, 1987; Okazaki and 
others, 1987. 
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within the BHV1 group. A number of authors have demonstrated 
serological cross -reactions, by ELISA and neutralization tests, 
between BHV1 and suid herpesvirus 1 (SHV1) in naturally or experi- 
mentally infected or immunised cattle as well as in experimental 
rabbits (Aguilar Setién and others, 1979b, 1979c and 1980b; Zuffa and 
others, 1983, Bush and Pritchett, 1986). In one study (Zuffa and 
others, 1986) cattle vaccinated against BHV1 appeared to be protected 
against virulent SHV1 challenge. Reciprocal DNA -DNA hybridization 
indicated 8% sequence homology between the two viruses, with the 
homologous sequences distributed throughout the genomes (Bush and 
Pritchett, 1985) located in three regions of the long unique region 
and one in the inverted repeat segment (Burger and others, 1984). 
Western blots indicated a two -way cross reaction between the viruses, 
involving nine SHV1 proteins, and three BHV1 proteins of 224, 125- 
130, and 58 -63KD (strong reactions) plus two weaker reactions at 87 
and 55KD (Bush and Pritchett, 1986). Levings and others (1984), 
using two dimensional immunoelectrophoresis, identified two common 
antigens in four herpesviruses of cattle: BHV1, BHV2, BHV4 and SHV1. 
A much closer relationship exists between BHV1 and BHV6 (Gregersen 
and others, 1983) but even here the cross reactivity (by immuno- 
precipitation with monoclonal antibodies) was much weaker than within 
the BHV1 group (DNA types 1, 2 and 3) (Friedli and Metzler, 1986 and 
1987). 
Comparative studies of BHV1 isolates were made by Bagust (1972) using 
two isolates from IPV, one from IBR and one from meningitis, all of 
Australian origin. Recent DNA typing (Brake and Studdert, 1985) 
suggests that Bagust was in fact working with DNA types 2 (IPV and 
IBR isolates) and 3 (meningitis). The four strains showed no 
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differences in thermostability at 40 °C or in buoyant density of the 
virions, but the meningitis strain produced smaller plaques in cell 
culture. Reciprocal cross neutralization tests showed that the 
meningitis strain was antigenically different from though still 
closely related to the other three. In experimental calves all four 
strains produced rhinitis, conjunctivitis and vaginitis when applied 
to the respective mucosae, but in addition the meningitis strain 
alone produced meningo -encephalitis after intranasal or intravaginal 
inoculation. House (1972) studied the growth characteristics 
in vitro of 12 American isolates. Although there were minor differ- 
ences between strains, these could not be related to the tissue from 
which the virus was originally isolated. In Britain, Wojciechowski 
(1974) showed that the Oxford (IBR) and Carmarthen (IPB) isolates did 
not differ in their plaque size and morphology, and only slightly 
differed in the kinetics of reciprocal cross neutralization. It is 
now known that both strains were of DNA type 2 (see below, Chapter 4). 
Pastoret and others (1980b) proposed that IBR and IPV isolates could 
be distinguished using the SDS -PAGE technique on the basis of minor 
variations in the molecular weight of three proteins at approximately 
99, 68 and 66 KD. Because of the overlap in antigenicity and patho- 
genicity between BHV1 isolates, it is only following initial DNA 
typing by the RE fingerprint that meaningful comparisons can be made 
between the viral proteins of different strains. Misra and others 
(1983) found only minor variations in the molecular weights of poly - 
peptides among their nine RE "subtypes" of BHV1. Gregersen and 
others (1985) also found only minor differences in polypeptide 
patterns and molecular weights between DNA types 1 and 2, while no 
antigenic differences were demonstrable either in reciprocal cross 
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neutralization or immunoprecipitation using hyperimmune rabbit 
sera. That the genetic differences between DNA types 1 and 2 are 
reflected in the antigenic makeup of the viruses, is now being reveal- 
ed by the application of monoclonal antibodies (Metzler and others, 
1985). This technique has also confirmed that DNA type 3 isolates 
are clearly distinct from types 1 and 2 (Metzler and others, 1986; 
Friedli and Metzler, 1986 and 1987). 
EXPERIMENTAL INFECTIOUS BOVINE RHINOTRACHEITIS 
McKercher and others (1963) infected calves intranasally with the Los 
Angeles strain of BHV1. They concluded that the primary site of 
viral multiplication was the nasal epithelium whence it spread by the 
lachrymal ducts to the eye where it established conjunctivitis, and 
in blood leukocytes to other organs, although they were unable to 
detect viraemia. 
Markson and Darbyshire (1966) gave a detailed account of the clinical 
and pathological responses of 15 calves inoculated with the Oxford 
strain of BHV1 by the intranasal and conjunctival routes. A rela- 
tively mild disease was induced, whose main features were pyrexia and 
intense conjunctivitis with lachrymation. Virus was recovered from 
the upper and lower respiratory tracts, the conjuctiva, and, in one 
calf killed 5 days after inoculation, the mediastinal lymph node and 
spleen. Three calves showed gross pneumonitis. Non -purulent sub - 
mucosal rhinitis, tracheitis, bronchitis and cholecystitis were 
regularly found, together with a slight non -purulent encephalitis in 
four calves. Encephalitis (in the absence of clinical nervous signs) 
was also described, following intranasal inoculation of BHV1, by 
Edington and others (1972) and Narita and others (1979b). Narita and 
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others (1978b) also produced a histological encephalitis by intra- 
conjunctival inoculation of the virus. They showed that the virus 
spread to the nasal epithelium and induced a mild rhinitis, in addit- 
ion to the intense conjunctivitis produced by this route of inoculat- 
ion, in agreement with the earlier work of Abinanti and Plumer (1961) 
and Hughes and others (1964). 
Schroyer and Easterday (1968) reproduced IBR experimentally by expos- 
ure of calves to aerosols of BHV1. Clinical signs included fever, 
dyspnoea, depression, anorexia and serous or purulent nasal discharge. 
Virus could be isolated up to 11 days after infection. They also 
showed contact spread to susceptible calves with clinical signs 
apparent 5 days after contact, compared with 2 days incubation for 
the aerosolised calves. Pathologically, they noted extensive loss 
of the ciliated epithelium of the respiratory tract, together with 
infiltration of the submucosa by neutrophils, eosinophils and mono- 
nuclear cells. Jericho and Darcel (1978) also used aerosol exposure 
of calves to BHV1 in order to evaluate the effect of ambient temperat- 
ure and humidity on the disease response. They hoped for wide expos- 
ure of the whole respiratory tract to the infection, and a quantitat- 
ively consistent exposure of individual calves although they were not 
satisfied on the latter point. The calves developed a febrile res- 
ponse but the only clinical respiratory sign was coughing. No corre- 
lation could be made between the clinico- pathological response and 
climatic conditions. The pathological lesions included alveolitis 
and bronchiolitis with epithelial necrosis and complete occlusion of 
some bronchiolar lumens. In the major airways (bronchi, trachea, 
nose) there was severe epithelial damage including denudation of 
cilia or even complete loss of columnar cells. This extensive loss 
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of cilia in the BHV1 infected respiratory tract was confirmed in 
scanning electron microscope studied by Allan and Msolla (1980). The 
consequent damage to pulmonary clearance may be a factor in the 
synergistic interaction between BHV1 and certain bacteria in inducing 
respiratory disease (Yates and others, 1983a). 
The severity of experimental IBR appears to be related to the age of 
cattle infected. Webster and Manktelow (1959) produced severe IBR in 
week -old calves by combined intranasal, conjunctival and intratra- 
cheal inoculation. There were necrotic rhinitis, bubbling tracheal 
sounds, cough, conjunctivitis and fever. At necropsy there was 
tracheitis with pseudomembrane formation. The same inoculum in 
yearlings and adults produced only mild disease. Similar age 
differences were reported by Msolla and others (1983a) who found that 
2- week -old or 5- week -old Ayrshires were more severely affected than 6 
or 18- month -old Friesians. In contrast, Narita and others (1982) 
found more severe disease in adult cows than in young calves. A 
definitive experiment on age susceptibility, in which other variables 
are carefully controlled, has yet to be reported. 
It was established 20 -25 years ago that different BHV1 isolates 
showed little tissue tropism, and would readily infect either the 
respiratory or the genital tract, whatever the tissue of origin 
(Gillespie and others, 1959; McKercher, 1963; Maré, 1964; House, 
1972; Bagust, 1972). Furthermore, virus was shed in both respiratory 
and genital secretions following either nasal or vaginal inoculation 
(House, 1972). It was reported that the respiratory disease induced 
by intranasal inoculation of IPV isolates was milder than that 
produced by IBR isolates (Maré, 1964; Gibbs and Rweyemamu, 1977) but 
such reports are somewhat confounded by variations in the response to 
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different IBR isolates (Markson and Darbyshire, 1966). The absence 
of definitive strain markers, until the recent advent of RE 
fingerprinting, makes interpretation of such comparative pathogen- 
icity studies difficult. As recently as 1983 a comparison of two 
British IBR isolates (Oxford and Strichen) and one from America 
(Colorado) (Msolla and others, 1983c) relied solely on descriptive 
clinical and pathological reports to compare the pathogenicity for 
calves. They hinted at preliminary studies which indicated that the 
Strichen strain was of RE type 1 and different from the Oxford 
strain. The calves infected with Strichen (isolated from severe IBR 
in Scotland - Wiseman and others, 1978) developed signs and patho- 
logical lesions of severe IBR, similar to, but slightly more severe 
than, those infected with Colorado. The Oxford strain produced a 
mild clinical response with minimal pathological lesions. 
Despite the considerable literature on experimental BHV1 infections 
there is little evidence of any attempt to quantify the disease 
response. Descriptive clinical assessment and pathology have been 
widely used. These methods have a valuable place, but are of limited 
application when attempting to compare strains of the same virus 
which produce very similar diseases, differing only in severity. 
Thomas and others (1977) proposed a quantitative method of evaluating 
respiratory disease in calves. They used it in studies of parain- 
fluenza type 3 and of combined respiratory syncytial virus and bovine 
viral diarrhoea virus infections in calves. The clinical response 
was measured by a score which combined the findings of a daily clin- 
ical examination, including rectal temperature, with weekly measure- 
ments of haematological parameters. The experiments were based on 
principles established for human common cold research (Tyrell, 1963) 
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in which experimental subjects were allocated randomly to treatments, 
including controls; neither patient nor clinical examiner were aware 
of treatment allocations; and an individual baseline was established 
by daily examinations for four days before inoculation. The double 
blind nature of the clinical evaluations greatly facilitated statist- 
ical analysis of the findings. Earlier attempts to quantify respirat- 
ory disease in calves included the "index of illness" used by Frank 
and Marshall (1971) for experimental parainfluenza type 3 infections. 
This was based on presence /absence of fever, leukopenia and any 
clinical signs. It indicated the duration but not the severity 
of disease. McKercher and others (1972) used analysis of variance 
techniques to evaluate the degree of protection afforded to calves in 
vaccination and challenge experiments with parainfluenza type 3 
virus. They statistically analysed only inherently quantitative 
data - rectal temperature, antibody titres, and virus shedding. 
Elazhary and others (1980) used a slightly modified version of the 
system of Thomas and others (1977) for experimental respiratory 
syncytial virus infection in calves. Verhoeff and Van Nieuwstadt 
(1984) extended the application to naturally occurring respiratory 
disease on farms, in order to evaluate the efficacy of a respiratory 
syncytial virus vaccine. 
Roney and others (1985) were the first to use numerical scores to 
evaluate clinical responses to BHV1, in this case to assess the effect 
of interferon on the disease. They produced a daily "lesion score" 
for each calf by which progression of the disease could be displayed 
graphically. Statistically, they compared mean lesion scores over 
the monitoring period between treatment groups. Rectal temperatures 
were analysed separately and not included in the lesion scores. 
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THE BOVINE IMMUNE RESPONSE TO BHV1 
The immunology of BHV1 infections in cattle has been the subject of 
considerable study. It has been reviewed by Aguilar- Setien and 
others (1980a) and Splitter and others (1985), as well as, in the 
broader context of vertebrate immunity to herpesviruses in general, 
Rouse and Babiuk (1978), Babiuk and Rouse (1979) and Rouse and Horo- 
hov (1984). In acute infections, cellular immunity, mediated by T 
lymphocytes or the interaction of antibody and Fc receptor bearing 
cells, is important in recovery from infection, whereas humoral 
immunity plays a major role in preventing re- infection. Antibody is 
also involved in maintaining the state of latent infection, while 
cellular mechanisms come into play in controlling recrudescent infec- 
tions after reactivation. 
Most studies have concentrated on single components of the immune 
response and it is not yet possible to give a holistic account of 
the phenomenon. Davies and Carmichael (1973) and Rouse and Babiuk 
(1974a) demonstrated a virus -specific cell mediated immune (CMI) 
response by antigen stimulation in vitro of blood lymphocytes from 
BHV1- infected cattle. The response was first detected 5 days after 
intranasal infection, peaked at days 7 to 10, and declined again by 
day 19. Similar findings were reported by Tsvetkov and others (1987) 
who noted that the sudden drop in virus excretion at about day 8 
after infection corresponded with the peak of the lymphocyte blas- 
togenic response and preceded the serum antibody response. An alter- 
native assay of lymphocyte activity was viral -plaque inhibition in 
cell culture (Rouse and Babiuk, 1975). Subsequently it was shown 
that the CMI activity was found in the T lymphocyte fraction of 
peripheral blood (Rouse and Babiuk, 1974b; Splitter and Eskra, 1986). 
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There was considerable variation in T cell responsiveness to BHV1 
antigen between individual animals, but this could not be related 
to breed of cattle (Miller -Edge and Splitter, 1986). Specific 
cytotoxic activity against BHV1- infected targets was demonstrated 
in non -adherent lymphocytes from immune cattle by Rouse and Babiuk 
(1977). The activity was not restricted by the histocompatibility 
antigens of the targets, and, although they proposed T lymphocytes as 
the effectors, it has since been suggested they were observing natural 
killer cell activity (Rouse and Horohov, 1984). BHV1 specific, gene- 
tically unrestricted cytotoxicity was also shown in an uncharacterised 
adherent cell fraction by Campos and Rossi (1985b). The effect was 
independent of antibody and was not due to natural killer cells. It 
peaked at 7 days after intranasal inoculation. Classic, histocompa- 
tibility antigen restricted, cytotoxicity directed against BHV1 
infected target cells has now been demonstrated with T lymphocytes 
from the blood of immune cattle (Campos and Rossi, 1986). 
Antibody- dependent cell- mediated cytotoxicity (ADCC) has received 
considerable attention and appears to be an important component of 
the bovine immune response to BHV1. K cells (lymphocyte effectors 
of ADCC in man) could not be detected in cattle (Campos and Rossi, 
1985a). The major bovine effector of ADCC against BHV1 infected 
targets is the polymorphonuclear leukocyte (Wardley and others, 1976; 
Thorne and others, 1984; Campos and Rossi, 1985a) although mono- 
nuclear phagocytic cells also show ADCC activity (Rouse and others, 
1976). The antibodies involved in ADCC were first detected from 4 to 
7 days after intranasal infection (Hanton and others, 1986). They 
reached a plateau after 2 weeks and persisted for at least 9 weeks. 
The ADCC reaction was enhanced by complement (Rouse and others, 1977; 
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Hanton and others, 1986), although Grewal and Rouse (1980) also 
demonstrated antibody independent cytotoxicity (ie non -specific 
immunity) against BHV1 infected targets by neutrophils in the pre- 
sence of complement. 
Other aspects of CMI which have been described include leukocyte 
migration inhibition (Aguilar -Setién and others, 1979a) and delayed 
type hypersensitivity measured by skin test (Aguilar -Setién and 
others, 1978 and 1983). The latter has been of particular interest 
for its diagnostic potential. 
As well as systemic immunity, local responses in the respiratory 
tract have a significant effect on the pathogenesis of, and recovery 
from, IBR (Le Jan and Asso, 1981). The cellular component of the 
local response includes the alveolar macrophages and infiltrating 
neutrophils. Alveolar macrophages can support the replication 
(poorly) of BHV1 in vitro and in vivo (Forman and others, 1982a and 
b). Macrophages infected in culture showed reduced ability to mediate 
ADCC, reduced Fc receptors and phagocytosis, and an initial increase 
followed by a marked reduction in complement receptors (Forman and 
Babiuk, 1982). In vivo studies on calves given BHV1 by aerosol, and 
macrophages recovered by lavage, showed complex effects and in general 
suggested a stimulation of the macrophages (Ohmann and Babiuk, 1986). 
It was suggested that subsets of the macrophage population may respond 
in different ways. Bouffard and others (1982) showed a specific 
cellular response in broncho -alveolar washings from infected calves. 
Cells recovered at 18 days after infection, but not pre- infection or 
at 30 days after infection, inhibited the replication of BHV1 in 
tracheal organ cultures. McGuire and Babiuk (1984) demonstrated 
impaired neutrophil function in BHV1 infected calves and considered 
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this was a major factor in the pathogenesis of the BHV1 - Pasteurella 
haemolytica model of calf pneumonia. Neutrophil infiltration into 
the lung, in response to the bacterial infection, was delayed by 
prior exposure to the virus and allowed the bacteria to establish 
more readily. 
Humoral factors, both specific (antibody) and non- specific (inter- 
feron), play an important role in local immunity. In young calves, 
maternal antibody of colostral origin (IgG1 class) was found in the 
nasal secretions, and gave protection against virulent virus chal- 
lenge (Pospisil and others, 1983). The local active antibody res- 
ponse to BHV1 respiratory infections includes IgA and IgG components 
and shows virus neutralizing activity (Gerber and others, 1978; Le Jan 
and Asso, 1981; Rodak and others, 1983). Local immunity has been of 
particular interest in the development of intranasally administered 
live virus vaccines (Todd and others, 1971; Todd, 1975; Sayan and 
others, 1979; Zygraich, 1980). BHV1 is a potent interferon inducer 
(Todd and others, 1972; Fulton and Pearson, 1980; Ahl and Straub, 
1985) although BHV1 itself is less susceptible to the anti -viral 
effects of interferon than are some other respiratory viruses 
such as parainfluenza 3 and respiratory syncytial viruses (Fulton and 
others, 1984 and 1986). 
The humoral component of the systemic immune response has received 
considerable attention, not only for the facility with which the 
assays can be carried out but also for its importance as a diagnostic 
aid. More attention has perhaps been given to the methodology of 
antibody assays than to the functional significance of antibodies in 
immunity to BHV1. Earlier work on BHV1 serology was included in the 
review by Gibbs and Rweyemamu (1977). A virus neutralizing serum 
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antibody response is a consistent finding in animals recovering from 
acute primary infection, and may persist for years (Chow, 1972). The 
earliest antibodies, after primary infection, were detected at day 7 
or 8 and were mainly of the IgM class (Rodak and others, 1983; Guy 
and Potgieter, 1985a). IgM showed neutralizing activity only in the 
presence of complement (Rossi and Kiesel, 1974; Potgieter, 1975). 
IgM peaked at 14 days then decreased rapidly, being replaced by IgG1 
(which neutralized in the absence of complement) by a month after 
primary infection (Rossi and Kiesel, 1976; Guy and Potgieter, 1985a). 
Secondary exposure to BHV1 in immune cattle produced an anamnestic 
response which may or may not include an IgM component (Rossi and 
Kiesel, 1976) but was predominantly IgG2 (Guy and Potgieter, 1985a). 
The form of the secondary response may have depended on the nature of 
the antigenic exposure. Reactivation of latent BHV1 infections by 
the administration of dexamethasone initiated a secondary immune 
response, again with an IgM component but predominantly IgG1 and IgG2 
(Guy and Potgieter, 1985b; Viso and others, 1986). Bitsch (1973) 
showed that in cattle undergoing repeated cycles of reactivation and 
latency, the antibody titre tended to rise at each recrudescence but 
with smaller and smaller increments as the plateau antibody titre 
increased and the reactivation phases became less frequent. 
Collins and others (1985b) and Van Drunen Littel Van Den Hurk and 
Babiuk (1986b) investigated the reactivity of bovine immune sera 
with the individual viral polypeptides. It is difficult to compare 
the results of the two studies because of discrepancies in protein 
molecular weight estimations, but both seem to agree that a major 
component of the antibody response is directed against an antigen - 
ically related cluster of glycoproteins of 102, 96, 69 and 55 KD 
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(Collins and others, 1985b) or 130, 74 and 55 KD (Van Drunen Littel 
Van Den Hurk and Babiuk, 1986b). These studies were extended by Babiuk 
and others (1987) who immunised cattle with individual BHV1 glyco- 
proteins and showed neutralizing and ADCC antibody responses, as well 
as protection against the BHV1-P.haemolytica model of disease. 
DIAGNOSIS OF IBR 
The methods available for the diagnosis of IBR were described by 
Nettleton (1986). In its severe epidemic respiratory form, IBR is 
a distinctive clinical syndrome characterised by upper respiratory 
and ocular signs combined with pyrexia. Many practising veterinar- 
ians have relied solely on clinical examination to provide a diag- 
nosis. Other forms of BHV1 infection are less easily recognized, and 
even IBR can be confused with other respiratory and ocular diseases, 
particularly in less severe cases. Laboratory confirmation of BHV1 
infection is therefore frequently indicated and sought, with a demand 
for rapid tests which can enable early intervention to control an 
outbreak. 
Detection of the virus 
A wide range of bovine cell cultures is permissive for BHV1 growth. 
The virus produces a clearly recognizable cytopathic effect within a 
few days of inoculation, and confirmatory tests for the virus identity 
can then be carried out (Schipper and Chow, 1968). Primary bovine 
cell cultures are the most sensitive system for growth of BHV1 (Gibbs 
and Rweyemamu, 1977) and isolation in cell culture remains the most 
sensitive method for detection of the virus even though it involves a 
delay in reporting of possibly up to 14 days (Nettleton, 1986). 
The use of culture for diagnosis is facilitated by the good surviva- 
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bility of this virus. In neutral buffered liquids such as cell 
culture medium BHV1 survives with little or no loss in titre for 15- 
30 days at 4 °C, and with only a small drop in titre in 5 -6 days at 
room temperature (Griffin and others, 1958; Hahnefeld and others, 
1963; Drew and others, 1987). Delays in transport of samples to a 
laboratory are not therefore a barrier to attempted virus isolation. 
Virus can even be frozen and thawed up to five times with impunity 
(Stevens and Groman, 1963; Drew and others, 1987). 
Appropriate samples are a key to successful diagnosis (Nettleton, 
1986) and the material used for sampling must be carefully monitored. 
Calcium alginate wool swabs are favoured for bacteriological speci- 
mens, but are virucidal to BHV1 (Doherty and others, 1967; Hanson and 
Schipper, 1976). 
Terpstra (1979) showed that direct immunofluorescence could be used 
to detect BHV1 antigen in cellular material in smears of nasal mucus, 
or in cryostat sections of respiratory epithelial tissues, the tonsil 
being the tissue of choice. The selection of appropriate cases from 
an outbreak was critically important: they should be early febrile 
cases with a serous nasal discharge but before the development of a 
mucopurulent discharge. In experimentally infected cattle immuno- 
fluorescence on nasal smears gave a positive diagnosis from day 2 to 
day 7 after inoculation, compared with days 1 to 11 by virus isola- 
tion in cell culture. Subsequent reports (Silim and Elazhary, 1983; 
Nettleton and others, 1983) confirmed the value of immunofluorescence 
for BHV1 antigen detection as a diagnostic test on field material. 
Antigen detection by enzyme -linked immunosorbent assay (ELISA) has 
also been used as a diagnostic test for IBR, with either polyclonal 
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sera (Nettleton and others, 1982) or monoclonal antibodies (Collins 
and others, 1985a). In the latter case the sensitivity of the ELISA 
was equivalent to 103.5 TCID50 per sample well, or 1.5 ng purified 
BHV1. Nevertheless it could still detect infection only up to day 5 
or 6 after experimental infection, compared with up to day 11 for 
virus isolation in cell culture. None of the available antigen 
detection techniques is sufficiently sensitive for diagnostic appli- 
cation during the second week after infection, even though this is 
the period when many cases are most apparent clinically (Edwards and 
Gitao, 1987). 
A new approach to virus diagnosis is provided by recent developments 
in DNA technology. The hybridization of labelled DNA probes with 
viral nucleic acids in samples, either in situ in cell or tissue 
preparations or by blotting on nitrocellulose filters, provides a 
virus detection technique of potentially high specificity and sensi- 
tivity although not, as yet, rivalling the rapidity of antigen 
detection methods. Because hybridization requires neither replica- 
tion of the virus nor expression of antigens, it can also detect 
latent viruses as shown with BHV1 by Lawrence (1983). The general 
application of hybridization to virus diagnosis was reviewed by 
Pagano (1982) and Petterson and Hyypia (1985). When applied to 
herpesvirus diagnosis, 5pg viral DNA could be detected in clinical 
specimens (Schuster and others, 1986). Dorman and others (1985) 
compared a variety of biotinylated cloned BHV1 DNA fragments as 
diagnostic probes for sample DNA extracted and blotted onto nitro- 
cellulose. In samples from naturally infected cattle, the sensi- 
tivity compared with virus isolation was 68% and the specificity 
95 %. Dunn and others (1986) extended this work to in situ hybridiza- 
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tion to cell cultures, and nasal epithelial and buffy coat cells from 
BHV1 infected cattle, immobilized on glass slides. Pacciarini and 
others (1986) used radiolabelled probes to detect BHV1 DNA in non - 
extended semen samples with a sensitivity of 2.5 x 105 virus part - 
ticles, or 40pg viral DNA. 
Detection of host response 
With the limited exception of intradermal hypersensitivity tests 
(Aguilar- Setién and others, 1983) CMI assays have not found applica- 
tions in diagnosis. In contrast, a wide variety of serological assays 
for BHV1- specific antibody has been used diagnostically including 
serum -virus neutralization, passive haemagglutination, gel immuno- 
diffusion, complement fixation, and indirect immunofluorescence 
(reviewed by Gibbs and Rweyemamu, 1977). More recently, ELISA has 
been increasingly exploited as a rapid, sensitive and reliable 
technique (Payment and others, 1979; Herring and others, 1980; Sol - 
sona and others 1980; Bolton and others, 1981). 
The virus neutralization (VN) test has been very widely used and is 
the internationally recognized standard procedure (Carbrey and others, 
1971; Office International des Epizooties, 1986). Nevertheless a 
number of workers have commented on the limited sensitivity of the 
method in comparison with other assays such as passive haemagglutin- 
ation (Vengris and Maré, 1971; Kirby and others, 1974) or ELISA 
(Payment and others, 1979; Bolton and others, 1981; Cho and Bohac, 
1985; Collins and others, 1985c). Others have modified the condi- 
tions of the VN assay to increase its sensitivity: for example, by 
addition of complement (Rossi and Kiesel, 1974; Potgieter, 1975), 
reducing challenge virus dose (Bitsch, 1970; Huck and Woods, 1972; 
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Darcel, 1975) addition of a second dose of challenge virus (Lüpcke 
and Göbel, 1979), use of constant serum -varying virus (House and 
Baker, 1971), and prolongation of the neutralization reaction (Bitsch, 
1978). The last technique, using a serum -virus reaction time of 24 
hours at 37 °C was shown by Edwards and others (1986b) to be specific 
and sensitive and was recommended as a standard procedure, although 
the ELISA had a similar sensitivity and was recommended for routine 
diagnostic application, in view of its speed and simplicity. 
The technique of ELISA was first described by Engvall and Perlman 
(1971), and applied to viral serology by Voller and Bidwell (1975). 
Since then it has found widespread application in diagnostic viro- 
logy. There have been numerous reports of its use for the detection 
of BHV1- specific IgG. Although, in the developmental stages of the 
test, purified viral antigens were generally used to coat microtitre 
plates (Payment and others, 1979; Solsona and others, 1980; Bolton 
and others, 1981) others have found that semi -purified antigens 
(Herring and others, 1980; Cho and Bohac, 1985; Durham and Sillars, 
1986) or even crude cell culture lysates (Bommeli and others, 1980) 
were adequate for diagnostic work. Collins and others (1985c) and 
Liauw and Eugster (1986) found that, although purified antigens gave 
a slightly more sensitive test, the extra expense and effort involved 
could not be justified for routine diagnostic applications in view of 
the observation that crude, simply prepared antigens gave a test of 
adequate sensitivity and specificity which correlated well with the 
VN test. Riegel and others (1987) achieved high sensitivity and spec- 
ificity in ELISA by competing test sera with a neutralizing monoclonal 
antibody for binding to BHV1 antigen. The ELISA method has also been 
adapted to the detection of BHV1 antibodies in milk (Stuker and 
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others, 1980; Perrin and others, 1984) with the implied possibility 
of testing bulk milk samples as a screening test for infected herds. 
The best sensitivity for bulk milk tests reported so far was the 
detection of one seropositive cow among 50 seronegatives (Forschner 
and Banger, 1986; Forschner and others, 1986; Wizigmann, 1987). 
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Chapter 2 
MATERIALS AND METHODS 
INTRODUCTION 
Many of the specific materials and methods used are described in the 
following chapters alongside the experiments to which they relate. 
Those of more general application are presented here. 
BUFFERS AND MEDIA 
O.O1M phosphate buffered physiological saline (PBS) 
pH7.2 pH7.6 
Sodium dihydrogen phosphate (NaH2P042H2O) 0.36g 0.20g 
Disodium hydrogen phosphate (Na2HP042H2O) 1.37g 1.55g 
Sodium chloride (NaCl) 8.5g 8.5g 
Distilled water to 1L to 1L 
For immunofluorescence work, pH7.6 was used. For enzyme immunoassays 
and general applications pH7.2 was used. For some of the ELISA work 
equivalent molar concentrations of potassium phosphates were used in 
the interests of standardization with other workers in the laboratory. 
Antibiotic Supplement 
100 IU penicillin, 100pg streptomycin, 20 IU mycostatin per ml. 
Swab elution medium (PBSL) 
PBS pH7.2 85ml 
Lactalbumen hydrolysate 5% 10m1 
Antibiotic supplement 5m1 
Earle's balanced salt solution (10x concentrate) 
Sodium chloride 
Potassium chloride 
Magnesium sulphate (Mg SO4.7H20) 
Sodium dihydrogen phosphate (NaH2P042H2O) 
Calcium chloride (CaC122H2O) 
Glucose 
Yeast extract 










Cell culture medium 1 (EYL) 
Earle's balanced salt solution (10x concentrate) 100m1 
(with yeast extract) 
Lactalbumen hydrolysate 5% 100m1 
Sodium bicarbonate 7.5% 25ml 
Antibiotic supplement 5m1 
Sterile deionised water to 1L 
Cell culture medium 2 (MEM) 
Eagle's minimal essential medium (l0X concentrate, 100m1 
Flow laboratories) 
Glutamine 0.2M 10m1 
Sodium bicarbonate 7.5% 20m1 
Antibiotic supplement 5m1 
Sterile deionised water to 1L 
For cell growth, fetal calf serum was added to 10 %, and for cell 
maintenance to 2% v /v. 
0.05M carbonate coating buffer 
Sodium carbonate 0.2M 79ml 
Sodium bicarbonate 0.2M 171m1 
Distilled water to 1L 
pH adjusted to 9.6 
Buffered saline with 0.05% Tween (PBST) 
PBS pH7.2 
Polyoxyethylene glycol (20) sorbitan monolaurate 
(Tween 20) 






Tween 20 0.5ml 
Ethylene diamine tetracetic acid (EDTA) 0.1M 10m1 
Egg albumen (Sigma) 5g 
Distilled water to 1L 
pH adjusted to 7.2 
Phosphate- citrate buffer for ELISA substrate 
Citric acid 0.1M 243m1 
Na2HPO4 0.2M 257m1 
Distilled water 500m1 
pH adjusted to 5.0 
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ELISA substrate (OPD) 
o- phenylene diamine 0.2g 
Phosphate- citrate buffer pH5 500m1 
The solution was stored frozen at -20 °C in the dark in 25ml aliquots. 
Immediately before use these were thawed to room temperature and 10u1 
hydrogen peroxide 30% was added per 25ml. 
Immunoperoxidase substrate (DAB) 
Di -amino benzidine tetrahydrochloride 5mg 
PBS pH7.2 10m1 
Hydrogen peroxide 30% 5u1 
The solution was prepared freshly immediately before use. 
VIRUS CULTURE AND TITRATION 
Stocks of BHV1 strains were prepared in primary calf kidney cell mono - 
layer cultures. These are prepared on a weekly basis at the Central 
Veterinary Laboratory (CVL) and checked retrospectively (after pass- 
age) for the absence of contaminating BVDV. Known BHV1 positive 
material was inoculated onto a confluent monolayer at the rate of 
1 -2ml per 180sq.cm. culture flask. After incubating at 37 °C for 1 
hour the culture was washed with fresh medium then overlaid with EYL 
or MEM with 2% fetal calf serum, and incubated at 37 °C. When the 
cytopathic effect was advanced to the point of detachment of most 
or all of the cells (usually in 2 -3 days), the cells were lysed by a 
freeze -thaw cycle at -70 °C and the harvest clarified by centrifugat- 
ion at 1000g for 15 minutes. The harvest was stored in small aliquots 
at -70 °C. 
The identity of isolates and virus stocks was confirmed by immuno- 
fluorescence using BHV1- specific conjugate on cultures grown on fly- 
ing coverslips in Leighton tubes and fixed in acetone at the stage of 
early cytopathic effect. 
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Stocks of BHV1 isolates were titrated by preparing a 10 -fold dilution 
series in MEM with 10% fetal calf serum, and transferring each dilu- 
tion into 4 replicate wells in a flat bottomed tissue culture grade 
96 well microtitre plate, 50u1 per well. A suspension of Madin -Darby 
bovine kidney (MDBK) cells was prepared by trypsinization of a 
confluent monolayer, resuspending the cells to a concentration of 3 
x 105 per ml in MEM with 10% fetal calf serum. 50u1 per well of cell 
suspension was added to the microtitre plate which was sealed and 
incubated at 37 °C for 5 days. The cells formed a monolayer on the 
bottom of the wells, and growth of the virus could be assessed by 
microscopic observation of the cytopathic effect. The titres were 
calculated as 50% infectious doses (TCID50) by the Spearman- Kärber 
method. 
For titrations where large numbers of samples were to be processed, 
as with the swabs from the experimental calves, 10 -fold dilution 
series from the swab eluting medium were made directly in the micro - 
titre plates using a transfer volume of 10u1 into a volume of 90111 
MEM per well. For this purpose, 12- channel micropipettes (Flow 
Laboratories) were used, with a change to fresh sterile pipette tips 
for each dilution step. 
SERUM -VIRUS NEUTRALIZATION TESTS 
A constant virus varying serum method was used as described by 
Frerichs and others (1982). Doubling dilutions of sera were made, in 
quadruplicate 25111 aliquots, in 96 well flat bottomed microtitre 
plates using MEM with 10% fetal calf serum as the diluent. BHV1 
(Oxford strain) was added at the rate of 100 TCID50 in 25u1 per 
well. 
The mixture was incubated for 1 hour at 37 °C. MDBK cell suspension 
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was then added as described under virus titration. After 5 days 
incubation the growth of virus was assessed by microscopic observation 
of the cytopathic effect. The 50% neutralizing end point titres were 
calculated by the Spearman- Kärber method, and expressed as the serum 
dilution before addition of the virus. 
ELISA FOR SEROLOGY 
For the preparation of antigen, BHV1 (Oxford strain) was grown in 
cell cultures of primary calf kidney or of MDBK cell line to the 
point of advanced cytopathic effect. Remaining adherent cells were 
scraped off then the cells pelleted from the culture medium by cen- 
trifugation at 1000g for 10 minutes. The supernatant was discarded 
and the pellet resuspended in a small volume (1m1 per 180 sq. cm. 
flask or 2m1 per roller bottle) of 0.5% polyoxyethyleneglycol (9) 
p -t -ocytl phenol (Nonidet P40) in PBS. After 1 hour at 4 °C the 
suspension was clarified by centrifugation and the supernatant re- 
served in small aliquots at -70 °C as the antigen. Control antigen 
was prepared in parallel from non -infected cultures. The antigens 
were titrated in the ELISA system to determine the optimum coating 
dilution, which was approximately at the upper shoulder of the sigmoid 
dose -response curve obtained at a fixed level of positive test serum. 
This dilution was usually in the range 1/500 to 1/4000 depending on 
the batch of antigen. 
The antigens were diluted in carbonate buffer for addition to 96 
well, polyvinyl microtitre plates (Falcon 3912, Microtest III, Becton 
Dickinson & Co.) at 100u1 per well with alternate rows of virus and 
control antigen. After overnight adsorption at 4 °C the plates were 
washed three times in PBST, then stored at -20 °C. 
Test sera were diluted 1 /100 in ELISA diluent then 50u1 was added to 
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two viruses and two control antigen coated wells. The plates were 
incubated for 2 hours at room temperature in a humid chamber, then 
washed five times in PBST. For IgG detection, 50u1 per well of rabbit 
anti -bovine IgG peroxidase conjugate was added at optimal dilution 
(1/500) in ELISA diluent and the plates incubated for 1 hour at room 
temperature. They were washed a further five times in PBST before 
the addition of 100u1 per well OPD substrate. The reaction was 
stopped after 15 minutes by the addition of 25u1 per well 2.5M sul- 
phuric acid. The optical densities (OD) were measured on a Multiskan 
photometer (Flow Laboratories) at 492nm wavelength. The calculations 
were initially done by hand and latterly by on -line data capture to 
an Apple IIe microcomputer, for which an appropriate program was 
written in Applesoft Basic. For each sample, the mean OD of the two 
replicate wells with control antigen was subtracted from the mean of 
the two with viral antigen to give the test result. Where the replic- 
ates for either virus or control antigens differed by more than 20 %, 
the sample was retested. 
For immunoglobulin class or subclass specific tests a similar 
procedure was followed except that the conjugate stage was replaced 
with a two stage process involving rabbit anti -bovine heavy chain 
specific (IgM, IgGl, IgG2 or IgA) antisera (Miles Scientific) used at 
dilutions in ELISA diluent of 1 /100, 1/400, 1/200 and 1 /100 respect- 
ively for 1 hour. After five washes in PBST, protein A - peroxidase 
conjugate (Sigma) was added to the wells at 125 pg /ml for 30 minutes, 
washed five times in PBST then substrate added as above. 
Standard sera for use in the assays were prepared by the inoculation 
of calves with BHV1 intranasally and bleeding at 10 days (IgM control) 
and 6 weeks post inoculation (IgG control). 
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PREPARATION OF HYPERIMMUNE SERA 
Gnotobiotic antiserum to BHV1 was provided by Miss M Lucas. It had 
been prepared in a hysterotomy- derived calf maintained in a sterile 
environment under positive pressure ventilation. The calf was inocu- 
lated with semipurified (pelleted) BHV1 Oxford strain, initially 
intranasally, two weeks later intranasally and intramuscularly and, 
at 4 and 8 weeks after the initial dose, intramuscularly and intra- 
peritoneally. It was killed and bled out one week after the final 
boost, when it had a VN titre of 1/256. 
For general diagnostic work, including the preparation of bulk stocks 
of virus -specific fluorescent antibody conjugates, a colostrum - 
deprived calf was inoculated intranasally with BHV1, maintained in 
isolation for two months then boosted with virus by the intravenous 
route. Serum was collected 11 days later and had a VN titre of 1/256. 
For the preparation of rabbit antisera to bovine immunoglobulin, IgG 
was purified from bovine serum by the batch method using DEAE- cellu- 
lose (DE52, Whatman) (Reif, 1969). 2004g IgG was dissolved in 1 ml 
PBS and emulsified with 1 ml complete Freund's adjuvant (Difco). 
Rabbits were inoculated with 0.25 ml emulsion at each of four intra- 
muscular sites. The inoculation was repeated three weeks later and 
serum collected one to two weeks after that. 
PREPARATION OF FLUORESCENT ANTIBODY CONJUGATES 
The method was based on that of Nairn (1976). Immunoglobulins were 
precipitated from hyperimmune antisera of the desired specificity by 
the addition of crystals of sodium sulphate (1.4g per 10m1 serum), 
stirring for 2 hours, then centrifugation at 1000g for 20 minutes, all 
at room temperature. The precipitate was dissolved in PBS pH7.2 then 
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reprecipitated and dissolved two more times. The final solution was 
dialyzed against PBS overnight at 4 °C. The protein concentration was 
estimated from the absorbance at 280nm wavelength using the formula: 
Concentration (mg /ml) = Absorbance x 10 x dilution factor 
E 
where the extinction coefficient (E) was 13.7 for bovine IgG and 15.0 
for rabbit. The concentration was adjusted to 10mg /ml. Carbonate 
buffer 0.5M pH9.0 (3.7g NaHCO3, 0.6g anhydrous Na2CO3, 100m1 distilled 
water) was added in the proportion 1 volume to 2 volumes protein 
solution. Fluorescein isothiocyanate (FITC, isomer 1, Becton Dickin- 
son) was added, with stirring, at the rate of 1mg per 60mg protein. 
The mixture was stirred gently overnight then extensively dialyzed 
against physiological saline (0.14M) buffered to pH8.7 with 0.O1M 
Tris- hydrochloric acid. The conjugate was separated from unconjugated 
material, initially by gel filtration on a column of Sephadex G25 
(Whatman) using the same Tris buffered 0.14M saline, then by ion ex- 
change chromatography on a DEAE- cellulose column (DE -23, Whatman) 
eluting fractions with 0.14M and 0.28M Tris buffered saline. Conju- 
gates were stored in small aliquots at -20 °C. The working dilution 
(in the range 1/4 to 1/16) was determined by titration on known 
positive and negative materials. 
PREPARATION OF PEROXIDASE CONJUGATES 
IgG was purified from hyperimmune antisera of the desired specificity 
by the batch method (Reif, 1969). For each lml of serum 6g of DE52 
was equilibrated in 0.O1M phosphate buffer pH7.4, washed and dried 
under suction in a Buchner funnel. The serum was dialyzed against 
the same buffer, diluted in it 1/3 and mixed with the equilibrated 
DE52. The mixture was kept on ice for one hour with intermittent 
stirring. The liquid phase was extracted by suction and washed out 
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with more of the buffer. The IgG in the eluate was concentrated by 
precipitation with sodium sulphate (see above), redissolution and 
dialysis against 0.O1M sodium carbonate buffer pH9.5. The protein 
concentration was estimated from the absorbance at 280nm (see above) 
and adjusted to 8mg /ml. 
The conjugation method was based on that of Wilson and Nakane (1978). 
4mg horseradish peroxidase (Sigma type VI) was dissolved in lml 
distilled water, then 0.2ml freshly prepared 0.1M sodium meta- perio- 
date was added and stirred for 20 minutes at room temperature. The 
solution was dialysed overnight against 1mM sodium acetate buffer 
pH4.4 at 4 °C. The next day the pH was raised by the addition of 20111 
0.2M sodium carbonate buffer pH9.5, and lml of the protein solution 
was added. The mixture was stirred for 2 hours at room temperature 
then 0.1m1 freshly prepared sodium borohydride 4mg /m1 was added and 
left for 2 hours at 4 °C. This conjugate was used without further 
purification and was stored in 50% glycerol solution at -20 °C. 
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Chapter 3 
TRENDS IN NATURALLY OCCURRING DISEASE ASSOCIATED WITH BOVID 
HERPESVIRUS 1 IN GREAT BRITAIN. 
INTRODUCTION 
Epidemiological data on BHV1 infection and its associated diseases 
in Great Britain are incomplete. Early papers were presented as case 
reports of IBR (Dawson and others, 1962; Darbyshire and Shanks, 1963) 
and IPB /IPV (Huck and others, 1971; Collings and others, 1972). 
Serological surveys gave estimated seroprevalence for the virus as 
2.1% (Dawson and Darbyshire, 1964), 6.8% (sampled in 1974) (Kirby and 
others, 1978) and 12% (sampled in 1977) (D H Roberts, personal 
communication, summarized by Virology Dept., 1978). The three values 
should not be compared quantitatively as different methods of measur- 
ing the antibody were used (VN in tubes, indirect haemagglutination, 
and VN in microplates respectively). 
Beginning in the winter of 1977 -78, widespread reports (summarized by 
Epidemiology Unit, 1979) indicated a sudden rise in the incidence and 
clinical severity of IBR, typically associated with high herd morbi- 
dity and variable but significant mortality. This was supported by 
clinical and pathological studies from the University of Glasgow 
(Wiseman and others, 1978; Wiseman and others, 1980; Allan and others, 
1980). Subsequently, Msolla and others (1981) suggested that the 
BHV1 seroprevalence in Scotland had increased (to 12 %) over earlier 
reports; notably in herds which had introduced Holstein cattle. They 
did not state the year in which the samples were collected. A similar 
prevalence (11.4 %) was reported by Peters and Perry (1983) for bulls 
-53- 
at performance testing stations in the period 1979 -1981. Further 
developments, likely to influence the disease epidemiology, occurred 
in 1979 and 1981 with the announcement of product licences and comm- 
ercial availability of live attenuated intranasal BHV1 vaccines 
(Tracherine, Smith Kline Animal Health [Veterinary Record 105 : 340] 
and Nasalgen, Wellcome [Veterinary Record 109 : 170]). 
In an attempt to gain an overall view, particularly for the period 
1970 -1986, data from the records of MAFF veterinary laboratories and 
Scottish Agricultural Colleges have been further analysed and are 
presented in this chapter. 
MATERIALS AND METHODS 
Three sources of data were used. None represents an unbiased sample 
of the cattle population and two were derived from the same source 
material - namely clinical incidents presented to the Veterinary 
Investigation (VI) Service for disease investigation and diagnostic 
laboratory testing. The material had been selected initially by the 
farmer, in choosing to consult his veterinary surgeon, and subse- 
quently by the veterinary surgeon in choosing to avail himself of the 
Veterinary Investigation services. 
1. VIDA II 
The Veterinary Investigation Diagnosis Analysis - Mark II (VIDA II) 
(Hall and others, 1980) commenced in 1975 and comprised over 2.2 
million computerised records by the end of 1986. The data were 
supplied by Veterinary Investigation Centres in England, Scotland and 
Wales. The VIDA II annual report (MAFF and others, 1987) cautions 
about the inherent bias in the data and the need to relate trends for 
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individual diseases to the figures for total incidents recorded. 
BHV1- associated disease was not recorded as a specific diagnosis on 
VIDA II until 1980, when it appeared under "Group 1: Systemic diseases 
of cattle and those not readily classified organically" as "IBR /IPV ". 
Additional entries were made in "Group 9: Diseases of the reproduct- 
ive and mammary systems of cattle" as "Foetopathy (sic) due to IBR/ 
IPV" The data were analysed temporally (by month and year) and geo- 
graphically (by county or region). 
2. CVL, Virology Department diagnostic testing 
Materials for diagnostic testing were received at the CVL only via 
the Veterinary Investigation Service. All incidents investigated at 
the CVL were therefore also recorded on VIDA. Nevertheless, more 
detailed records were available at the CVL than were entered on VIDA 
and a separate analysis was carried out. Conversely, not all VIDA 
incidents were investigated at the CVL - during the study period, an 
increasing number of diagnostic tests for BHV1 were carried out in 
Veterinary Investigation Centres without further referral, whilst in 
Scotland the majority of tests were carried out at the Moredun 
Institute in Edinburgh. Nevertheless, sufficient testing was done at 
the CVL to warrant analysis of the data. 
Information on the number of tests done and number of positive 
diagnoses was available, through the Virology departmental annual 
reports, from 1969. In addition, from 1977 onwards detailed case 
records were kept of all incidents in which a diagnosis of active 
BHV1 infection was considered to be established, either by virus 
isolation /antigen detection or by seroconversion. These records 
included laboratory reference numbers, date, VI centre of origin, 
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basis of the laboratory diagnosis, and as much of the clinical and 
pathological history as was supplied on the sample submission document. 
The history varied from nothing at all to a fully detailed account of 
the incident. The data in this case records file was subsequently 
reduced to a codified form and entered into a database using Prime 
Information software on the CVL Prime minicomputer. The data 
format is shown in Table 3.1. Analysis was carried out on -line using 
the Inform query language, which forms part of the software system. 
3. CVL, Virology Department statutory and export testing 
Serum samples are submitted directly to the CVL by veterinary 
practitioners and by artificial insemination (AI) organisations for 
screening for BHV1 antibodies, the result being purely qualitative, 
ie positive or negative. The samples are from healthy animals, 
either prior to export or prior to entry to AI studs. The data are 
not recorded on VIDA and represent a section of the cattle population 
different from the previous analyses, ie predominantly pedigree 
breeding herds and, in the case of the AI samples, males only. 
Diagnostic test methods are continuously subject to review and 
modification, which may lead to changes in apparent prevalence and 
incidence rate over a period of years, with the inherent risk of 
false assumptions about the disease epidemiology. In particular, two 
major changes in serological procedures for BHV1 diagnosis were made 
at the CVL during the period under review, in each case involving an 
increase in test sensitivity and therefore the possibility that more 
seropositive animals were detected. Until April 1976 the virus 
neutralization test was carried out in test tube cell cultures using 
0.1 ml per tube of serial serum dilutions mixed with an equal volume 
-56- 
of medium containing 100 TCID50 BHV1 as described by Dawson and others 
(1962). From April 1976 until August 1985 the VN test was done in 
the microtitre plate system using 0.025 ml of serum dilution and 100 
TCID50 virus per test well following the procedure described by 
Frerichs and others (1982). The method is still in use for most 
export tests. Some export tests and all AI and routine diagnostic 
tests have been done by ELISA since August 1985, using the method 
described in Chapter 2. 
4. Statistical analysis 
Frequency distributions of the incidence and prevalence of BHV1 
infections were analysed by the chi -squared technique for one or two 
dimensional tables as appropriate. Secular trends were expressed 
graphically by the use of rolling averages (Thrusfield, 1986b). 
RESULTS 
1. General 
4724 incidents of IBR /IPV were recorded on VIDA II for the period 
1980 -86, the majority (4372) under the heading of systemic diseases 
and the remainder (352) as fetopathies. At the CVL, serological 
investigations for BHV1 were carried out on paired sera from 2656 
incidents of respiratory disease in the period 1971 -1986. Rising 
antibody titres to BHV1 were shown in 426 (16 %) of the incidents. 
Similar figures for reproductive disease for 1970 -1986 were 2086 
incidents investigated, of which 158 (7.6 %) had rising titres to BHV1. 
Submissions of tissues and swabs for virus isolation could not be 
separated by disease category but BHV1 was isolated from 513 of the 
total 19,189 disease incidents investigated in the period 1969 -1986. 
An unquantifiable proportion of these incidents was also investigated 
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by serology and therefore included in both totals. Separate success- 
ive submissions of samples to the CVL from the same disease incident 
in any one herd could not be identified from the available data. 
Such submissions were therefore recorded as separate incidents for 
the CVL analysis although recorded only once in the VIDA II analysis. 
Evidence from the CVL case records analysis, for which this informat- 
ion was available, suggested that this accounted for only a small 
proportion of over -reporting. The case record analysis included 888 
BHVlassociated clinical incidents, in the decade 1977 -86. 
Testing of bulls for BHV1 antibody before entry to AI centres commenced 
in 1970. 26,585 animals were tested up to the end of 1986, of which 
2716 (10.2 %) were positive. For the period 1969 -1986, 61,257 cattle 
were tested for BHV1 antibody for export certification purposes; of 
these 5447 (8.9 %) were positive. 
2. Temporal analysis 
The distribution of IBR /IPV incidents recorded on VIDA II is shown in 
table 3.2. There was a highly significant variation (P <0.001) between 
monthly totals and between yearly totals for both systemic disease 
and fetopathy. The overall distribution for systemic disease also 
showed a significant variation (P <0.001) when analysed as a 12 x 6 
contingency table. The chi -squared test was not valid for the latter 
analysis on fetopathy incidents due to the low frequencies in many 
cells. The seasonal and annual trends are shown graphically in fig 
3.1, which also shows that a similar seasonal trend was observed in 
the CVL case records analysis. 
A longer annual analysis, embracing the important period in the 1970s 












































































































































































































































Virology Dept archives. The results of diagnostic tests for respirat- 
ory and reproductive diseases are shown in table 3.3 and fig 3.2. A 
three -year rolling mean was used to calculate the percentage diagnosis 
rate for fig 3.2, in order to smooth year to year fluctuations and 
demonstrate longer term trends. The calculations for chi -squared in 
table 3.3 were based on the null hypotheses that the diagnostic rates 
(as a proportion of total submissions in each category) were the same 
for all years. It was concluded that the proportion of respiratory 
disease serological investigations in which a diagnosis of BHV1 
infection was made, increased significantly during the period 1975- 
1978 and has remained high since. The absolute number of IBR diag- 
noses in the same period showed an even more marked increase. No 
parallel increase in BHV1 diagnoses from reproductive disease serology 
(mostly abortion cases) was seen and the differences between years 
were not significant. This could suggest that paired maternal ser- 
ology was not the best method of diagnosis for BHV1- induced abortion, 
or it may signify a genuine epidemiological observation that abortion 
is not, in Britain, a common sequel to the respiratory disease, IBR. 
The majority of isolations of BHV1 were from nasal or ocular swabs or 
tissues of the respiratory tract. Very few were from aborted fetal 
tissue, or from IPV /IPB type genital disease. Both the actual number 
of isolations and the proportional diagnosis rate increased markedly 
in the period 1976 -79. The variation between years was highly signif- 
icant. Latterly, the number of isolations began to fall again. The 
percentage diagnosis rate for BHV1 by isolation fell considerably 
after 1982. This reflects, in part at least, the difficulty in 
separating the figures for submissions from different types of disease, 
together with a marked increase in submissions at this time for 
bovine virus diarrhoea /mucosal disease investigations. 
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The data are the percentage of submissions of paired sera in which 
rising titres to BHV1 were found, expressed as 3 -year rolling means. 
Fig. 3.2 Proportional BHV1 diagnosis rate for bovine respiratory 
and reproductive diseases tested by paired serology at 
the CVL 
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Serum samples tested at the CVL are not randomly selected nor are 
they representative of any particular segment of the cattle popul- 
ation. Nevertheless they were used to give some idea of the preval- 
ence of BHV1 seropositive animals. The most complete set of data is 
for healthy pedigree animals tested for AI or export purposes (Table 
3.4). It was considered that the two groups were sufficiently similar 
in origin to produce combined values for the prevalence. The chi - 
squared test for the null hypothesis that the prevalence had not 
changed was highly significant. The long term trends indicated by 
the 3 year rolling mean (Fig. 3.3) showed an increase from 4.7% 
(1970 -72) to 11.4% (1984 -86). 
Further estimates of the seroprevalence were obtained from samples 
submitted for diagnostic purposes - ie mainly diseased animals, from 
all types of cattle herd - for the periods 1969 -73 and 1984 -86 (Table 
3.5). This information was not recorded for the intermediate period. 
In calculating the prevalence, allowance was made for duplicate 
testing of the same animals, when paired sera were submitted, by 
giving half weighting to such submissions. No information was 
available on the age structure of the sample population. For the 
estimate of the prevalence of positive herds, each submission of a 
batch of sera was considered as a sample of a new herd. This was not 
strictly true, but as no records were kept of herd identities it was 
the closest approximation possible. The prevalence of seropositive 
animals and of herds containing seropositive animals showed signific- 
ant variation between years (P <0.001). The most marked feature was a 
rise in mean animal prevalence from 9.1% in the period 1969 -73 to 
34.7% for 1984 -86; and a corresponding increase in prevalence of sero- 
positive herds from 17.6% (1970 -73) to 48.0% (1984 -86). 
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Fig. 3.3 Percentage seroprevalence of BHV1 antibodies in healthy 
pedigree cattle tested at the CVL (3 -year rolling means) 
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3. Geographical analysis 
The frequency distribution of IBR /IPV incidents by county, from 
the VIDA II records, is shown in appendix 3 (i) and (ii) together 
with census statistics for England (MAFF, 1983), Wales (Welsh Office, 
1984) and Scotland (DAFS, 1985). 
There may be some discrepancies in the Scottish data as VIDA returns 
were made for the traditional counties whereas the census statistics 
were given for the modern regions or for broader geographical zones. 
There were no consistent geographical patterns for IBR /IPV incidence 
(Fig 3.4). As shown in table 3.6, there was no significant correlation 
between the incidence rate per 100,000 cattle and either the cattle 
density per hectare for the county or the average number of cattle 
per farm for the county. The only significant correlation found was 
between the actual number of cases of IBR /IPV per county and the 
total number of cattle per county. Nevertheless, chi -squared indicat- 
ed a significant variation in incidence per 100,000 cattle between 
counties. It was concluded that in the absence of a more detailed 
breakdown of the figures according to size and type of farm, the 
reasons for this variation could not be deduced. It could not be 
linked simply to geographic location. 
A second geographical analysis of the VIDA II data, by VI centre, is 
shown in appendix 3 (iii). Although less informative than the 
county data, it provides a comparison with the case records file 
(also summarised in appendix 3 (iii)) for which this was the only 
geographical information available. The case records data covered 
mainly England and Wales. The calculation of chi -squared for England 
and Wales, 1980 -86, showed that the distribution of incidents in the 
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Incidents (1980 -86) 






Fig. 3.4 IBR (systemic) incidents recorded on 
VIDA II, 1980 -86 as proportions of 
county cattle populations 
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case records file differed significantly from the expected distri- 
bution based on the VIDA II returns (x2 = 1020.9, df = 24, 
P <0.001). This was a reflection of the differing policies of 
individual centres for referring diagnostic materials to the CVL. As 
this indicated a non -uniform geographical sampling frame for the case 
records data they were not further analysed by location but were 
treated as a single set indicative, though not truly representative, 
of national trends. 
4. Case Records 
The age structure of the case records file is shown in tables 3.7 and 
3.8. No information on age was provided for 337 (38 %) of the 
incidents. For both tables chi -squared indicated a significant 
variation from the expected distribution. Notable trends in the 
yearly analysis were an increase in the number of calf incidents in 
later years and a dip in the number of adult incidents in the early 
1980s with a subsequent rise at the end of the study period. In the 
monthly analysis, the adult group (which included all cases where 
abortion was recorded as one of the clinical signs) had a higher than 
expected frequency in the late summer (July- September) whilst yearl- 
ings had a lower than expected frequency at the same time and were 
higher than expected in November -December. 
Tables 3.9 and 3.10 show the case records distribution according to 
clinical signs. Apart from code X (no history given) the clinical 
codes are not mutually exclusive and the yearly and monthly totals do 
not represent the sums of each column. Chi -squared was calculated 
for codes with a total of more than 20 observations. In the yearly 
analysis (Table 3.9) abortion (code A) ocular disease (E) pneumonia 
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(L) tracheitis (T) mortality (Z) and no history (X) differed signifi- 
cantly from the expected distribution. The proportion of cases 
involving abortion rose in later years. The proportion of pneumonia 
cases was high in the last two years of the study whereas tracheitis 
and mortality were both relatively more frequent in 1978 -79. 
Only abortion (code A) differed significantly from the expected 
seasonal distribution (Table 3.10). It was lower than expected in 
the winter period (December -April) and higher from July to September. 
This corresponded with the observed trend for the adult age group 
(Table 3.8). 
Of the 888 cases analysed, laboratory tests used to confirm the 
diagnosis of BHV1 infection were: serology 460 incidents (417 by 
serology alone); virus isolation 460 incidents (409 by virus isolation 
alone); antigen detection 22 incidents (8 by antigen detection alone). 
Antigen detection by the fluorescent antibody technique was widely 
used by the VI service to diagnose IBR by testing nasal mucus smears 
(see Chapter 6) but suitable samples were only occasionally available 
at the CVL, hence the low figure in this category. The distribution 
of samples in which BHV1 or its antigen were detected is shown in 
table 3.11. This indicates the predominance of the respiratory form 
of BHV1 infection. 
SUMMARY AND MAIN CONCLUSIONS 
Analysis of BHV1 diagnostic test results from the Virology Dept, CVL 
(1969 -86), case histories from investigations done at the CVL on 
behalf of the VI service (1977 -86), and VI service diagnostic data 
(VIDA II, 1980 -86), using chi -squared to test for significance, have 
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shown the following trends: 
1. BHV1- associated disease had a seasonal incidence. Systemic 
disease (mainly IBR) predominated from October to April, and fetopathy 
from July to September. 
2. Anecdotal reports of a marked rise in IBR incidence in the late 
1970s are supported by the data, which showed the peak incidence in 
1983. Fetopathy diagnoses were still rising at the end of the study 
period. 
3. The seroprevalence of BHV1 antibody in cattle also rose, particu- 
larly in the period 1977 -81, and the number of BHV1 isolates at the 
CVL increased at the same time. The latest estimates (1986) for 
seroprevalence were 31% for diseased cattle (sera submitted for 
diagnosis) and 13% for healthy pedigree cattle (export and AI testing). 
Estimates from the early 1970s gave values of <10% in both cases. 
4. The proportion of herds tested in which one or more BHV1 sero- 
positive animals were found also increased from 16% in 1970 to 44% in 
1986. 
5. The incidence of BHV1- associated disease per 100,000 cattle varied 
significantly between counties but could not be related either to the 
county average cattle density per hectare of agricultural land or to 
the county average number of cattle per farm. The disease was record- 
ed in all parts of mainland Britain. 
6. Case history analysis indicated a changing pattern of BHV1- 
associated disease in the study period. In the first septennium of 
the 1980s the incidence in calves (<6 months) and adults ( >2 years) 
-68- 
increased, as did the incidence of pneumonic disease and abortion. 
In contrast, the incidence of the more severe manifestations of upper 
respiratory disease, exemplified by tracheitis and mortality, 
decreased during this time. 
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TABLE 3.1 IBR /IPV case records computer database format 
Field name Data content 
@ID Case number 
YEAR Year 
MONTH Month when case first 
reported. 
VIC VI Centre submitting 
samples 
DIAG Laboratory tests used to 
confirm diagnosis 
AGE Age group of animals 
affected 1 letter code 
CLINIC Coded clinical signs Up to 8 single letter codes 
DNA Restriction endonuclease 
type of virus (if known) 1 digit 
Data format 




2 digit numeric code 
2 letter code (up to 3 
entries per case) 
Diagnosis codes 
First letter 
S = serology 
Second letter 
(R = rising titre 
(H = high titre (only if considered 
( diagnostically significant) 
(M = IgM 
V = virus isolation (N = nasal swab E = eye swab 
A = antigen detection (V = vaginal swab P = preputial swab 
(L = lower respiratory T = trachea, larynx, 
( tract pharynx 
(F = fetus or placenta G = alimentary tract 
(B = cns H = blood 
(0 = others 
Age codes 
C = calf ( <6 months) Y = "yearling" (6 months -2 years) 
A = adult ( >2 years) N = not recorded 
Clinical codes 
A = abortion, B = nervous signs, C = cough, D = diarrhoea /dysentery, 
E = eye discharge /conjunctivitis, F = fever, G = gastro= intestinal 
lesions, H = haemorrhagic lesions, I = infertility, L = lung lesions/ 
clinical pneumonia, M = reduced milk yield N = nasal discharge, 
rhinitis, and unspecified respiratory signs, P = retained placenta, 
Q = skin and teat lesions, R = reduced appetite, S = salivation, 
T = tracheitis, laryngitis, pharyngitis, V = vaginal lesions or discharge, 
X = no history supplied (but if nasal swab submitted, record as N), 
Z = deaths. 
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TABLE 3.2 IBR /IPV incidents recorded on VIDA II 
Month 1980 1981 1982 1983 1984 1985 1986 TOTAL 
Systemic disease 
Jan 73 74 91 86 85 109 51 569 
Feb 74 91 94 74 82 74 55 544 
Mar 50 68 71 110 57 68 63 487 
Apr 64 52 72 70 61 49 50 418 
May 32 33 33 28 30 42 40 238 
Jun 29 31 29 23 21 24 14 171 
Jul 20 31 18 29 18 26 14 156 
Aug 16 24 17 25 21 27 18 148 
Sep 17 25 39 32 26 24 19 182 
Oct 30 38 54 66 53 70 38 349 
Nov 45 62 79 129 102 78 61 556 
Dec 67 73 108 108 75 63 60 554 
TOTAL 517 602 705 780 631 654 483 4372 
Fetopathy 
Jan 0 2 4 1 4 6 26 
Feb 5 1 8 4 8 4 8 38 
Mar 0 2 1 4 5 8 3 23 
Apr 2 1 6 4 2 6 3 24 
May 0 1 1 2 2 7 3 16 
Jun 0 0 0 3 2 7 10 22 
Jul 2 2 3 7 12 15 141 55 
Aug 1 0 1 4 9 18 12 45 
Sep 1 3 1 9 7 7 11 
39 
Oct 1 0 1 6 8 5 5 26 
Nov 1 1 2 2 6 4 6 22 
Dec 1 0 2 6 2 1 4 
16 
TOTAL 14 13 30 52 72 86 
85 352 
TOTAL CATTLE 





TABLE 3.2 (Contd) 
Statistical analysis 
X2 d.f. P 
Systemic disease: Months (a) 938.22 11 <0.001 
Years (b) 91.59 6 <0.001 
Months x Years 134.64 66 <0.001 
Fetopathy: Months (a) 55.45 11 <0.001 
Years (b) 118.38 6 <0.001 
Months x Years 91.69 66 (<0.05)(c) 
Notes (a) Null hypothesis: all months had the same frequency. 
(b) Null hypothesis: IBR incidents were a constant 
proportion of total cattle incidents of VIDA II. 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































for AI No. positive 
Animals tested 




1969 - - 766 3 0.4 
1970 427 20 503 3 2.5 
1971 1091 80 510 16 6.0 
1972 1033 66 517 5 4.6 
1973 1565 122 862 11 5.5 
1974 1379 107 656 19 6.2 
1975 1134 108 830 42 7.6 
1976 1519 101 2288 91 5.0 
1977 1470 156 1472 124 9.5 
1978 1822 153 7254 435 6.5 
1979 1729 287 12746 1235 10.5 
1980 3412 162 8892 787 7.7 
1981 1347 223 4754 472 11.4 
1982 1435 224 3646 482 13.9 
1983 1432 185 1415 142 11.5 
1984 3258 226 2886 168 6.4 
1985 1629 263 6870 899 13.7 
1986 1330 253 4390 513 13.4 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 3.6 Statistical analysis of IBR /IPV incidence for 1980 -85 by 
county (from VIDA II) 
SUMMARY OF DATA (No. of incidents) 
Year 1980 1981 1982 1983 1984 1985 1986 TOTAL 
IBR /IPV (systemic) England 409 487 563 617 438 500 354 3368 
Wales 25 26 26 41 50 56 26 250 
Scotland 82 100 108 118 138 97 100 743 
IBR /IPV (fetopathy) England 9 8 19 41 48 71 64 260 
Wales 0 0 1 3 9 5 9 27 
Scotland 5 5 10 9 15 9 15 68 
CHI SQUARED TEST ON COUNTY VALUES (six year totals) (from Appendix 
3(i) and (ii)): 
Mean No. 
of incidents x2 d.f. P 
Incidence per 100,000 cattle: 
systemic disease 42.5 1466 65 <0.001 
fetopathy 2.7 288 65 <0.001 
Incidence per 100,000 hectares: 
systemic disease 32.1 3782 65 <0.001 
fetopathy 2.2 507 65 <0.001 
CORRELATIONS FOR COUNTY DATA: 
r n P 
Systemic disease /100,000 cattle vs. cattle /hectare -0.15 66 >0.05 
vs. cattle /holding -0.13 58 >0.05 
Fetopathy /100,000 cattle vs. cattle /hectare -0.01 66 >0.05 
" " " vs. cattle /holding -0.02 58 >0.05 
Systemic disease incidents vs. No cattle in county 0.73 66 <0.01 
Fetopathy incidents vs. No cattle in county 0.65 66 <0.01 
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TABLE 3.7 Analysis of case records file by age and year 
Year 1977 78 79 80 81 82 83 84 85 86 TOTAL 
Age group 
Adults 9 31 31 26 22 15 30 25 43 40 272 
Yearlings 4 13 21 21 18 21 15 14 13 7 147 
Calves 2 7 9 10 9 14 16 18 25 22 132 
Unknown 2 30 51 50 62 61 35 28 13 5 337 
Total 17 81 112 107 111 111 96 85 94 74 888 
Chi -squared (27 d.f.) = 138.45 (P<0.001) 
Chi -squared (18 d.f.) = 40.03 (P<0.01) 
(omitting unknown age group) 
TABLE 3.8 Analysis of case records file by age and month 
Month 1 2 3 4 5 6 7 8 9 10 11 12 TOTAL 
Age group 
Adult 37 44 41 25 14 7 14 22 9 13 21 25 272 
Yearling 24 13 15 22 11 4 2 3 1 5 25 22 147 
Calves 16 19 16 30 7 7 7 4 2 2 10 12 132 
Unknown 67 42 33 52 24 11 7 5 3 21 40 32 337 
TOTAL 144 118 105 129 56 29 30 34 15 41 96 91 888 
Chi -squared (33 d.f.) = 79.40 (P<0.001) 
Chi -squared (22 d.f.) = 54.28 (P <0.001) 
(omitting unknown age group). 
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TABLE 3.9 Analysis of case records file by clinical sign and year 
Number of incidents: 




A 2 6 10 11 6 5 12 11 21 23 107 45.52 <0.001 
B - - - - 2 - - - 2 - 4 
C 1 6 15 10 16 11 10 6 4 1 80 14.26 NS 
D 2 2 8 3 2 6 4 4 1 2 34 10.93 NS 
E 5 22 42 51 49 51 35 26 27 11 319 22.48 <0.01 
F 2 23 37 36 39 38 29 28 18 10 260 15.26 NS 
G - 4 4 3 2 1 - 3 1 3 21 8.93 NS 
H - 2 2 - 1 5 
I - - - 2 1 3 
L 1 12 21 11 12 16 10 12 28 27 150 36.10 <0.001 
M 3 11 12 6 8 4 11 5 5 7 72 12.48 NS 
N 14 50 61 66 62 60 45 41 45 22 466 14.86 NS 
P - - - - 1 - - - 1 - 2 
Q - 3 1 - - 4 
R 2 7 11 13 14 7 5 7 6 3 75 8.46 NS 
S - 8 7 8 5 4 2 5 3 1 43 11.52 NS 
T 1 8 14 5 7 3 3 1 7 4 53 17.33 <0.05 
V 1 - 2 - - - 1 1 1 - 6 
X - 5 14 6 8 13 16 8 3 5 78 17.03 <0.05 
Z 1 13 16 9 6 5 4 8 5 9 76 17.28 <0.05 
Total cases 17 81 112 107 111 111 96 85 94 74 888 
NS = not significant (P>0.05) 
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TABLE 3.10 Analysis of case records by clinical sign and month 
Number of incidents: 





A 13 9 6 4 6 4 12 20 8 5 9 11 107 118.2 <0.001 
B 1 2 - - 1 - - - - - - - 4 
C 13 15 15 6 4 2 - 2 1 3 12 7 80 12.89 NS 
D 3 8 5 3 2---- 1 7 5 34 12.85 NS 
E 60 50 39 44 23 10 9 6 1 15 36 26 319 11.75 NS 
F 44 48 38 30 12 8 9 4 3 7 31 26 260 16.24 NS 
G 1 2 3 6 4 - 1 - - 1 3 - 21 14.64 NS 
H 1 - - - 3 - - - - 1 - - 5 
I 
L 25 16 16 26 13 4 6 7 - 8 14 15 150 6.73 NS 
M 10 18 11 11 3 3 2 2 1 1 7 3 72 13.75 NS 
N 72 62 63 75 28 15 8 9 7 21 58 48 466 11.61 NS 
P 
Q - 1 - 1 - 1 - - - - - 1 4 
R 8 14 11 13 5 3 2 1 1 2 5 10 75 8.01 NS 
S 6 9 7 4 4 2 1 -- 2 2 6 43 9.02 NS 
T 7 8 5 7 4 - - 1 1 5 7 8 53 9.09 NS 
V 2 - 1 --- 1-- 1 - 1 6 
X 17 11 7 10 5 3 1 1 - 5 7 11 78 7.88 NS 
Z 9 7 9 13 11 1 1 5 1 6 9 4 76 17.33 NS 
Total 
cases 144 118 105 129 56 29 30 34 15 41 96 91 888 
NS = not significant (P>0.05) 
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TABLE 3.11 Summary of sample types used for BHV1 isolation and 
antigen detection (CVL case records file). 
No. incidents: 
Sample Virus isolated Antigen detected 
Nasal swab 285 10 
Eye swab 128 3 
Lung 59 6 
Trachea 42 2 
Alimentary tract 18 
Fetus 12 2 
Vagina 2 




Total 460 22 
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Chapter 4 
COMPARISON OF FIELD ISOLATES OF BOVID HERPESVIRUS 1 
BY DNA FINGERPRINTING 
INTRODUCTION 
Six field isolates of BHV1, as used for experimental pathogenicity 
studies (Chapter 5), were examined by the restriction endonuclease 
fingerprinting technique. The three endonucleases most useful for 
distinguishing viral genotypes were selected and used to characterize 
a further 71 British isolates, together with the two live vaccine 
strains available in Britain and a miscellany of isolates from other 
countries. 
MATERIALS AND METHODS 
Kirby phenol 
Phenol (A.R. grade - BDH) 500g was melted at 60 °C in a water bath, 
200m1 distilled water and 0.5g 8- hydroxyquinoline added quickly, then 
(with care) 70g m- cresol. 
Restriction digest buffers 
The restriction endonucleases were obtained from Bethesda 
Research 
Laboratories and the digestion conditions and buffers recommended 
by 
the manufacturers were complied with. In each case 
100ug /ml nuclease - 
free bovine serum albumen was added to the buffer 
prior to incuba- 
tion. 
EcoRI 
Tris 50mM, magnesium chloride 10mM, sodium 
chloride 50mM, dithio- 
-81- 
threitol 1mM, pH adjusted to 7.5. Digestion 4 hours at 37 °C. 
Hind III 
Core buffer as supplied with the enzyme, pH adjusted to 7.4. Diges- 
tion 4 hours at 37 °C. 
Hpa I 
Tris 20mM, magnesium chloride 10mM, potassium chloride 20mM, 
dithiothreitol 1mM, pH adjusted to 7.4 Digestion 1 hour at 37 °C. 
Bam HI 
Tris 20mM, magnesium chloride 7mM, sodium chloride 100mM, 2- mercap- 
toethanol 2mM, pH adjusted to 8.0. Digestion 4 hours at 37 °C. 
Pst I 
Core buffer as supplied with the enzyme, pH8.0. Digestion 4 hours at 
37 °C. 
Bst EII 
Core buffer as supplied with the enzyme, pH8.0. Digestion 1 hour at 
60 °C. 
Stop -sink solution 
EDTA 10mM 
Bromophenol blue 0.01% 




Sodium di- hydrogen phosphate 28mM 
EDTA 
pH to 7.8 
Virus preparation 
1mM 
Virus stocks were prepared in primary calf kidney cells as described 
in Chapter 2. The culture harvest was brought to concentrations of 
0.5M sodium chloride, 20mM tris- hydrochloride pH7.4, and 9% w/v 
polyethylene glycol (molecular weight 6000 -8000). After thorough 
mixing the suspension was held overnight at 4 °C then centrifuged for 
1 hour at 8000g. The precipitate was resuspended, to approximately 
one tenth of the original volume, in 20mM tris- hydrochloride buffer 
pH7.4 then left to stand for 3 to 4 hours to ensure complete dispers- 
ion of the pellet. 
DNA extraction 
An equal volume (typically 10m1) of kirby phenol was added to the 
concentrated virus suspension, followed by gentle roller mixing for 
15 minutes. The emulsion was centrifuged at 1000g for 15 minutes, 
the aqueous layer decanted off and extracted with a further treat- 
ment of kirby phenol. After a second centrifugation the aqueous 
layer was shaken with 10m1 chloroform: n- octanol (9:1) and left to 
settle. The aqueous layer was retreated with chloroform: n- octanol, 
then twice with chloroform alone. The aqueous fraction (purified 
DNA) was dialysed overnight against 10mM tris- hydrochloride 
pH8.0, 
1mM EDTA. The DNA concentration was calculated from 
the absorbance 
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at 260nm (50ug /ml corresponded to absorbance of 1.00) and the solu- 
tion concentrated to 500ug /ml, made 0.02M with sodium chloride, and 
stored at 4 °C. 
Restriction digests 
Equal volumes of 30u1 digestion buffer with albumen and DNA solu- 
tion were mixed. The enzyme (5ul) was added and incubated with gentle 
mixing under the appropriate time and temperature conditions. Diges- 
tion was stopped by the addition of 15u1 stop -sink solution. 
Electrophoresis 
Agarose (Seakem low electroendosmosis - Miles Laboratories) was pre- 
pared in 0.5% gels in electrophoresis buffer in a Bethesda Research 
Laboratories submerged horizontal slab gel tank (Fig 4.1) with a gel 
depth of 6mm. Aliquots of digestion mixtures (40u1) were pipetted 
into the wells, together with appropriate molecular weight markers 
(restriction digests of lambda phage: DNA molecular weight markers I 
or II, Boehringer- Mannheim). The gel was just covered with buffer 
and electrophoresis carried out for 16 hours at 30 volts and 125 
milliamps. The DNA was stained by the addition of 2mg ethidium 
bromide to the buffer. After 1 hour the gel was photographed under 
ultra -violet light in a darkroom, using a Polaroid camera. The 
relative migration distances were measured on the photographic 
prints using a precision digital caliper (Jocal, C.E. Johansson Ltd). 
The sizes of the digestion fragments were estimated (in kilobase 
pairs - kbp) with reference to the standard markers by using the 
computer program "Fragsize" described (and supplied) by Campione 

























































































































































which relate molecular size to the reciprocal of the mobility and 
incorporate a correction for non -linearity. 
Selection of viral isolates 
Five field isolates (Table 4.1) used for experimental animal studies 
were originally chosen at random, as described in Chapter 5, and com- 
pared with the Oxford strain of BHV1. These six strains were diges- 
ted with the restriction enzymes Eco RI, Hind III, Hpa I, Bam HI, 
Pst I and Bst EII. This study indicated that EcoRI, Hind III and Hpa 
I gave a useful distinction between the main BHV1 genotypes. These 
enzymes were used to examine further British isolates, namely all 
available isolates from the 1960s and 1970s, although these were few, 
and all isolates from the earliest year when an extensive collection 
was available (1980) together with a more recent year (1984). Restric- 
tion digests were also carried out on miscellaneous British isolates 
from other years in the 1980s, and the currently available live 
vaccine strains. Comparisons were made with strains from the USA, 
Northern Ireland and Italy. The DNA type of the British isolates was 
related to the computer coded clinical signs as described in Chapter 
3. 
RESULTS 
Photographs of the DNA digestion fragments of strains ED1 -ED6 
are 
shown in figs 4.2 and 4.3. The calculated fragment sizes 
based on 
means of several gels are given in appendices 4 (i 
-vi) and shown 
graphically in figs 4.4 - 4.9. Although there were some 
discrepancies 
in absolute molecular weights between the results 
and those of 
Mayfield and others (1983) it was concluded that 
strains ED1, ED3, 
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Fig. 4.2 Ethidium bromide stained gel photgraphed under 
ultra violet light, showing restriction digest 
fragments of BHV1 strains ED1 -ED6 with Hpa I, 
Hind III and Eco RI 
Lanes 1 and 20: 
Lanes 2 -7: 
Lanes 8 -13: 
Lanes 14 -19: 
molecular weight marker I (Boehringer Mannheim) 
Hpa I digests of strains ED6 -ED1 respectively 
Hind III digests of strains ED6 -ED1 respectively 
Eco RI digests of strains ED6 -ED1 respectively 
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Fig. 4.3 Photographs of two gels which 
together show the 
restriction digest fragments of strains 
ED1 -ED6 
with Bst EII, Pst I and Bam HI 
Lanes 1 and 20: 
Lanes 2 -7: 
Lanes 8 -13: 
Lanes 14 -19: 
molecular weight marker II (Boehringer 
Mannheim) 
Bst EII digests of strains ED6 
-ED1 respectively 
Pst I digests of strains ED6 -ED1 
respectively 




Figs. 4.4 -4.9 DNA fingerprints for BHV1 strains ED1 -ED6 
digested with restriction enzymes as shown 
The mean molecular weights of the digestion fragments are shown 
in kilobase pairs (Kbp) and compared with published data where 




















































































































































































































































































































































































































































































ED4 and ED5 were of DNA type 1 (Metzler and others, 1985) and ED2 and 
Oxford (ED6) of type 2b. It was also concluded that the strains were 
all genetically distinct as shown by minor differences in the mobility 
of their DNA digestion fragments. 
The results of fingerprinting 78 British field isolates of BHV1 
(including strains ED1 -ED6) are shown in Table 4.2. The four 1960s 
strains all were of type 2b, whereas the combined data for 1980 and 
1984 gave 52 isolates of type 1 and four of type 2b. Assuming the 
isolates were independent, the probability of obtaining 4/4 type 2 
strains in the 1960s if the distribution had been the same as in the 
1980s was 0.0001, i.e. very unlikely. This supports the view that 
there was a change in virus DNA -type distribution between the 1960s 
and the 1980s. The Aberdeen (IBR) and Aylesbury (IPB) isolates 
appeared to be very similar to the prototype Oxford (IBR) strain, 
whereas the Carmarthen (IPB) isolate differed slightly in its finger- 
printing with EcoRI and Hind III (Figs. 4.10 and 4.11). 
The relationship of DNA type to clinical signs reported in the 
corresponding outbreaks is shown in Table 4.3. Chi squared analysis 
did not reveal any association between DNA type and any particular 
clinical sign (P >0.10) although the numbers of type 2 isolates were 
so low, that any association would need to be strong to be demon- 
strable. It is interesting to note that ocular signs were recorded 
for five of the seven type 2 iolates, whereas in cases where mortality 
was recorded only type 1 was found. There was no discernable geo- 
graphical trend when the isolates were grouped by VI Centre of origin. 
The fingerprints of the live vaccine strains are shown in Figs. 4.10- 
4.12. Although both resemble type 1 isolates, a unique pattern 
was 
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Fig. 4.10 Eco RI digestion fragments of BHV1 strains 
Lanes 1 and 16: molecular weight marker I 
Virus strains: lane 2 Aberdeen; 3 Aylesbury; 4 Carmarthen; 
5 Nasalgen vaccine; 6 Tracherine vaccine; 
7 fetal isolate; 8, 9 incomplete digestion; 
10 ED6 (Oxford); 11 ED5; 12 ED4; 13 ED3; 
14 ED2; 15 ED1 
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Fig. 4.11 Hind III digestion fragments of BHV1 strains 
Lanes as for Fig. 4.10 
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Fig. 4.12 Hpa I digestion fragments of BHV1 
strains 
Lanes 1 and 14: molecular weight 
marker I 
Virus strains: Lane 2 Aberdeen; 
3 Aylesbury; 4 Carmarthen; 
5 Nasalgen vaccine, 6 Tracherine 
vaccine; 
7 fetal isolate; 8 incomplete 
digestion; 
9 ED5; 10 ED4; 11 ED3; 
12 ED2; 13 ED1 
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shown by Nasalgen digested with Hind III and by Tracherine with Hpa I. 
The Tracherine pattern was only once detected in a field isolate, 
as noted in Table 4.2. This was from a farm where Tracherine had been 
used, and the isolate possessed the temperature sensitive growth 
pattern of Tracherine. The Nasalgen pattern has also been identi- 
fied once in a field isolate (in 1987) from a farm where the cattle 
had been vaccinated with Nasalgen four days previously. The finger- 
prints are therefore believed to be specific markers for these vaccine 
strains. 
The American strains of BHV1 had been stored at the CVL since the 
1960s and no information was available other than that shown in table 
4.4. The IPV strain was believed to be the prototypic K22 strain 
(Kendrick and others, 1958). The LA, Colorado and Blythe strains, 
were among the prototypic IBR isolates of the 1950s (Madin and others, 
1956; York and others, 1957). The Colorado strain is believed to be 
synonymous with the Cooper strain mapped by Mayfield and others 
(1983). The American type 1 viruses all had closely similar finger- 
prints which corresponded most nearly to strain ED3 among the six 
British isolates studied in detail. The type 2 strains resembled 
strain ED2. The four IBR isolates received from Italy had type 1 DNA 
fingerprints, whereas the five from Northern Ireland were of type 2b 
(Table 4.4). 
CONCLUSIONS 
Early British isolates of BHV1 correspond with DNA type 2 along with 
the prototype American IPV strain. More recent isolates, since 1977, 
are predominantly of DNA type 1, resembling the prototype IBR strains. 
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Northern Ireland appears to be in the same situation as Great Britain 
before 1977 in that only type 2 strains have been identified. This 
is supported by fingerprinting of more isolates at the Veterinary 
Research Laboratory, Stormont (McFerran, personal communication, who 
also reports the absence of virulent IBR in that country). The fact 
that current British isolates correspond genetically to strains found 
in the USA in the 1950s and 1960s, as well to strains from other 
countries, suggests that the current wave of type 1 viruses arose 
through importation rather than mutation of pre- existing British 
strains. 
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TABLE 4.1 - Details of field isolates of BHV1 used for restriction 










VI CENTRE CLINICAL SIGNS 





purchase 2 weeks 
previously 
ED2 78/3887 22.2.78 eye swab Weybridge Conjunctivitis 







cardiac lobes of 
lung, diphtheri- 
tic necrosis of 
trachea, laryn- 
geal ulceration 
ED4 80/10638 12.5.80 nasal swab Carmarthen Dullness, anor- 
exia, tachypnoea 
temperature 
103 °F, scleral 
congestion, nos- 
trils inflamed 




ED5 80/12514 10.6.80 eye swab Weybridge 18 month old 
Friesian male 
with dullness, 
fever (105.5 °F) 
and serous 







1961 eye swab Reading Conjunctivitis, 
ocular discharge 
rhinitis, cough 
in store cattle 
-98- 
TABLE 4.2 - Classification of British BHV1 isolates by DNA type 






TRACHERINE TOTAL EXAMINED 
1961 - la - 1 
1962 - lb - 1 
1969 - 2c - 2 
1977 1 - - 1 
1978 4 3 - 7 
1980 31 1 - 32 
1981 2 - - 2 
1982 - - Id 1 
1984 21 3 - 24 
1985 6 - - 6 
1986 1 - - 1 
Notes : a - Oxford IBR strain (Dawson and others, 1962) 
b - Aberdeen IBR strain (Darbyshire and Shanks, 1963) 
c - Carmarthen IPB strain (Huck and others, 1971) 
and Aylesbury IPB strain 
d - this isolate was from a farm where Tracherine vaccine 
had been used. It also showed temperature sensitive 
growth characteristics 
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TABLE 4.3 - Classification of 74 post -1977 isolates of BHV1 
by DNA type and clinical signs 
CLINICAL CODES 






A 2 - - 2 
B 2 - - 2 
C 6 - - 6 
D 4 - - 4 
E 31 5 - 36 
F 27 1 - 28 
G 5 - - 5 
H - - - - 
I - - - - 
L 8 - 1 9 
M 3 1 - 4 
N 45 3 - 48 
P - - - - 
Q - - - - 
R 7 1 - 8 
S 6 1 - 7 
T 3 - - 3 
V 2 - - 2 
X 2 - - 2 
Z 14 - - 14 
TOTAL NO. OF 66 7 1 74 
ISOLATES 
Tr = Tracherine vaccine type 
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TABLE 4.4 - Restriction endonuclease typing of overseas strains of 
BHV1 (based on digests with EcoRI, Hind III, HpaI and Bam HI) 
COUNTRY OF ORIGIN STRAIN REFERENCE DNA TYPE 
USA Colorado 1 
IPV 2 
Ledi IV 2 
Salinas VII 2 
Blythe VII 1 
Conjunct 1 
Kleck IX 1 
McDougall VII 1 
LA III 1 
Reno 1 
Palmer 1 
Nanny V 1 
ITALY V77 (IBR) 1 
80 (IBR) 1 
82 (IBR) 1 
13a la 
NORTHERN IRELAND VC 
VC 
64b -100 (IBR) 
74 -235 (subclinical infection 
2 
in a bull) 2 
VC 74 -366 (calf pneumonia) 2 
VC 82 -569 (IBR) 2 
EC 84 -11/73 (subclinical infection 
in a herd) 2 
Notes : (a) this strain was of uncertain origin having been found in 
a deep freeze. Plaque cloning revealed a mixture of two 
distinct genotypes, one of type 1 and one with additional 
bands. 
(b) the first two digits of the Irish strains represent the 
year of original isolation 
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Chapter 5 
CLINICAL AND SEROLOGICAL RESPONSES OF EXPERIMENTALLY INFECTED CALVES 
INTRODUCTION 
In order to establish a satisfactory system of clinical evaluation, 
together with appropriate sampling regimens, a pilot experiment was 
carried out by experimentally infecting calves with different strains 
of BHV1. Five recent isolates were selected at random and compared 
with the UK prototype strain, "Oxford ". Fortuitously, when restric- 
tion endonuclease mapping was subsequently applied to the 6 strains, 
it was found that one of the 5 recent isolates had a genotype similar 
to the Oxford strain (type 2), whereas the other 4 corresponded 
to DNA type 1. This aspect has been fully described in chapter 4. 
To confirm the trends observed in the pilot experiment, two of the 
strains, both first isolated in 1978, and corresponding to the two 
DNA types, were selected for a more detailed assessment of the clini- 
cal, virological and serological responses of calves to experimental 
inoculation. 
MATERIALS AND METHODS 
Experiment 1 
In the pilot study, each of the six selected BHV1 strains was inocu- 
lated into three calves. For logistical reasons it was necessary to 
subdivide the experiment into three replicate blocks (A, B and C), in 
each of which one calf was allocated per viral strain. Additionally, 
one or two calves per block were sham inoculated with the medium 
harvested from non -infected cell cultures. These calves served as 
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controls both for spontaneously arising intercurrent diseases, and to 
monitor the efficacy of disinfectant procedures for personnel passing 
between the calf pens. In blocks A and C the calves were housed in 
individual loose boxes, divided to ceiling height by a solid wall, 
and with solid doors opening onto a common service passage containing 
hypochlorite dips between each pen. The pens were individually fan 
ventilated. In block B the calves were housed in individual self - 
contained calf hutches, naturally ventilated through weld mesh fronts 
and sides, and standing in a concrete yard with 1 to 1.5 metres 
separation between the hutches. All staff attending the calves were 
obliged, for the period of the experiments, to wear waterproof cloth- 
ing and to disinfect between each calf pen. 
The intention was to use calves which were, at least within blocks, 
of a uniform type, age and size, although in practice this was partly 
confounded by what was available at the time. In blocks A and B the 
calves were either dairy -type or beef crosses from this type, and 
were of mixed sexes (Table 5.1). They were purchased at the usual 
market age (approximately 1 -2 weeks) and were experimentally inoculat- 
ed 2 -4 weeks later. Better uniformity was achieved for block C where 
the calves were all Friesian -type and male. The calves were allocated 
to treatments (i.e. viral strains) by random number selection. 
Virus stocks grown in primary calf kidney cells were diluted in cell 
culture medium to provide an inoculum of each strain containing 3.5 x 
107 TCID50 per ml. Each calf was inoculated with 5 ml of this 
preparation by intranasal installation, plus a further 0.5 ml dropped 
onto the surface of the left eye. The nasal and ocular inoculations 
were repeated at 2 and 4 hours after the initial dose. Each calf 
thus received a total viral dose of 5 x 108 TCID50 intranasally 
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plus 5 x 107 TCID50 supraconjunctivally. The five recent isolates 
of the virus had been passaged four times in cell culture from the 
original field sample, whilst the Oxford strain was used at the 6th 
passage level, having been grown from liophylized 5th passage material. 
Details of the six viral strains used (referred to as ED1 to ED6) 
were given in chapter 4 (Table 4.1). 
Experiment 2 
For the second phase of the study the opportunity was taken to use 
Friesian calves from the CVL Ripley herd, which was being dispersed 
in 1983 as part of government economies. This herd had been built up 
over a number of years and maintained free of specific pathogens, 
including BHV1 and BVDV. To offset the advantage of having these 
calves from a single source and of known history, it was necessary to 
accept a wider age range (24 to 5 months on the date of inoculation) 
and mixed sexes. They were divided into age- matched pairs of calves, 
then randomly allocated, within pairs, to two treatment groups (Table 
5.2). The six calves for each group were housed together in a large 
loose box, separated by solid walls and an empty box from the other 
group. Strict disinfection procedures between groups were maintained, 
as in experiment 1. The viral strains selected for experiment 2 were 
ED1 and ED2, both at the third cell culture passage level. The 
inocula were prepared as before, but a lower dose was given than in 
experiment 1. Each of four calves in each treatment group was inocul- 
ated intranasally with 107 TCID50 virus in a single dose of 1 ml, 
plus 106TCID50 supraconjunctivally in the left eye, in a volume of 
0.1 ml. The remaining two calves per group served as in- contact 
controls. 
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Following recovery from the acute infection and the conclusion of 
the initial monitoring period, the three castrated male calves from 
this experiment were separated from their groups and were inoculated, 
56 days after the BHV1 inoculation, with 8 mg dexamethasone intraven- 
ously, followed, on each of the subsequent four days, by the same dose 
intramuscularly. The pattern of recrudescent virus shedding was 
monitored by the daily collection of nasal and preputial swabs. 
On day 88 after the original BHV1 inoculation, two of the remaining 
female calves from each group (numbers 9378, 9406, 9407 and 9408) 
were challenge inoculated with the opposite strain of virus (ED2 or 
ED1 respectively) but at the same dose and routes as the original 
inoculation. 
Experiment 3 
The final calf study was carried out as a minor addition, to test the 
hypothesis, suggested by the results of experiment 1, that there was 
a difference in virulence between two strains (ED1 and ED5) of appar- 
ently similar genotypes. The six calves selected were, for reasons 
of economy and availability, male Jerseys, of uniform age. The 
inoculation was carried out when the calves were 2 months old, using 
the same dose of virus and routes of inoculation as for experiment 2. 
The housing was similar (but not identical) to experiment 2, and both 
experiments 2 and 3 were done in the same month (July) in successive 
years. 
Sampling procedure 
In all the calf experiments, a standard procedure was adopted for 
sampling and clinical monitoring. Cotton wool swabs (Exogen Ltd., 
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Clydebank, Scotland) were inserted ventromedially through the nostril 
to the full extent (approximately 11 cm) of their wooden sticks. One 
nasal swab was taken per day from each calf and was inserted into 
both nostrils in turn. Separate swabs were used to sample the 
lachrymal secretions of the left and right eyes, by gently everting 
the lower eyelid. The swabs were broken off into 3 ml PBSL in screw 
capped vials, and processed for antigen detection and virus isolation/ 
titration as described in chapter 6. All the swabs collected on one 
of the sampling days (experiment 1B, day 8) were weighed before and 
after sampling, to determine the amount of mucus collected. Swabs 
were taken immediately prior to viral inoculation, then daily through- 
out the monitoring period, except for experiment 3 where nasal swabs 
only were collected, on days 4, 7, 9 and 11 after inoculation. 
Clotted blood samples were collected by evacuated blood tubes 
(Vacutainer, Beckton Dickinson) from the jugular veins of the calves 
at varying intervals, as indicated in the serology results section. 
After overnight storage, the sera were separated from the blood clots 
and stored at -20 °C to await serological testing. The serological 
test procedures (virus neutralization and ELISA) are described in 
chapter 2. 
In block C of experiment 1 and in experiment 2, samples of nasal mucus 
for serology were collected by inserting a tampon (Lil -lets mini 
tampons, Lilia White Ltd., Birmingham) into one nostril of the calf, 
pulling it out 20 -30 minutes later, and squeezing out the mucus by 
compression in the barrel of a 50 ml syringe. 
Clinical assessment 
All the viral and sham inocula were coded by an assistant and sup- 
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plied to the author in identical bottles so that I did not know, 
during the monitoring period, which calf had received which inoculum. 
Each calf was fully examined clinically, at the same time daily, for 
one week before the inoculation and for 11 -15 days after inoculation. 
The longer period was used in experiment 2 where disease in the 
in- contact calves ran a time course some days later than the inocu- 
lated calves. Rectal temperature was measured with an electronic, 
digital thermometer (Model GC20, Edale Instruments Ltd., Cambridge) 
accurate to 0.1 °C. The clinical findings were recorded on a daily 
record sheet without reference (other than memory) to the previous 
days' results. A specific score, graded according to severity, was 
allotted for each of a list of signs for each calf on each day, as 
shown in table 5.3. The list of signs was constructed on the basis 
of the clinical findings in the initial experiments. The absence of 
other signs from the list, for example mouth lesions, does not imply 
a less than complete clinical examination but merely that no clinical 
score was allotted for that particular sign in any of the calves 
during the course of the experiments. In assessing the scores for 
apathy and anorexia, a knowledge of the individual calves' general 
behaviour, gained during the pre -inoculation monitoring, was of 
considerable value. Due regard was also given to comments by the 
animal attendant, particularly in respect of feeding behaviour and 
appetite. Throughout this series of experiments, all the clinical 
assessments were made by the same veterinary surgeon. 
At the end of the intensive monitoring period for each experiment, 
the raw clinical scoring data was transformed to give a numerical 
assessment of the clinical severity of the disease in each calf. A 
number of methods were tried in order to establish the most satisfac- 
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tory assessment, as elaborated in the discussion. The selected 
method used for the definitive analysis of the data is described 
here. 
The score for each clinical sign was multiplied by a weighting factor 
(shown in Table 5.3). Although arbitrary, this was an attempt to 
apportion greater significance to signs such as apathy and anorexia, 
which were considered to indicate the calf's general well- being, as 
opposed to more specific signs such as nasal discharge. Because only 
one eye was inoculated, the ocular signs for the two eyes were asses- 
sed separately and given a weighting of 1. The combined left and 
right eye scores thus had a weight of 2, the same as the other speci- 
fic signs. The respiratory rates of the calves were rarely elevated, 
so that the only objectively quantitative measure of the calves' 
clinical response was the rectal temperature. For this reason, and 
that it was also considered an important indicator of the calves' 
general well -being, it was given a considerable weighting, a score of 
1 being allotted for every 0.1 °C elevation above 39.0 °C. The weighted 
post -inoculation scores for each calf were totalled to give a 
cumulative score for each clinical sign. Any scores recorded for the 
same sign during the week of pre -inoculation monitoring were also 
totalled, then adjusted to give an estimate of an 11 day or 15 day 
cumulative pre- inoculation score, as appropriate to the period used 
for calculation of the post -inoculation scores in the particular 
experiment. The adjusted pre -inoculation score for each clinical 
sign was then subtracted from the post -inoculation value for that 
sign. Expressed algebraically, this calculation is:- 
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calculated score for any particular clinical sign for one 
calf 
daily score recorded at time of examination in the post - 
inoculation period 
daily score recorded at time of examination on days 7 -0 pre - 
inoculation. 
post -inoculation monitoring period in days 
arbitrary weighting for the particular sign 
The total value of all the clinical signs, ES, was used as an overall 
assessment of the severity of the disease experienced by the individ- 
ual calf. The temporal progression of the disease was also assessed, 
by calculating a daily total score (not cumulative) for all the 
clinical signs in each calf. 
Statistical analysis 
Experiment 1 was analysed as a 2 -way randomized block design in which 
the six viral strains represented treatments, and the three replicate 
trials represented blocks. Further analysis was carried out by 
comparison of two treatment groups representing the two main DNA 
types. Experiments 2 and 3 were analysed as comparisons of two 
treatments, using methods for paired comparisons where appropriate. 
The cumulative clinical scores for individual calves were analysed by 
both parametric (analysis of variance and Student's t test) and 
non -parametric methods (Friedmann's test for randomized blocks, 
Wilcoxon's rank -sign test for paired comparisons, Mann -Whitney U test 
for comparing two treatments, and Kruskal- Wallis test for multiple 
comparisons). The simpler analyses were done manually following 
standard procedures (Snedecor and Cochran, 1967; Hollander and Wolfe, 
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1973; Neave, 1981). For the more complex manipulations (such as the 
Kruskal- Wallis test) the Minitab statistical package, available on 
the CVL Prime computer, was used. 
As explained in the results, the clinical score for one calf (virus 
ED2, experiment 1A) was considered invalid, and in order to produce a 
balanced table for the analysis of variance (anovar) an estimated 
value was calculated by the method of Yates (1933) using the formula:- 
X = t.T + b.B-S 
(t-1)(b-1) 
where t = number of treatments (virus strains) 
T = sum of observations in the treatment with the missing value 
b = number of blocks 
B = sum of observations for treatments in the block with the 
missing value 
S = sum of all the observations 
the total degrees of freedom used = t.b -2 
the mean square for treatments was adjusted as described by 
Snedecor and Cochran (1967) by subtracting from it the value:- 
[B-(t-1)X]2 
t(t-1)2 
In order to compare viral shedding between treatments, a cumulative 
value for each calf was calculated by summing the log10 of the virus 
titres in the daily swab extraction media. The data included a high 
proportion of negative results in which no viral growth was detected 
from undiluted samples (recorded as ' -') or from samples diluted 1 /10 
(recorded as <1, the undiluted test being unreadable). Both these 
results were assigned an arbitrary log10 value of 0 for the analyses, 
for which non -parametric methods based on rank were used as described 
above. 
For the comparison of antibody responses, as measured in OD units by 
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the ELISA, the data from experiment 1 were analysed for the day on 
which the response had peaked for the majority of calves. Analysis 
of variance and Student's t test were used. The missing datum formula 
(as above) was used for the seropositive calf where necessary to 
construct balanced tables. An additional two way anovar was done for 
experiment 1, comparing daily OD values between calves within each 
block. The ELISA responses for the post inoculation sampling period 
were compared for the two DNA types by a two sample t test using a 
pooled variance estimate. To determine the first samples after 
inoculation in which a rise could be detected in each class of anti- 
body, Student's t test was applied as a paired comparison between OD 
values on the day of test and those on the day of inoculation (day 0). 
Experiment 2 ELISA results were analysed as a paired comparison, using 
Student's t and Wilcoxon's rank -sign tests on the daily pair differ- 
ences for the period of the main response (days 11 -56 for IgG1 and 
IgG2, days 11 -21 for IgM). Student's t was also used, as in experi- 
ment 1, to determine the first sample after inoculation in which 
antibodies of each class were significantly elevated above day O. 
Similar methods were used to analyse the secretory antibody responses 
in the nasal mucus. 
RESULTS 
Clinical scores 
One calf in experiment 1 (inoculated with strain ED2) failed to deve- 
lop more than transitory and slight clinical signs of disease, al- 
though a successful inoculation was confirmed by the isolation of 
virus from swabs. In retrospect this calf was found to be seroposit- 
ive to BHV1 prior to the inoculation. Following this experience the 
pre- inoculation screening procedures for the calves were tightened up. 
With the exception of the above -mentioned calf and the control (sham - 
inoculated calves in experiment 1, all the calves developed a clini- 
cally apparent disease following exposure to the virus. The quali- 
tative features of the disease were similar for all six viral strains. 
There was typically a high fever beginning on day 2 or 3 after inocul- 
ation and lasting for approximately 5 days. A severe conjunctivitis 
and lachrymal discharge (Fig. 5.1) was evident from about day 2 to 
day 10 in the left (inoculated) eye, with a milder, more variable 
response in the right eye. A characteristic feature of the conjunct- 
ivitis was the presence of white pustular lesions in both the bulbar 
and palpebral parts of the conjunctival membrane (Fig. 5.2). Nasal 
discharge and rhinitis characterized by necrotic ulcerative lesions 
visible through the external nares, developed slightly later, from 
about day 5, and were resolving usually by day 10, but with some 
exceptions noted below. The nasal and ocular discharges were in- 
itially clear and watery, but soon showed white flecks and within two 
days were usually mucopurulent (Fig. 5.3). Coughing was not a consis- 
tent finding; when present it was mild and infrequent and generally 
only provoked when the calves were disturbed. In some calves the 
upper respiratory changes were severe enough to induce very noisy 
respirations, akin to snoring, but these were not generally classed 
as dyspnoea. Only a few calves were judged to be genuinely dyspnoeic 
and this was transitory, of only one or two days duration. Inappet- 
ance and apathy, usually around 5 -7 days after inoculation, were 
inconstant findings and were only observed with some of the viral 
strains. 
The signs of disease had resolved in the majority of the calves by 
12 days after inoculation. A few calves had residual slight nasal 
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Fig. 5.1 Experimentally infected calf showing nasal discharge, 
ocular discharge and conjunctivitis 
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Fig. 5.2 Conjunctival injection and pustule formation in an 
an experimentally infected calf 
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Fig. 5.3 Mucopurulent nasal discharge in an experimentally 
infected calf 
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and /or ocular discharges for a further 2 -3 days. One calf in experi- 
ment 1B, and one in experiment 1C, developed persistent mucopurulent 
nasal discharges which were considered on clinical grounds to be due 
to secondary bacterial infection rather than directly caused by the 
virus itself. The total clinical scores calculated for experiment 1 
are shown in table 5.4. The detailed scores by clinical sign and by 
days after inoculation are recorded in appendix 5 (i) and (ii). The 
two -way statistical analysis of the data is shown in table 5.5. The 
score for the seropositive calf was replaced by an estimated value of 
65 for the analysis of variance. The ranking for the Friedmann test 
was not affected whether the actual or the estimated score was used. 
Only the Friedmann test gave a significant effect due to virus strains. 
However, the use of data (either real or estimated) from the seroposit- 
ive calf, to produce a balanced table, obliges a cautious interpretat- 
ion of the significance test. A Kruskal- Wallis test on the scores in 
table 5.4 indicated a significant effect of viral strain if the value 
of 29 at (a) was included (H = 12.19, P <0.05) or replaced by the 
estimated value (H = 11.84, P<0.05) but not if it was omitted al- 
together (H = 10.95, P>0.05). 
As there was no evidence of significant variation due to blocks, the 
data were re- analysed as a simple comparison between two treatments, 
corresponding to the two types of viral DNA identified by restriction 
endonuclease analysis. The results are shown in table 5.6 and indi- 
cate that strains of DNA type 1 produce a significantly more severe 
clinical response (as assessed by the score) than strains of DNA type 
2 given at the same dose by the same route. 
The clinical responses following primary inoculation of the calves 
in experiment 2 are summarised in table 5.7. For every pair of 
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calves, virus strain ED1 produced a higher clinical score than ED2. 
The difference between the strains was statistically significant at 
the 1% level using Student's t test. The finding was confirmed by 
non -parametric tests which gave significance at the 5% level. The 
major contributor to the score differences was the rectal temperature 
(higher fever, rather than longer duration) with increased severity 
also noted for inappetance (no scores with ED2), rhinitis, nasal 
discharge, conjunctivitis and ocular discharge. The in- contact 
calves showed disease of character and severity similar to the inocu- 
lated calves for each virus, except that both calves in the oldest 
pair had a rather lower clinical score than the younger calves infect- 
ed with the same virus strains. There was a significant correlation 
between clinical score and age of calf (Fig. 5.4) with strain EDI 
(r= -0.90, p <0.05) but not with strain ED2 (r= -0.46, p >0.05). No 
allowance has been made, in fitting the regression lines to fig. 5.4, 
for any confounding effects of in- contact versus inoculated calves 
within each strain. 
The progression of clinical signs with time is shown in fig. 5.5. 
The curves for the in- contact calves are displaced approximately 
three days to the right compared with the inoculated animals. 
No clinical signs were detected when the three male calves were given 
dexamethasone. In the four females which were challenge inoculated 
with virus of the opposite DNA type, no clinically significant signs 
were recorded. Small scores were recorded on single days for ocular 
or nasal discharge or for pyrexia (particularly with ED1 as challenge 
virus), but none of the scores exceeded values that might be encoun- 
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Fig. 5.4 Relationship of clinical score to age in calves 
infected with BHV1 strains ED1 or ED2 (experiment 2) 
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Fig. 5.5 Clinical responses of calves inoculated or in- contact 
with BHV1 strains ED1 or ED2 (experiment 2) 
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attributable to the viral strain used for challenge were not signific- 
ant (Mann Whitney test, 8 observations for each strain, U = 18, 
P >0.10). 
Table 5.9 shows the clinical scores obtained in experiment 3, the 
comparison between strains ED1 and ED5 in Jersey calves. One calf 
inoculated with strain ED1 showed an atypical response. It was 
rather emaciated, even for a Jersey calf, at inoculation, but appeared 
otherwise healthy. During the following 12 days it became progres- 
sively dull and cachexic, whilst exhibiting only mild signs of IBR 
(nasal and ocular discharges and a slight fever). It died on day 13 
after the BHV1 inoculation. There were no obvious gross post mortem 
findings to explain the clinical response of this calf, or why it had 
died. The respiratory tract and abdominal viscera appeared macroscop- 
ically normal. No BHV1 antigen could be detected in frozen sections 
of the lung and tracheal epithelium. 
The differences in clinical scores between strains ED1 and ED5 were not 
significant in this experiment, either by a Mann Whitney test on the 
individual scores for each sign, or by Student's t test for the differ- 
ence between the mean cumulative scores (Table 5.9). A two -way 
analysis of the data by Friedmann's method (7 clinical signs vs. 6 
calves) gave highly significant differences between calves (M = 
17.86, P <0.01). 
Comparing these results in Jersey calves for strain ED1 with those 
obtained earlier in Friesians with the same inoculum (Table 5.7) the 
clinical responses in experiment 3 were significantly lower (Mann 
Whitney test, nl = 3, n2 = 6, U = 1, P = 0.05). Although the two 
experiments were carried out a year apart, the climate and housing 
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were very similar, and the only obvious difference was the breed of 
calf. 
Virus shedding 
The results of the swab weighing exercise, before and after sampling, 
are shown in table 5.10. After elution into the extraction medium (3 
ml) this gave, on average, a 1/21 dilution of nasal mucus and 1/75 
dilution of ocular secretion. The virus titres in the following 
account are expressed in 1og10TCID50 per 90u1 of extraction 
media. To express them as estimated log10 titres per ml of mucus, 
values of 2.37 (= log10 233) for nasal mucus, 3.05 (= log10 1111) 
for right ocular or 2.82 ( =log10 667) for left ocular secretions, 
should be added. 
Details of the daily virus titres from experiment 1 are given in ap- 
pendix 5(iii). Measurable titres of virus were present in the 
nasal secretion 24 hours after the inoculation. Peak virus shedding 
was from days 2 to 5 after inoculation. Virus was detected only 
sporadically at low titre from day 8 onwards. The cumulative virus 
titres for each calf are shown in table 5.11, together with the 
statistical analysis. A significant effect (P <0.05) on cumulative 
virus titre could be attributed to viral strains, whilst the compari- 
son of DNA types gave a very highly significant difference (P <0.001). 
A Kruskal- Wallis analysis of the 198 observations for daily virus 
titre (Table 5.12) showed significant variation due to DNA type 
(P <0.01) and day of sampling (P <0.001), but the differences between 
strains were not significant. If however the analysis was restricted 
to samples collected on days one to seven after inoculation, which 
was the main period of virus shedding and thus excluded a large 
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number of negative results, the differences between strains were 
highly significant (P<0.01), as were those due to DNA type (P<0.001) 
and day (P <0.001). Thus differences in virus excretion between 
treatments were mainly apparent in the first week after inoculation. 
Although overall in experiment 1 there was a significant correlation 
between the cumulative clinical scores and titres of virus excreted 
(r = 0.597, P <0.01), the relationship did not hold within DNA types 
(type 1, r = 0.369, P >0.05; type 2, r = -0.662, P >0.05). 
The general pattern of virus shedding in the lachrymal secretions of 
the left (inoculated) eyes of the calves was similar to that found in 
the nasal secretion. However, the titres measured were rather vari- 
able from day to day, presumably due to the small and variable sample 
size picked up on the ocular swabs (Table 5.10). Virus recovery from 
the right (uninoculated) eyes was intermittent and generally at low 
titres. The detailed results for the eye swabs from experiment 1 are 
recorded in appendix 5 (iv and v). The results are summarized, 
together with the statistical analysis, in table 5.13. As with the 
nasal swabs, a cumulative virus titre was calculated for the Friedmann 
analysis. No significant effects attributable to blocks or to viral 
strains were shown. A significant effect of viral strains (P <0.05) 
was demonstrated by the Kruskal- Wallis test on the daily values for 
virus titre in the left eye samples, but not the right eye. In the 
Mann Whitney comparison of cumulative titres according to viral DNA 
type, calves inoculated with type 1 strains shed significantly more 
virus in their left ocular secretions (P<0.001) than those infected 
with type 2 strains. The differences for the uninoculated (right) 
eyes were not significant. The virus titration results for the nasal 
swab samples in experiment 2 are given in table 5.14. The temporal 
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pattern of virus excretion is illustrated graphically in fig. 5.6. 
This may be compared with the curves for clinical scores in fig. 5.5. 
As with the clinical signs, virus excretion by the in- contact calves 
mimicked that from the inoculated animals with a 3 day time -lag. 
There was no significant difference in cumulative titre between 
inoculated and in- contact animals (Mann Whitney, nl = 4, n2 = 8, U = 
11, P>0.10). For each of the six pairs, the calf infected with 
strain ED1 had a higher cumulative virus titre than the ED2 infected 
calf. The differences were significant (P<0.05) by both Mann Whitney 
and Wilcoxon procedures. The Mann Whitney test failed to show a 
significant difference in virus shedding between strains when the 180 
daily titrations were analysed. However when this data was analysed 
for each pair, the Wilcoxon signed rank test showed significant 
differences (P<0.05) for two pairs (nos. 3 and 4). 
Details of the ocular swab titrations experiment 2 are given 
appendix 5 (vi). The calculated cumulative titres and the statistical 
analysis are in table 5.15. The left eyes of the in- contact calves 
received no different treatment from any of the right eyes and they 
were therefore analysed together as a non -inoculated group. As with 
the nasal swabs, there was a tendency for ED1 infected calves to shed 
higher titres than the ED2 group. This difference was statistically 
significant (P <0.05) in the non -inoculated eyes using the Wilcoxon 
signed rank test for a paired comparison, but not by the Mann Whitney 
method for comparing two treatments. 
Virus recovery from the three male calves in experiment 2 following 
dexamethasone treatment is shown in table 5.16. These samples were 
screened at 1/2 and 1 /10 dilutions of the extraction medium, but the 
end -point titres of virus growth were not determined. Virus was 
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Days post inoculation 
+ ED1 inoculated 
-e--- ED1 in contacts 
w- ED2 inoculated 
- ED2 in contacts 
Values plotted are the mean log titre per 90 pl 
swab extraction medium 
Fig. 5.6 Pattern of virus excretion in nasal mucus of calves 
inoculated or in- contact with BHV1 strains ED1 or ED2 
(Experiment 2) 
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detected in all 3 calves during the week after dexamethasone treat- 
ment, from both nasal and preputial sampling sites. 
The pattern of virus shedding in the four calves following challenge 
with the opposite strain of BHV1 was similar in all four calves as 
shown in table 5.17. Only the nasal swabs gave sufficient data for 
meaningful analysis which showed no significant differences between 
calves (Friedmann's test; k, n = 4, 11; M = 5.97; P>0.10) or between 
challenge strains of virus (Mann Whitney; n1= n2 = 22, U = 217, 
P>0.05). 
In experiment 3 (comparison of ED1 and ED5) swabs were taken only 
from the nose, and only on 4 days selected to represent virus shed- 
ding around the peak levels and during the fall off in the following 
week. The results are shown in table 5.18. The statistical analysis 
gives no evidence of any significant difference in virus shedding 
between calves or between the 2 strains. 
Serum Antibody Responses 
As noted above, one calf in experiment 1 replicate A was seropositive 
by both VN and ELISA before the experiment began. Its antibody titre 
did not rise following the viral inoculation, although it changed 
from a falling trend to a plateau from 14 days after the inoculation. 
This calf was omitted from the statistical analysis. All the other 
calves seroconverted to BHV1 following exposure to the virus. The 
control calves in experiment 1 remained seronegative to BHV1, indicat- 
ing that the measures to prevent pen to pen transmission had been 
successful. 
The VN antibody responses of the calves in experiment 1 are shown in 
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Fig. 5.7 Virus neutralizing antibody responses of individual calves in 
experiment 1. The labels on each line indicate the virus strain 
inoculated (ED1 to ED6). 
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dual calves, all the virus strains induced an essentially similar 
pattern of neutralizing antibody response. The major rise in titre 
occurred between days 10 and 15 with a further rise in some indivi- 
dual calves between days 20 and 30. Thereafter the titre reached 
a plateau and in some cases was falling by the end of the monitoring 
period. 
The IgGl, IgG2, and IgM responses to the virus in experiment 1, 
as measured by the ELISA, are shown in fig. 5.8. Because of differ- 
ences in sampling times, the data from the 3 blocks could not be 
combined. Nevertheless the curves for the mean responses for each 
replicate are closely aligned. The results for the individual calves 
are tabulated in appendix 5(vii, viii and ix). The shape of the 
response curves for each immunoglobulin class was consistent for all 
the calves, with the exception of the controls (which did not respond 
serologically) and the calf with pre- existing antibody in block A. 
The ELISA results for the latter animal gave high readings for IgGl, 
low IgG2 and slightly elevated IgM. The results for this calf were 
omitted from the calculations to produce fig. 5.8. 
The statistical analysis of the data is shown in table 5.19. No 
significant differences attributable to blocks or to virus strains 
could be shown on days 28 -30 for IgG1 and IgG2, and days 10 -11 for 
IgM. These days were selected as representing the periods of maximal 
response for the respective immunoglobulin classes, and for which 
samples were available from all three blocks. The two -way anovar for 
the full set of data was done separately within each block because of 
the differences in sampling days. Thus it was not possible to separate 
variation due to strain of virus from that due to individual calf 
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Fig. 5.8 Mean serological responses of calves experimentally infected 
with BHV1 (experiment 1) as measured in immunoglobulin sub 
class specific ELISA 
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differences. The variation due to day post -inoculation was (as ex- 
pected) uniformly highly significant (P <0.001) but there was also 
significant variation between calves for all three immunoglobulins, 
except for IgG1 and IgM in block B (Table 5.19). No significant 
differences in antibody response between calves infected with the two 
DNA types could be detected, with the sole exception of the IgM 
response in block B (P <0.05) (Table 5.20). 
As shown in table 5.21, the first significant rise in antibody was 
detected on day 8 (block C) in the IgM class, although some individ- 
ual calves appeared to be starting a response on day 7. High levels 
of virus -specific IgM were detected between days 9 and 16 inclusive, 
with the peak typically at day 12. The IgM reached a low plateau 
from three weeks after the inoculation, although there was again some 
individual variation in the height of this plateau. 
Significant rises in the IgG classes occurred on day 9 or 10 (Table 
5.21) with a marked rise in IgGl coinciding with the similar rise noted 
for VN titre between days 10 and 15. The levels of IgG2 rose slowly 
through to the end of the monitoring period in the eighth week; 
whereas IgGl levels during this latter period variously rose, fell or 
were steady, approximately in line with the VN titre. No virus - 
specific IgA antibody was detected in any of the sera in this experi- 
ment (OD values were all <0.05). 
The calves in experiment 2 showed a serological response similar to 
that described above. This is illustrated in fig. 5.9. The detailed 
individual results are recorded in appendix 5(x, xi and xii). The 
statistical analysis of the temporal pattern is shown in table 5.22. 
In the inoculated calves, no significant antibody was detected on day 
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Fig. 5.9 Mean serological responses measured by sub class specific 
ELISA in calves inoculated or in contact with BHV 1 strains 
ED1 or ED2 (experiment 2) 
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7, but all three immunoglobulin classes were significantly elevated on 
day 11. As with the clinical and virological features of the experi- 
mental disease, the in- contact calves were approximately 3 days behind 
the inoculated ones. Significant rises in IgM and IgGl were not 
detected until day 14, and in IgG2 until day 21. A similar analysis 
following dexamethasone treatment failed to show a significant change 
in antibody. Nevertheless, the number of calves (3) was low for 
statistical analysis and using the criteria for test variation estab- 
lished in chapter 6, significant rises occurred in OD value for IgG1 
and IgG2 for each of the three calves on day 70 (14 days after the 
start of dexamethasone treatment) (Fig. 5.10). 
In the four calves given heterologous virus challenge, there was a 
significant decrease in both IgG subclasses on day 92 (4 days after 
challenge) followed by a rise in IgG1 (7 days after challenge) and 
IgG2 (10 days after challenge) (Table 5.22 and Fig. 5.11). Although 
there was no statistically significant group change in IgM values, 
one individual calf showed evidence of an IgM response from days 10- 
42 following challenge (Appendix 5 (xii)). This was the calf with the 
lowest IgG response to the primary inoculation. 
A statistical comparison of the primary responses to the two viral 
strains is shown in table 5.23. There was a significantly higher 
IgGI and IgG2 response in calves infected with strain ED1 than with 
strain ED2, although in some individual pairs the pattern was reversed. 
A detailed serological analysis was not attempted in experiment 3. 
Blood samples collected from the six calves prior to inoculation were 
seronegative to BHV1 by ELISA for IgG, and samples collected from the 
five surviving calves on day 14 after inoculation were all seroposit- 
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Fig. 5.10 Mean serological responses (by sub class specific ELISA) of 
three calves recovered from experimental BHV1 infection and 
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Fig. 5.11 Mean serological responses (by sub class specific ELISA) 
of four calves following challenge with a heterologous 
strain of BHV1 
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In the experimental calves from all three experiments, paired sera 
collected pre -inoculation and post- recovery were tested for antibodies 
to respiratory syncytial virus and parainfluenza virus type 3 by 
ELISA, and to bovine viral diarrhoea virus by VN. No significant 
rises in titre were detected, indicating the absence of possible 
confounding effects on clinical responses due to intercurrent infect- 
ion with other respiratory viruses, and also indicating the freedom 
from contamination of the inocula with these agents. 
Antibodies in Nasal Secretions 
The serological results obtained with samples of nasal mucus from 
experiments 1C and 2 are given in appendix 5 (xiii - xvii). In 
experiment 1C, virus neutralizing antibody was detected at low titres 
only, from day 12 onwards. In a number of samples the VN test was 
unsatisfactory as toxic effects on the cells prevented interpretation 
at the lower dilutions of mucus. The VN test was not therefore 
carried out in experiment 2. 
Preliminary trials indicated that the best signal -noise discrimination 
in the ELISA was achieved at a 1/20 dilution of nasal secretion. 
Antibody responses of all four classes (IgM, IgA, IgG1 and IgG2) were 
detected, although there was some variation in the character of the 
response between individual calves. The trends are illustrated 
graphically in figs. 5.12 and 5.13. As with serum antibodies, 
Student's t test was used to compare the ELISA responses with values 
at the time of inoculation, with the first significant rise being 
detected on day 12 for all four immunoglobulins (Table 5.24). Although 
not significant by this method, there was evidence of a definite rise 
in IgM in nasal secretions in at least one calf (inoculated with ED6) 
on day 8 (Appendix 5 (xiii)), using the criteria for significant rises 
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Values plotted are mean OD in sub -class specific ELISA or median 
log VN titre for six calves. For VN an arbitrary value of -0.1 
was plotted where all six samples were seronegative. 
Fig. 5.12 Local antibody responses in nasal mucus of calves 


































































































































































































































































































































in titre described in chapter 6. 
In experiment 2, all four immunoglobulin classes were significantly 
elevated in the inoculated calves at the first sampling (day 14) 
compared with day 0 (Table 5.25). IgM, IgG1 and IgG2 were also 
significantly increased by the same day in the in- contact group. The 
IgA responses in experiment 2 varied considerably between calves 
(Appendix 5 (xvii) and strong IgA increases were detected only in the 
anamnestic responses following reactivation or challenge. All four 
immunoglobulins rose in the nasal mucus in the 3 calves given 
dexamethasone, by what were considered significant amounts on general 
criteria (see chapter 6), but within the present limited data the 
rises were not significant. Significant rises in IgM, IgGl and IgG2 
were detected in the mucus samples collected 14 days (day 102) after 
the heterologous challenge. 
The calves given primary exposure to strain ED1 developed significant- 
ly higher IgGl and IgG2 responses in the nasal mucus, than those 
given strain ED2 (Table 5.26). 
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SUMMARY AND CONCLUSIONS 
Experiment 1 
Eighteen individual calves were exposed to one of six field isolates 
of BHV1 by intranasal and unilateral conjunctival inoculation, in a 
randomized block design. None of the observations showed significant 
variation attributable to blocks. There was significant variation 
attributable to the strain of virus, in the clinical responses and 
the shedding of virus in nasal and left (inoculated) eye swabs. With 
one exception no significant differences in serum antibody responses 
were found. When the data were grouped according to the DNA type of 
the virus inoculum (types 1 and 2 as defined in chapter 4), calves 
inoculated with type 1 had a significantly more severe clinical 
response, and shed significantly more virus in the nasal and left 
ocular secretions, than those given the same dose of type 2 viruses. 
The statistical findings are summarized in table 5.27. 
Experiment 2 
Twelve calves were used in an age- matched pair comparison between two 
of the six BHV1 strains from experiment 1, chosen to represent the two 
types of DNA. Four pairs were exposed by intranasal and unilateral 
conjunctival inoculation of the virus and the remaining two pairs 
were exposed by contact transmission from the inoculated calves. 
After recovery from the primary infection, the three castrated male 
calves were treated with dexamethasone to reactivate latent virus, 
which was shed in both nasal and preputial secretions. Subsequently 
four of the female calves (ie two pairs) were challenge inoculated with 
the opposite strain of virus to that they had received on primary 
exposure. 
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As in experiment 1, virus of DNA type 1 on primary exposure produced 
more severe clinical disease, and the calves shed more virus, than 
with DNA type 2. In addition the IgG1 and IgG2 antibody responses 
in serum and nasal secretions were higher in the calves exposed to 
type 1 virus. The statistical tests in support of these findings are 
summarized in table 5.28. The same trends were observed in both 
inoculated and contact -infected groups but with an approximately 3 
day time lag in the latter case. On heterologous virus challenge, only 
very mild clinical signs were recorded. There were no significant 
differences in clinical score or virus shedding attributable to the 
strain of challenge virus. 
Experiment 3 
Two groups, each of three Jersey calves, were inoculated with one of 
two BHV1 strains from experiment 1, both representing type 1 DNA, but 
in which there was a suspicion of difference in virulence. Neither 
the clinical scores nor the virus shedding differed significantly 
between the two strains although the clinical disease was milder than 
in Friesian calves given the same inoculum in experiment 2, suggesting 
a difference in breed susceptibility. 
Serological responses 
Notwithstanding the differences in height of IgG responses noted 
above in experiment 2, a consistent pattern of humoral and secretory 
antibody development was observed in all the experiments (Figs. 5.7 - 
5.13). A significant rise in antibody was assessed either by a paired 
t test of ELISA values on sample day compared with day 0 of the 
treatment, or by the general criteria of test variation (see chapter 
6) which allow acceptance as significant of a rise in OD of at least 
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0.20 between two samples from the same calf. 
The earliest serum antibody detected after primary inoculation was 
IgM on day 8 closely followed by IgG1 and IgG2 on days 9 -10. IgM 
peaked on days 12 -14 and was greatly diminished by day 21, while the 
IgG sub -classes were more persistent. Both IgGi and virus neutraliz- 
ing antibody rose sharply between days 10 and 15. 
Increases in the IgG subclasses were noted following both dexamethas- 
one- induced recrudescence (day 14 after start of treatment) and 
secondary exposure to the virus (day 7 after inoculation). 
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TABLE 5.1 Details of calves used in the pilot study 
(experiment 1) 
Replicate: A B C 
Sex Breed Sex Breed Sex Breed 
Virus strain: ED1 M FR F HX M FR 
ED2 M FR F RD M FR 
ED3 F HX M FR M FR 
ED4 F HX F FR M FR 
ED5 M HX F RD M FR 
ED6 F HX F HX M FR 
Control (1) M FR F HX M FR 
Control (2) M FR - - - - 
Key to breeds: FR Friesian type 
HX Hereford cross 




5.2 Details of calves used in experiment 2 
ED2 Virus Strain: ED1 
Calf No Sex(a) Age(b) Treatment(c) Calf No Sex(a) Age(b) Treatment(c) 
1 9366 F 21 C 9370 F 20 C 
2 9378 F 16 I 9406 F 15 I 
3 9408 F 15 I 9407 F 15 I 
4 9409 M 14 I 9412 M 12 I 
5 9414 F 12 C 9411 F 13 C 
6 9416 F 10 I 9415 M 11 I 
Notes: (a) Male calves had been castrated 
(b) Age in weeks on the date of inoculation 
(c) C= In- contact, I = inoculated 
-140- 
TABLE 5.3 Clinical signs used to evaluate the daily disease scores 
Sign Score range used Weighting applied 
Apathy 0 -2 5 
Inappetance 0 -2 5 
Diarrhoea 0 -3 2 
Dyspnoea 0 -2 2 
Cough 0 -2 2 
Adenitis 0 -3 2 
Rhinitis 0 -2 2 
Nasal Discharge 0 -3 2 
Ocular Discharge: (R eye) 0 -3 1 
(L eye) 0 -3 1 
Conjunctivitis: (R eye) 0 -3 1 




<30 =0 ) 2 
30 -39 =1 ) 
40 -49 =2 ) 
50 -59 =3 etc ) 
°C above 39.0 °C 10 
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TABLE 5.4 Cumulative 11 day clinical scores in calves inoculated 










ED1 1 166 246 166 193 166 
ED2 2 (29)a 82 78 75b 78 
ED3 1 207 227 189 208 207 
ED4 1 113 127 285 175 127 
ED5 1 134 111 51 99 111 
ED6 2 85 118 36 80 85 
Control 6 5 0 ) 
) 3 2.5 
Control o ) 
Notes (a) Score replaced by an estimated value of 65 for 
analysis of variance 
(b) Using estimated value at (a) 
TABLE 5.5 Two way statistical analysis of cumulative clinical 
scores for experiment 1 (omitting the uninoculated 
controls) 
(i) Anovar 
Source of Degrees of Sums of 
variation Freedom Squares Variance F P 
Blocks 2 1797 899 0.28 >0.05 
Virus strains 5 54389 (10878 -963a) 
= 9915 3.11 >0.05 
Error 9 28676 3186 
TOTAL 16 84862 
(ii) Friedmann's test 
Comparison k,n M P 
Blocks 3,6 4.08 >0.10 
Virus 6,3 10.81 <0.05 
Note (a) Correction because of use of 
estimated value 
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TABLE 5.6 Comparison of clinical scores in experiment 1 by 
viral DNA type 
Type 1 Type 2 DNA 
Number of calves 12 5 
Mean score 169 80 
Median score 166 82 
Variance 4365 853 
Pooled variance 3429 
Student's t (15 d.f.) 2.85 (P <0.02) 
Mann Whitney U 6 (P <0.01) 
NOTE: The seropositive calf (virus ED2, block A) was omitted 
from this analysis. 
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TABLE 5.7 Cumulative 15 day clinical scores in age- matched pairs 
of calves inoculated or in contact with two strains of 
BHV1 (experiment 2) 



















Apathy 0 0 
Inappetance 5 10 15 5 10 7.5 0 
Diarrhoea 0 0 
Dyspnoea 4 0.7 0 
Cough 2 4 6 6 4 6 2 2.7 
Adenitis 2 0.3 0 
Rhinitis 24 16 22 10 22 14 30 14 18 22 6 2 20.3 13 
Nasal 
discharge 8 14 32 10 24 20 30 16 28 26 24 10 24.3 16 
Ocular 
discharge: 
R eye 4 21 1 1 3 6 1 4 1 6.2 0.8 
L eye 14 11 10 13 16 6 13 5 20 11 12.2 7.7 
Conjunctivitis: 
R eye 3 25 6 1 4 4 2 4 4 8 3 7.5 3.2 
L eye 4 18 16 6 20 20 13 14 11 25 16 13.8 13.3 
Respiratory 
rate 8 2 2 1.7 0.3 
Rectal 
temperature 44 13 51 32 69 42 73 22 73 58 72 23 63.7 31.7 
TOTAL (CS) 102 49 195 85 152 119 174 82 161 131 177 66 160.1 88.6 
Difference 
(D = CS1 -CS2) 53 110 33 92 30 111 71.5 
Median score 167.5 83.5 
Student's t (5 d.f.) for pair differences = 4.68 (P<0.01) 
Wilcoxon's signed rank test for pair differences, t, T = 0,21 (P <0.01) 
Mann Whitney test for comparison of virus strain medians, U = 2 (P<0.05) 
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TABLE 5.8 Cumulative 11 day clinical scores in calves challenged 
with BHV1 of a different genotype from the primary 
inoculum 
Pair No: 2 3 
Original inoculum: ED1 ED2 ED1 ED2 
Challenge virus: ED2 EDI ED2 ED1 
*Clinical signs: 
Nasal discharge 0 2 0 4 
Ocular discharge: R eye 2 1 0 1 
L eye 1 0 1 0 
Rectal temperature 0 5 0 1 
TOTAL 3 8 1 6 
*Note: Full daily examinations were made, but no clinical 
signs were observed other than those shown. 
TABLE 5.9 Cumulative 11 day clinical scores in calves inoculated 
with two strains of BHV1 of similar genotypes 
(experiment 3) 
Virus Strain: ED1 ED5 
Calf No. 54(a) 60 62 53 55 61 
Clinical sign (a): 
Rhinitis 2 22 22 12 4 18 
Nasal discharge 6 24 24 22 20 12 
Ocular discharge: R eye 0 3 0 0 0 0 
L eye 2 9 10 1 0 6 
Conjunctivitis: R eye 0 1 0 0 0 0 
L eye 1 11 9 0 3 8 
Rectal temperature 9 42 35 33 36 60 
TOTAL SCORE 20 112 100 68 63 104 
Mean score 77 78 
Student's t (4 d.f.) for difference between strain means = 0.032 
(P>0.10) 
Mann Whitney test for difference between strains (individual scores, 
7 observations per calf) n1 = n2 = 21, U = 194 (P>0.10) 
Note (a) calf died, 13 days after inoculation (see text). If the 
data from this calf is omitted, as an outlier, the 
differences between strains are still not significant 
(t = 1.62, P>0.10; ni = 14, n2 = 21, U = 97, P >0.10) 
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Table 5.10 Weight of nasal /ocular secretion collected on swabs 







1 0.15 0.04 0.07 
2 0.17 0.05 0.04 
3 0.22 0.03 0.07 
4 0.14 0.01 0.06 
5 0.11 0.02 0.03 
6 0.09 0 0.01 
7 0.11 0.04 0.05 
Mean 0.14 0.03 0.05 
Standard deviation 0.04 0.02 0.02 
Mean dilution (w /v) in 1/21 1 /100 1/60 
3 ml extraction medium 
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TABLE 5.11 Cumulative virus titres (logi0TCID50) for days 






EDI 1 28.50 30.25 21.25 
ED2 2 22.25 17.50 17.50 
ED3 1 32.00 27.00 25.00 
ED4 1 28.50 24.25 25.50 
ED5 1 30.25 26.50 20.50 
ED6 2 12.00 16.50 18.75 
Control o o o 
Control 0 
Two way analysis by Friedmann's test (excluding 
the control calves) 
k, n M P 
Blocks 3,6 2.58 >0.10 
Strains 6,3 11.24 <0.05 
Comparison of DNA types by Mann Whitney test 
DNA type No. observations Median cusum titre U P 
1 12 26.75 ) 
2 <0.001 
2 6 17.50 ) 
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TABLE 5.12 Analysis of variation for daily virus titres in nasal 
swabs (logi0TCID50 per 90111 extraction medium) using 
Kruskal- Wallis test (experiment 1) 
Source of 
variation 
Days 1 - 11 Days 1 - 7 
Median 
titre 
n H P Median 
titre 
n H P 
Block: A 1.875 66 ) 3.875 42 ) 
B 1.750 66 ) 1.18 >0.10 3.375 42 ) 3.30 >0.10 
C 2.125 66 ) 3.250 42 ) 
Virus: ED1 2.50 33 ) 4.00 21 ) 
ED2 1.50 33 ) 2.50 21 ) 
ED3 2.50 33 ) 8.83 >0.10 3.75 21 ) 15.14 <0.01 
ED4 2.50 33 ) 3.25 21 ) 
ED5 1.75 33 ) 4.00 21 ) 
ED6 0.75 33 ) 2.50 21 ) 
DNA type: 1 2.500 132) 8.31 <0.01 3.75 84 ) 13.56 <0.001 
2 0.875 66 ) 2.50 42 ) 
Day: 1 2.00 18 ) 2.00 18 ) 
2 4.87 18 ) 4.87 18 ) 
3 3.75 18 ) 3.75 18 ) 
4 3.75 18 ) 3.75 18 ) 66.54 <0.001 
5 4.00 18 ) 4.00 18 ) 
6 2.75 18 ) 154.3 <0.001 2.75 18 ) 
7 1.37 18 ) 1.37 18 ) 
8 0 18 ) 
9 0 18 ) 
10 0 18 ) 
11 0 18 ) 
n = number of observations 
H = Kruskal- Wallis statistic (adjusted for ties) 
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TABLE 5.13 Virus isolation from ocular swabs in experiment 1. 
Median daily titres (loginTCID5n per 90p1 extraction 
medium) and cumulative titres for days 1 -11 after 
inoculation 
L eye R eye 
Cusum titres Cusum 
titres 
Daily Daily 
DNA Block median Block median 
Virus type A B C titre B C titre 
ED1 1 21.00 16.75 17.75 1.25 9.25 0 0 
ED2 2 8.75 8.00 10.00 0 1.75 1.50 0 
ED3 1 27.25 11.50 19.00 1.50 2.00 7.75 0 
ED4 1 21.00 13.75 24.50 1.75 4.25 4.25 0 
ED5 1 23.00 14.50 15.75 1.00 0 0.50 0 
ED6 2 4.50 13.25 6.75 0 3.00 0.50 0 
Two way analysis of Cusum titres by Friedmann's test 
Comparison k, n M P 
L eye blocks 3, 6 4.00 >0.10 
L eye strains 6, 3 8.67 >0.10 
R eye blocks 2, 6 too few to analyse 
R eye strains 6, 2 3.79 >0.10 
Analysis of daily titres by Kruskal Wallis test 
Comparison k, n H P 
L eye blocks 3, 66 2.12 >0.10 
L eye strains 6, 33 14.61 <0.05 
R eye blocks 2, 66 0.04 >0.10 
R eye strains 6, 22 9.66 >0.05 
Comparison of cusum titres by DNA type using Mann Whitney test 
Median cusum 
Eye DNA n titre U P 
L 1 12 18.375 ) 1 <0.001 
L 2 6 8.375 ) 
R 1 8 3.125 ) 12.5 >0.10 
R 2 4 1.625 ) 
Notes 
Right eyes were not swabbed in block A 
k = number of levels in the analysis 
n = number of observations per level 
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TABLE 5.14 Patterns of virus shedding in nasal secretions 
(experiment 2) 
Notes: - Tabulated values are log10 TCID50 per 90ul extraction 
medium. 
- A value of <1 indicates no growth of virus in the 1 /10 
dilution, where it was not possible to evaluate the 
wells with undiluted sample due to toxic effects on 
the cells. An arbitrary value of 0 was assigned. 
- A reading of ' -' indicates no growth of virus in the 





























test for dai- 
ly titres in 
each pair 








<1 <1 <1 <1 
<1 <2 <2 <1 
<1 <1 <1 <1 
0.6 <1 <1 2.0 
1.5 1.75 4.5 2.25 
4.5 2.75 4.25 3.75 
4.75 3.25 5.5 3.75 
3.75 3.5 4.5 2.5 
3.5 3.5 5.5 3.5 
3.0 3.25 4.75 2.0 
0.75 1.5 2.0 0.15 
<1 1.25 1.5 <1 
<1 <1 <1 
- <1 - 
<1 - - 






2 3 4 6 
1 2 1 2 1 2 1 2 
<1 <1 1.25 <1 1.25 1.0 <1 0.75 
4.5 3.5 1.75 <1 2.5 2.75 2.5 1.0 
4.75 <1 3.75 1.75 4.0 3.0 1.5 <1 
4.0 3.5 4.5 3.5 4.75 3.0 3.5 1.75 
3.25 3.5 4.0 3.5 4.0 3.5 3.75 3.5 
3.5 2.0 3.25 2.25 4.0 2.25 3.25 3.75 
3.5 2.0 3.25 1.75 3.25 1.75 2.5 2.5 
<1 0.75 2.5 1.0 2.0 1.75 1.0 1.0 
0.75 0.6 <1 0.6 1.5 1.25 <1 0.75 
0.3 <1 - <1 0.75 0.45 <1 0.6 
<1 <1 <1 <1 <1 0.6 <1 <1 
<1 <1 <1 <1 <1 <1 <1 <1 
<1 <1 <1 <1 <1 <1 <1 <1 
- - <1 - - - <1 <1 





Median cusum titre, strain ED1 = 24.40 
strain ED2 = 17.88 
Mann Whitney test to compare strain medians, U = 
9.90 6.70 2.40 
9 11 8 
2,43 10,56 14,22 
<0.05 <0.05 >0.10 
3 (P<0.05) 
Wilcoxon's signed rank test on cusum pair differences, t, T = 0,21 (P<0.05) 
Mann Whitney test to compare virus strains by daily titres, ni = n2 = 90, 
U = 3627 (P>0.10) 
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TABLE 5.15 Cumulative virus titres for ocular swabs in 
experiment 2 
Method of 
infection Pair Virus L eye R eye 
Contact 
( 1 1 0 5.60 
( 2 1.20 0.90 
( 
( 5 1 12.25 15.05 
( 2 11.00 2.35 
( 2 1 6.50 1.60 
( 2 8.95 0.90 
( 
( 3 1 12.50 2.25 
( 2 9.80 1.50 
Inoculation ( 
(nose + L eye) ( 4 1 9.75 6.00 
( 2 3.00 3.50 
( 
( 6 1 10.25 6.10 
( 2 7.50 2.55 
Inoculated eyes (L eye, pairs 2, 3, 4, 6) 
Wilcoxon signed rank test (for differences ED1 - ED2): 
t, T = 1, 9 (P >0.10) 
Mann Whitney comparison of medians ED1 vs. ED2: 
nl = n2 = 4, U = 4 (P >0.05) 
Non -inoculated eyes (all R eyes, plus L eye, pairs 1 and 5) 
Wilcoxon signed rank test (for differences ED1 - ED2): 
t, T = 3, 33 (P <0.05) 
Mann Whitney comparison of medians ED1 vs ED2: 
nl = n2 = 8, U = 19 (P>0.10) 
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TABLE 5.16 Recovery of BHV1 from calves following reactivation 











Swab site Nose Prepuce Nose Prepuce Nose Prepuce 
Day 0* - - - - - 
1* + + + + - + 
2* + + + + + + 
3* + + + + - + 
4* + + + + + + 
5 + + + + - - 
6 + + + + + + 
7 + - + + - + 
8 + - + + + + 
*dexamethasone injected on these days 
TABLE 5.17 Virus shedding (TCIDSn per 90u1 extraction medium) in 
calves following heterologous BHV1 challenge 
(experiment 2) 
Pair 2 3 
Calf 9378 9406 9408 9407 
Original inoculum ED1 ED2 ED1 ED2 
Challenge inoculum ED2 ED1 ED2 ED1 
Days after N R L N R L N R L N R L 
challenge 0 - - - - - - - - - - - - 
1 3.25 - - 2.5 - - 1.5 - - 0.75 - - 
2 2.0 - 0.15 4.5 - - 3.5 - - 3.0 - - 
3 3.75 - 2.25 4.0 - - 1.75 - - 3.25 - - 
4 1.75 - 0.45 4.5 - 0.15 3.0 - - 3.5 - - 
5 3.0 - - 3.75 - - 3.0 - - 2.75 - - 
6 1.5 - - 2.5 - - - - - 2.25 - - 
7 0.15 - - 0.75 - - - - - - - - 
8 - - - - - - 0.6 - - - - - 
9 - - - - - - - - - - - - 
10 0.6 - - - - - - - - - - - 
11 - - - - - - - - - - - - 
cumulative 
titre 16.00 0 2.85 22.50 0 0.15 13.35 0 0 15.50 0 0 
N = nasal swab 
R, L = right and left eye swabs 
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TABLE 5.18 Comparison of nasal shedding of virus in calves 









Titres are expressed in log TCID50 per 90111 extraction 
medium. 
EDI ED5 
x54 x60 x62 
2.25 3.0 3.25 
4.5 4.0 3.75 
<1 2.25 1.75 
<1 <1 <1 
x53 x55 x61 
4.0 2.25 2.25 
2.5 <1 3.5 
<1 <1 0.75 






6.75 9.25 8.75 
8.75 
6.5 2.25 6.5 
6.5 
Friedmann's test for differences in daily titres between calves: 
k, n = 6,4; M = 4.68 (P>0.10) 
Mann Whitney comparison of daily titres between virus strains: 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 5.20 Comparison of antibody responses measured by ELISA 
according to DNA type of the virus (experiment 1) 
Block Days tested No. observations Student's t statistic 
(and significance) 
DNA 1 DNA 2 IgG1 IgG2 IgM 
A 3 - 28 24 6 1.40 (NS) 0.94 (NS) 0.85 (NS) 
B 7 - 51 24 12 0.33 (NS) 0.13 (NS) 2.10 (<0.05) 
C 7 - 56 48 24 1.96 (NS) 1.38 (NS) 0.91 (NS) 
Notes: A pooled variance estimate for the two DNA types was used 
for each analysis. 
NS = not significant (P>0.05) 
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TABLE 5.21 Values of Student's t statistic and probability levels (P) 
comparing mean ELISA values for serum antibodies on 
sampling days post -inoculation with those on the day of 
inoculation (experiment 1). 
IgG1 IgG2 IgM 
Block Day t P t P t P 
A 3 -0.38 NS -1.00 NS 0.59 NS 
7 -0.71 NS -1.00 NS 1.68 NS 
10 3.54 <0.05 5.49 <0.01 4.23 <0.05 
14 6.08 <0.01 6.29 <0.01 3.89 <0.05 
B 7 -1.46 NS 1.00 NS 1.10 NS 
11 4.57 <0.01 4.47 <0.01 5.74 <0.01 
22 8.02 <0.001 4.66 <0.01 1.48 NS 
30 7.77 <0.001 5.49 <0.01 0.72 NS 
C 7 0 NS 1.00 NS 2.28 NS 
8 0.55 NS 1.46 NS 3.43 <0.05 
9 1.70 NS 2.71 <0.05 4.10 <0.01 
10 4.17 <0.01 4.18 <0.01 4.22 <0.01 
12 5.29 <0.01 6.01 <0.01 3.61 <0.05 
NS = not significant (P >0.05) 
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TABLE 5.22 Values of Student's t statistic and probability levels (P) 
for the mean difference in ELISA values for serum antibodies 




Days IgGl IgG2 IgM 
DT Ds t p t p t p 
4 Contact 0 7 1.36 NS -1.00 NS -0.93 NS 
exposure 0 11 1.51 NS 0.52 NS 1.59 NS 
0 14 4.43 <0.05 2.94 NS 7.79 <0.01 
0 21 6.18 <0.01 6.99 <0.01 3.73 <0.05 
8 Inoculated 0 7 -0.15 NS 1.56 NS 1.51 NS 
0 11 6.56 <0.001 4.02 <0.01 5.28 <0.001 
0 14 7.94 <0.001 9.27 <0.001 5.31 <0.001 
0 21 8.06 <0.001 9.22 <0.001 8.44 <0.001 
3 Dexamethasone 56 63 -1.96 NS 0.70 NS -1.00 NS 
56 70 2.45 NS 2.98 NS 3.21 NS 
56 88 1.70 NS 3.36 NS 2.32 NS 
4 Heterologous 88 92 -3.74 <0.05 -3.34 <0.05R -0.64 NS 
challenge 88 95 5.06 <0.05 -0.15 NS 1.28 NS 
88 98 7.43 <0.01 8.74 <0.01 0.77 NS 
88 102 8.88 <0.01 7.84 <0.01 1.28 NS 
NS = not significant (P>0.05) 
R = significant decrease in OD value 
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TABLE 5.23 Paired comparison of serum antibody responses to primary 
challenge with virus strains ED1 or ED2 (experiment 2) 
IgG1 IgG2 IgM 
Sample days 11 -56 11 -56 11 -21 
No. pair differences 36 36 18 
No. pair differences ' 0 
(for Wilcoxon test) 
35 34 17 
Wilcoxon t, T 91.5, 538.5 178.5, 416.5 52, 101 
P <0.001 <0.05 >0.10 
Student's t 4.64 2.40 1.99 
P <0.001 <0.05 >0.05 
TABLE 5.24 Values of Student's t statistic and probability levels (P) 
for the mean difference in ELISA values for nasal secretory 
antibodies between day of sample and day 1 after inoculation 
in experiment 1C. 
IgG1 IgG2 IgM IgA 
Day t P t P t P t P 
5 0 >0.10 -1.00 >0.10 -0.85 >0.10 -2.39 >0.05 
8 2.24 >0.05 -1.11 >0.10 1.99 >0.05 1.28 >0.10 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 5.26 Paired comparison of nasal secretory antibody responses to 
primary challenge with virus strains ED1 or ED2 (experiment 2) 
Sample days: 14 -56 
No. pair differences (ED1 -ED2): 30 
Student's t 
(29 d.f.) P 
IgG1 2.80 <0.01 
IgG2 3.84 <0.001 
IgM 0.43 >0.10 
IgA 0.19 >0.10 
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Source of Variation 
Blocks Virus strains Virus DNA type 
Clinical score a NS NS P<0.05 
b NS P<0.05 P<0.001 
Virus titre 
excreted 
- nasal cusum b NS P<0.05 P<0.001 
- nasal daily 
(days 1 -7) 
b NS NS P<0.001 
- L eye cusum b NS NS P<0.001 
- R eye cusum b X NS NS 
- L eye daily b NS P<0.05 X 
- R eye daily b NS NS X 
Serum antibody 
response 
- IgG1 a NS NS NS 
- IgG2 a NS NS NS 
- IgM a NS NS S 
Notes: a parametric tests 
b non -parametric tests 
NS not significant (P >0.05) 
S significant (P <0.05) for one block only 
X not analysed 
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Clinical score a P <0.01 X 
b P<0.05 NS 
Virus titre in 
swabs: 
nasal cusum b P <0.05 X 
nasal daily b NS NS 
inoculated eyes b NS X 
uninoculated eyes b P<0.05 X 
Serum antibody: 
IgG1 a P<0.001 X 
IgG2 a P <0.05 X 
IgM a NS X 
Nasal secretory 
antibody: 
IgG1 a P <0.01 X 
IgG2 a P<0.001 X 
IgM a NS X 
IgA a NS X 
NOTES: a parametric tests 
b non -parametric tests 
NS not significant (P >0.05) 
X not analysed 
-162- 
Chapter 6 
ASSESSMENT OF DIAGNOSTIC METHODS FOR INFECTIOUS BOVINE RHINOTRACHEITIS 
INTRODUCTION 
The specific diagnosis of IBR may be said to have begun with the 
first recorded in vitro isolation of the virus from diseased animals 
in the USA (Madin and others, 1956). Virus isolation in cell culture 
remains a useful diagnostic method, although in recent years its 
importance has diminished as developments in immunoassay technology 
have liberated viral diagnosis from dependence on the constant availa- 
bility of cell cultures. Samples received at the Central Veterinary 
Laboratory from natural cases of suspected IBR, as well as materials 
from experimentally infected calves, were used to compare and contrast 
a variety of diagnostic techniques for the disease. The two major 
areas investigated were the detection of viral antigens and the detec- 
tion of the hosts' responses by serology. Because the chapter is 
largely concerned with optimisation of the methodology, the materials, 
methods and results have been combined under each sub -heading. 
EXPERIMENTAL ANIMALS 
Some materials were collected from the animals in experiments 1 and 2 
(described in chapter 5). In addition, two further series of animal 
experiments were conducted. In experiment 4, three 6 -7 month old 
Friesian calves, seronegative to BHV1, were inoculated intranasally 
with a single dose of 4 x 108 TCID50 of virus strain ED4. Three 
control calves in an adjacent but separate pen were inoculated with 
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non -infected cell culture harvest. All six animals were examined 
daily although full clinical scoring was not carried out. The three 
infected calves developed a febrile upper respiratory disease, (simi- 
lar to that described in chapter 5) with elevated rectal temperature 
on days 2 to 6 or 7 inclusive. Short cotton wool nasal swabs were 
taken daily, as described in chapter 5. In addition, on days 1 to 3 
after inoculation, long nasopharyngeal brush swabs, as described by 
Thomas and Stott (1975), were taken. Both swab types were eluted 
into 3 ml PBSL for transport to the laboratory. 
Experiment 5 was an investigation into possible interactions between 
bovine virus diarrhoea virus and BHV1 vaccination. It has been fully 
described elsewhere (Edwards and others, 1986a). The final part of 
the experiment consisted of challenging the 24 male Jersey calves 
with virulent BHV1 (strain ED1) using the same dose of virus and 
routes of inoculation as in experiments 2 and 3. Ten of the calves 
had previously been vaccinated intranasally with live temperature - 
sensitive vaccine against BHV1 (Tracherine, Smith Kline Animal 
Health). 
One of the non -vaccinated animals (No. 62) appeared to have acquired 
vaccine virus infection by lateral spread, as evidenced by its 
antibody response, titre of virus shed and clinical score. With this 
exception, the non -vaccinates developed clinical signs of IBR follow- 
ing challenge, with a pattern of disease similar to that reported for 
the other experiments. As also noted for experiment 3 (chapter 5), 
the severity of disease, indicated by the clinical scores (Edwards 
and others 1986a), was less in these Jersey calves than in the 
Frie- 
sians used for the earlier experiments. In the comparison, 
for virus 
ED1 only, between clinical scores in experiment 2 (Friesians) 
and 
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experiment 5 (Jerseys), the Mann Whitney U statistic was 1 
(ni = 13, n2 = 6, P <0.001); but comparing experiments 3 and 5 (both 
Jerseys), U = 14 (n1 = 13, n2 = 3, P>0.10). Clinical signs in the 
vaccinated calves for experiment 5 were transient or absent. Short 
swabs were collected as described above, during the post -challenge 
period, and used for further assessment of antigen detection methods. 
COMPARISON OF SAMPLE PREPARATION METHODS FOR ANTIGEN DETECTION 
In experiment 1, blocks A and B, smears of nasal secretion were 
prepared by wiping freshly -collected swabs across glass microscope 
slides and allowing the mucus smears to air -dry. These were subse- 
quently fixed in cold acetone then stained by the direct fluorescent 
antibody method (see below). On examination by fluorescence micro- 
scopy, a confident diagnosis of BHV1- specific fluorescence was made 
on samples collected on days 2, 3 and 4 after inoculation, but beyond 
this period considerable doubt entered into the interpretation due to 
a paucity of positively stained cells and high, confusing background 
fluorescence. An attempt to enhance the specific fluorescence on 
duplicate smears by using the indirect staining method (unlabelled 
bovine antiserum followed, after thorough washing, by rabbit anti - 
bovine IgG FITC conjugate (Nordic)) also increased the background 
fluorescence and worsened the perceived signal /noise ratio. 
Samples from experiment 4 (which chronologically preceded experiments 
1C, 2 and 3) were used to establish a better method of cytological 
smear preparation, which was used in the remaining animal experiments 
and subsequently recommended for field diagnostic use. Nasal swabs, 
immediately after collection, were broken off into (or agitated 
vigorously in) 3 ml aliquots of PBSL which were transported to the 
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laboratory in small screw -capped bottles. After agitation on a vortex 
mixer the swabs if still present were removed and the samples centri- 
fuged at 500g for five minutes. The supernatant was reserved for 
virus isolation, or detection of soluble antigens. The preparation 
of cell smears was based on the methods of Minnich and Ray (1980) and 
Thomas and Stott (1981). The cell deposit was mixed with 1 ml PBS 
(for short nasal swabs) or 5 ml PBS (for long, brush swabs) and 
single drops were spotted onto PTFE coated multispot glass slides 
(C.A. Hendley Ltd) and evaporated to dryness. The slides were fixed 
in cold (4 °C or -20 °C) acetone for 10 minutes and rinsed in distilled 
water before immunolabelling. 
The cell suspension could be further washed in PBS before spotting 
onto the slide but this was found to confer little advantage. An 
alternative procedure assessed was the centrifugation of cells from 
the sample suspension directly onto glass slides using a 'cytospin 2' 
centrifuge (Shandon) operating at 400g for 5 minutes. The prepara- 
tions were as good as, but no better than, the simple drying tech- 
nique. The cytospin method was also more cumbersome, requiring 
cleaning of the apparatus after each centrifugation; and produced 
only one spot smear per slide, compared with 12 by the drying tech- 
nique. 
The washed -cell, dried -smear technique gave very satisfactory prepar- 
ations, with a good density of cells for examination (Figs 6.1 -6.3) 
and low background labelling, enabling the detection of small numbers 
of infected cells such as were observed as the acute phase of infection 
regressed, typically on days 6 and 7 after inoculation. In the experi- 
mental intranasally- inoculated calves, the long brush swabs generally 
gave poorer preparations and fewer positive cells than the short 
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cotton wool swabs. Subsequent field reports from veterinary investi- 
gation centres (personal communications) have indicated satisfactory 
results with long wire and cotton wool swabs ('Laryngeal Swabs', 
Medical Wire Co.) which are finer and less damaging to the epithelial 
tissues than the brush swabs. 
CYTOLOGICAL LABELLING METHODS FOR ANTIGEN DETECTION 
Gnotobiotic bovine immunoglobulins specific for BHV1, conjugated to 
either FITC or peroxidase and stored at -20 °C as 50% glycerolised 
stocks, were further diluted 1 in 4 (immunofluorescence) or 1 in 5 
(immunoperoxidase) respectively, in PBS, initially at pH 7.2, but 
latterly at pH 7.6 which was found to give more consistent results 
with immunofluorescence. The optimum dilution of each batch of 
conjugate was determined by close interval titrations (e.g. 1/3, 1/4, 
1/5, 1/6, 1/8, 1 /10, 1/12) to establish the highest dilution which 
gave strong labelling on known positive material (virus- infected cell 
cultures) together with acceptably low background signal on known 
negative samples. 
The diluted conjugates were reacted with the fixed cell smears for 30 
minutes in a humid chamber at either 37 °C or room temperature; both 
gave satisfactory results. Washing was carried out for 10 minutes in 
each of three changes of PBS. Fluorescent -labelled smears were then 
counterstained with Evans blue 1 /100,000 for one minute, rinsed then 
mounted in buffered 50% glycerol (pH 7.6) for examination under 
incident light fluorescence (50W mercury vapour light source, x 40 
objective lens). Immunoperoxidase- labelled smears were reacted 
with DAB substrate mixture for 10 minutes, rinsed, lightly 
counter - 
stained with toluidine blue, dehydrated and mounted in DPX 
medium for 
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examination by bright field microscopy. Specificity of the immuno- 
peroxidase label was monitored by staining duplicate smears with 
conjugates specific for other viruses. 
Both fluorescent and enzyme labels enabled a confident diagnosis of 
BHV1 infection to be made on samples collected on days 2 to 5 inclu- 
sive after inoculation of the experimental animals. Control unin- 
fected animals were uniformly negative. The microscopic picture is 
illustrated in figs. 6.1 to 6.3. Beyond this period a diagnosis 
became progressively more difficult to establish, as the number of 
positively labelled cells in the smears diminished, and then the 
intensity of labelling became reduced. The results for experiment 1C 
and experiment 2 are shown in tables 6.1 and 6.2. The positive 
results were accumulated for each calf, using a scoring system as 
shown in the tables, to produce a cusum value representing the number 
of days on which a positive result was found, weighted for the degree 
of positivity recorded for each sample. The scores were analysed by 
a paired t -test, comparing immunofluorescence with immunoperoxidase 
(no significant difference, Table 6.1) and virus strain EDI with ED2 
(significantly higher scores for EDI, P <0.05, Table 6.2). In experi- 
ment 4 an estimate of the proportion of cells in the smears, labelled 
positively for viral antigen, was made by differential cell counting 
of the immunoperoxidase preparations, as shown in table 6.3. The 
peak values for positively labelled cells occurred on day 3. 
In the immunoperoxidase system no problem was encountered, in the ex- 
perimental animals, with endogenous cellular enzymes yielding "false 
positive" coloured reaction products. If present this would have 
appeared equally in test and control smears. In view of the accepted 
risk of this phenomenon (Benjamin, 1979) the effect of enzyme block- 
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Fig. 6.1 BHV1 antigen in nasal epithelial cells of an experimentally 
infected calf, labelled by direct immunofluorescence 
Fig. 6.2 Nasal epithelial cells from an uninfected control calf, 
labelled for BHV1 antigen by immunofluorescence. 









Fig. 6.3 Nasal epithelial cells from a BHV1 experimentally 
infected calf labelled by immunoperoxidase for 
BHV1 (L) and BVDV (R) antigens 
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ing pretreatments on the labelling of viral antigen was investigated. 
0.5% hydrogen peroxide in aqueous solution produced gas bubbles which 
disrupted the smears from the slide. 0.5% hydrogen peroxide in metha- 
nol (10 minutes) markedly reduced the positive labelling of viral 
antigen and was therefore considered unsatisfactory. 0.1% phenyl - 
hydrazine (1 hour at 37 °C and pH 7.0) did not impair the antigen 
labelling and has been shown to block effectively endogenous peroxi- 
dase activity (Miry and others, 1983). This finding was supported by 
other work by the author (unpublished observations) on frozen and 
paraffin sections of bovine tissues. 
Following the successful results with the cell labelling technique in 
the experimental animals, and encouraging results with preliminary 
studies on field samples received at the CVL, it was decided to make 
the immunofluorescence technique widely available through the 
Veterinary Investigation Service in England and Wales. The programme 
consisted of 5 parts:- 
(i) provision of fluorescent antibody conjugate for the direct 
labelling of smears and tissues from suspect IBR cases. The 
antiserum was prepared in a colostrum deprived calf, and con- 
jugated to FITC, in bulk quantities. The conjugate was freeze 
dried in 2 ml aliquots for distribution to the diagnostic lab- 
oratories. Freeze drying was found to cause only a slight 
drop in optimum working dilution. 
(ii) training of staff from every VI centre, so that they could 
distinguish specific and non -specific fluorescence, recognize 
characteristic features of the fluorescence for IBR (and other 
viruses), and learn the appropriate technical procedures. 
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(iii) provision of suitable equipment (i.e. fluorescence microscopes) 
for each centre. 
(iv) monitoring of performance through a quality assessment scheme. 
(v) recording of results through a voluntary reporting scheme, the 
data being collated by the author in a Prime Information 
account on the CVL computer. 
The recording scheme began during 1984 and was fully operational in 
time to provide a full year's data for 1985. The results for IBR are 
shown in table 6.4. The figures shown are for disease episodes on 
individual farms. Data was also collected on an individual animal 
basis which gave diagnostic rates for IBR of 10.0% for live animals 
with respiratory disease (i.e. nasal cell smears, 336/3366 cases), 
and 4.8% for dead cases of respiratory disease (i.e. sections or 
smears of trachea and lung, 51/1067 cases). In addition, of 138 
aborted fetuses examined for BHV1 antigen by immunofluorescence, six 
(4.3 %) were reported positive (5/134 outbreaks). There were insuf- 
ficient positives for a meaningful monthly analysis of abortion 
results although there was a marked seasonal trend in the number of 
fetuses examined, most being from May- November, with the peak in 
August. 
A chi -squared analysis on the monthly figures from respiratory dis- 
ease outbreaks showed a significant seasonal trend (P <0.001) both in 
numbers of outbreaks examined, and the proportion of these attributed 
to BHV1 infection (Table 6.4). It should be emphasised that immuno- 
fluorescence is not the sole diagnostic test used to confirm IBR in 
many outbreaks. A more comprehensive account of confirmed IBR out- 
breaks has been given in chapter 3. The purpose of the present 
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analysis is to assess the value of immunofluorescence as a diagnostic 
tool. 
For quality assessment, VI centres were sent coded acetone -fixed 
nasal cell smears from the experimental animals to label by immuno- 
fluorescence. A summary of the overall performance is shown in table 
6.5, although this fails to reveal that some individual centres 
consistently achieved 100% success, whilst others have had technical 
problems on particular occasions although generally performing well. 
The overall sensitivity of the VI centres, compared with CVL, was 81% 
(95% confidence limits + 8 %) and specificity was 88% (+ 10 %). 
ELISA FOR ANTIGEN DETECTION 
An antigen- capture ELISA was developed for the detection of BHV1 
antigen in the supernatants of swab transport media. The influence 
of a number of technical variations on the test results was assessed, 
including the use of the avidin- biotin system to amplify the response. 
Microtitre immunoassay plates were coated overnight at 4 °C with 
100 ul per well of IgG from the gnotobiotic calf antiserum to BHV1 
diluted 4ug /ml in carbonate coating buffer. The plates were washed 
three times in PBST, then dried and stored at 4 °C to await testing. 
Undiluted samples were added for 2 hours at 37 °C, then the plates 
washed before addition of the detection steps for bound antigen. 
In the simple sandwich (SS) assay, peroxidase conjugated IgG from the 
gnotobiotic antiviral serum was added at a dilution in ELISA diluent 
of 1 /1000 from 50% glycerolised stock conjugate. The optimal 
concentrations of coating and conjugate layers were determined by 
chequerboard titrations with a known positive sample (cell culture 
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harvest of the virus). The working dilutions were chosen to optimise 
both the signal /noise ratio and the absolute difference in OD reading 
between positive and negative samples. The chromogenic substrate was 
OPD and the colour reaction stopped after 15 minutes by the addition 
of 25 pl per well 2.5M sulphuric acid. The steps used in the SS 
assay are shown diagramatically in fig. 6.4. 
The type of microtitre plate used had a marked effect on the results. 
Table 6.6 shows the comparison between plate types M129A and M129B 
(Dynatech Laboratories Ltd.) for a sample close to the lower limit of 
antigen detectability. M129B gave unacceptably high colour reactions 
in the negative sample wells and was not used further, even though it 
produced much higher ODs with the positive samples. Both these 
plates were of the rigid polystyrene type, and M129A plates were used 
for subsequent work (Tables 6.7 -6.8) until flexible polyvinyl types 
became available. For the statistical analysis in table 6.6, the 
arithmetic difference in OD between the weak positive and the nega- 
tive sample was calculated for each location in the chequerboard 
matrix. This was more useful than the ratio (positive: negative) 
which became very high, even with weak positive reactions, as the 
negative value approached zero. The test was analysed as a three -way 
anovar. The concentration of coating antibody did not significantly 
affect the discrimination between positive and negative, although at 
the higher levels it markedly increased the absolute OD values, 
giving an unacceptably high colour reaction with the negative sample 
(data not shown). Addition of 4% polethylene glycol (PEG, molecular 
weight 6000) to the conjugate diluent as suggested by Salonen and 
Vaheri (1981) appeared to increase slightly the OD of the positive 
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Fig. 6.4 Schematic representation of the simple sandwich (SS) 
ELISA for BHV1 antigen detection 
statistically significant and, after use in a few more trials, the 
addition of PEG to the diluent was discontinued. The only signifi- 
cant source of variation in table 6.6 was the concentration of conju- 
gate used. The use of 1 /1000 dilution of the conjugate for the test 
was selected on the basis of this and further tests at varying antigen 
concentrations. 
Table 6.7 shows the effect of incorporating 1% bovine serum albumen 
(BSA) in the conjugate diluent. There was a significant reduction in 
background noise, affecting the results of both positive and negative 
samples, although the distinction between positive and negative 
readings was hardly affected (P>0.10). In subsequent tests, 1% BSA 
was incorporated as a standard component of the conjugate diluent. 
The results obtained with this test on the swab extraction medium 
supernatants from experiment 4 are shown in table 6.8 and fig 6.5. 
The mean of the 30 results for the control (non- infected) calves was 
0.087 with a standard deviation of 0.046, a standard error of 0.008 
and upper tolerance limits (using one -tailed values for t) of 0.17 
(at P = 0.05) and 0.24 (at P = 0.001). In interpreting the test 
these values were used to define positive (>0.24), negative ( <0.17) 
and indeterminate results. It can be seen in table 6.8 that two 
samples from the noninfected calves fell into the inconclusive cate- 
gory. The infected calves were positive from day 2 to day 8 (2 
calves) or to day 11 (1 calf). 
A further assessment of the effects of microtitre plate character- 
istics on the results of the ELISA was made by comparing the Dynatech 
M129A type (rigid polystyrene) with Falcon 3912, Microtest III 
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Fig. 6.5 Simple sandwich ELISA for BHV1 antigen. Mean OD 
values for nasal swab extracts from three infected 
and three control calves (experiment 4) 
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table 6.9 there was a small but significant rise in background OD 
values with negative samples on the polyvinyl plate, but this was 
considered on acceptable disadvantage, in view of the much greater, 
and highly significant (P <0.001), increase in positive OD values on 
the same plates. For subsequent work, the flexible polyvinyl plates 
were used. 
The development of the amplified ELISA utilising the avidin- biotin 
interaction has been described fully elsewhere (Gitao, 1984; Edwards 
& Gitao, 1987). The principles of the tests are shown diagrammat- 
ically in fig. 6.6. In the labelled avidin (LAB) system a two stage 
detection procedure was used, namely biotinylated antiviral antiserum 
with a 2:1 molar ratio of biotin: immunoglobulin, followed, after 
washing, by an avidin -peroxidase conjugate (Sigma) at a dilution of 
1 /1000. The bridged avidin- biotin (BAB) system employed biotinylated 
antiviral antibody at a 4:1 molar ratio of biotin: immunoglobulin, 
followed after washing by avidin (Sigma) 1011g /ml, then, after further 
washes, biotinylated horseradish peroxidase (molar ratio 10:1 biotin: 
peroxidase). The proteins were biotinylated by addition of the 
appropriate amount of 0.1M biotin -N- hydroxysuccinimide (Sigma) dis- 
solved in dimethylformamide to a 10 mg /ml solution of the protein in 
O.1M sodium bicarbonate. After reacting for 1 hour at room tempera- 
ture, unbound biotin was removed by dialysis against PBS pH 7.2. 
As a further refinement on the three ELISA systems (SS, LAB and BAB) 
control wells were introduced, coated with bovine immunoglobulin 
lacking antibodies to BHV1. The test results were then calculated as 
(OD in test well - OD in control well). When calculated by this 
method, the 0.1% upper tolerance limit for negative samples (the 
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Fig. 6.6 Schematic representation of the amplified ELISAs for 
BHV1 antigen detection: labelled avidin biotin (LAB) 
and bridged avidin biotin (BAB) systems 
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The sensitivity of the three ELISAs was compared by titrating, to the 
end -point of detection in each system, both density -gradient purified 
BHV1 and crude freeze -thaw cell culture harvest of BHV1. The SS 
could detect gradient -purified virus at a concentration equivalent to 
106'0 TCID50 /ml, whereas the amplified ELISAs had detection limits of 
104'5 TCID50 /ml (LAB) and 104'2 TCID50 /ml (BAB), equivalent to 30- 
and 60 -fold increases in assay sensitivity, and a detection rate for 
BAB of 5118 viral protein per test well (10014/m1). The sensitivity 
enhancement when testing the crude viral harvest was approximately 
10- (LAB) and 20 -fold (BAB) over the SS method, as illustrated in 
fig. 6.7. 
REVERSE PASSIVE HAEMAGGLUTINATION (RPHA) 
Sheep red blood cells were washed, then treated with chymotrypsin as 
described by Cranage and others (1985). Anti -viral specific immuno- 
globulin was prepared from gnotobiotic calf antiserum to BHV1 using 
the caprylic acid method (Steinbuch and Audran, 1969). After dialy- 
sis against 0.9% sodium chloride the antibody was coupled to the 
enzyme treated erythrocytes using chromic chloride (Scott and others 
1981). A 1% suspension of the coated cells was stabilised by glutar- 
aldehyde treatment (Cranage and others, 1983) and kept at 4 °C. The 
test was carried out by mixing 30111 of serial doubling dilutions of 
swab extraction media with equal volumes of 1% coated red cell sus- 
pension in a 96 well round -bottomed micro -titration plate. The 
haemagglutination reaction in each well was graded visually, after 2 
hours at room temperature, on a scale from 0 (absent) to 4 (complete 
agglutination). The end point was taken as the highest dilution 
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Fig. 6.7 Comparative sensitivities of three ELISAs and RPHA 
for the detection of BHV1 antigen in serial dilutions 
of cell culture fluid 
were uncoated sheep erythrocytes, and sheep erythrocytes coated with 
antibody negative to BHV1. 
The sensitivity of the RPHA on cell culture harvest of BHV1 was 
similar to the amplified BAB ELISA, as shown in fig. 6.7. 
COMPARISONS OF ANTIGEN DETECTION METHODS 
The extracts from the short nasal swabs in experiment 4 were tested 
for BHV1 antigen by immunofluorescent and immunoperoxidase labelling 
of cell smears and by SS ELISA. The comparison of the 3 methods in 
relation to virus isolation is shown in fig. 6.8. Only the solid 
bars represent results which would be considered unequivocally 
positive in a diagnostic assay on unknown field material. The samples 
were stored at room temperature and retested by cell -labelling after 
3 and 7 days and by ELISA and virus isolation after 7 days. After 3 
days, the cell -labelling systems (immunofluorescence and immuno- 
peroxidase) gave satisfactory results, similar to fresh samples. 
After 7 days storage, a few samples could still be read with confi- 
dence by these methods but in most cases the cell structure was 
greatly disrupted, there were very few intact cells in the smears, 
and although fluorescence or coloured substrate were still detectable 
in the cell debris of positive samples a confident diagnosis could 
not be established. The effects of room temperature storage on the 
ELISA and virus isolation results are shown in fig. 6.9. The strong 
positives remained positive but there was a reduction in positive 
results for both tests from the eighth day after inoculation. Gross 
bacterial or fungal contamination of some of the samples was evident 
after the week at room temperature, but this did not appear to inter- 








































































































































































































































































































































































































































































































































The swab extracts from experiment 5 were tested by BAB ELISA, RPHA 
and virus isolation. The detailed results are given in Appendices 6 
(i) and (ii). Irregular reactions with RPHA occurred at up to the 
1/4 dilution of the sample when both the other assays were negative. 
In the absence of further evidence these agglutination reactions were 
considered to be non -specific. Thus the RPHA was only classed as 
positive when the titre was > 1/8 (3 units on the scale in appendix 
6 (i) and (ii)). Similarly the ELISA was classed positive only if 
the OD was ) 0.10. All the calves shed virus following the challenge 
inoculation but, except for one sample (titre 106'0 TCID50 /ml) from 
one calf, neither the ELISA nor RPHA gave a positive result after 
challenge of the vaccinated calves, the samples from which contained 
< 105'5 TCID50/ml (Appendix 6 (i)). 
In the unvaccinated calves undergoing primary challenge with BHV1, 
both antigen detection tests gave positive results for samples with a 
wide range of infectivity titres (103'5 to 106'75 TCID50 per ml) 
(Appendix 6 (ii)). The two antigen detection tests showed a high 
degree of agreement (r = 0.89, P <0.01) but the correlation between 
antigen level and infectivity titre was much poorer although still 
significant (BAB ELISA vs. infectivity, r = 0.60, P<0.01; RPHA vs. 
infectivity, r = 0.65, P <0.01). Figs. 6.10 and 6.11 illustrate the 
pattern of virus and antigen shedding in the nasal secretions of a 
representative single calf (Fig. 6.10) and the mean values for the 
group (Fig. 6.11). The infectivity titre of virus appeared to rise 
faster than the detectable antigen level in the first 3 days after 
inoculation. Thereafter the curves for the antigen detection tests 
follow that for the infectivity titre, except that infectious virus 
remained detectable at a moderate to low level (< 105'25 TCID50 /ml) 
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Fig. 6.10 Comparison of virus isolation, amplified ELISA and 
RPHA for the detection of BHV1 in nasal swab extracts 
from a single calf 
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Fig. 6.11 Group mean results of 13 calves (experiment 5) 
for 
BHV1 detection in nasal swab extracts using cell 
culture, amplified ELISA and RPHA methods. 
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for several days when the antigen detection tests had become negative. 
DETECTION OF IgG -CLASS ANTIBODY RESPONSES BY ELISA 
The standard procedure adopted for the ELISA for IgG -class antibodies 
to BHV1 in bovine sera has been described in chapter 2. In arriving 
at this protocol a number of factors which might influence the assay 
results were examined in detail. Initially a satisfactory antigen 
was prepared from BHV1- infected cell cultures, frozen and thawed to 
release virus from the cells. Enhanced antigenicity was found when 
the cell and medium mixture was treated with non -ionic detergent 
(Nonidet P40) at an optimum concentration of 0.1% (Fig. 6.12). 
Subsequently a more potent antigen was prepared by omitting the 
freeze -thaw step, discarding the cell culture medium and treating the 
cellular fraction with 0.5% Nonidet P40. In all cases a control 
antigen was made from non- infected cell cultures. Unless stated 
otherwise, test results quoted are in optical density units calculated 
by subtracting the mean of two control wells from the mean of two 
virus test wells for the individual sample. Use of the control 
antigen virtually eliminated problems arising from samples giving 
high non -specific or false positive reactions. 
As with the antigen- detection ELISA the type of microtitre plate 
affected the results of the assay. The eventual decision to standard- 
ise within the laboratory on Falcon 3912 plates was based on the over- 
all performance in a wide range of assays, not just those for BHV1. 
Polyvinyl plates (Falcon 3912) performed significantly better than 
polystyrene (Dynatech M129A) as shown in table 6.10. This table also 
shows the effect of different storage procedures on the potency of 
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Fig. 6.12 The effect on BHV1 ELISA antigen potency of treatment 
of cell cultures and media with different concentrations 
of nonidet P40 
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solution still in the wells) at either 4 °C or -20 °C appeared to 
preserve the antigenicity better although the effects were not 
significant in this experiment. For practical reasons it was often 
more convenient to wash and dry a batch of plates so that they were 
ready for immediate use. 
Results of development work with a similar ELISA for antibodies in 
bovine sera to respiratory syncytial virus (unpublished data) had 
indicated that the incorporation of a protein solution into the serum 
and conjugate diluent reduced non -specific reactions with the control 
antigen. Bovine serum albumen as the protein also reduced specific 
reactions of positive sera with the viral antigen, whereas ovalbumen 
reduced the noise levels without affecting the specific signal. 0.5% 
ovalbumen was therefore used in the diluent for the BHV1 assay. 
In an attempt to further reduce background noise levels, extraction 
of the BHV1 and control antigens with an organic fluorocarbon solvent 
(Arklone, ICI), with or without n- butanol, was evaluated (Nandapalan 
and others, 1984). In addition, post- coating of the plates with 2% 
gelatin in PBS pH 7.2 was tried, to block any unoccupied binding 
sites on the plastic. The results are in table 6.11. Gelatin treat- 
ment had no significant effect, suggesting that any non -specific 
colour reactions were not due to unoccupied protein binding sites on 
the plastic. Arklone extraction significantly increased (P<0.01) the 
binding to the control antigen (columns C in Table 6.11) and decreased 
the specific binding with viral antigen. Further treatment of the 
antigen, by n- butanol precipitation of the protein and redispersal, 
almost completely destroyed its antigenicity. None of these methods 
was pursued further. 
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The effect of variation between wells on the plate was studied by 
coating two plates with virus antigen in all wells, and adding ali- 
quots of a single dilution (1 /100) of a positive serum to all wells 
for the test. Two -way analyses of variance were carried out and the 
results expressed as standardized differences for rows and columns, 
using the formula:- 
Row (or column) mean - overall mean 
Standard error for row (or column) mean 
As shown in table 6.12, there were significant differences between 
wells on the same plate and the most marked differences were observed 
in the end columns. Low and high values tended to occur in adjacent 
rows and columns, giving a clustering effect. Differences between 
columns were more highly significant than those between rows. 
For the subsequent tests the microtitre plates were sub -divided into 
24 blocks of 4 wells. Each block provided 2 readings for the test 
serum dilution with viral antigen (Ti and T2) and two with control 
antigen (Cl and C2). A set of six pairs of acute and convalescent 
sera from an IBR outbreak in Northamptonshire were tested by ELISA 
(a) by titrating the sera in a two -fold dilution series from 1/50 to 
1/6400, (b) by testing at a single serum dilution of 1 /100. In the 
latter test, eight replicate blocks were used for each serum, with 
four 4 -well blocks allocated at random on each of two plates. Ana- 
lysis of variance was used to estimate the variation between and 
within blocks, and to determine the least significant difference in 
OD (between acute and convalescent sera from the same animal) neces- 
sary to establish a diagnostic rise in antibody level. 
The log dilution - response curves for ten of the twelve sera were 
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approximately linear over the dilution range 1/50 to 1/3200 or 1/50 
to 1/6400 (Table 6.13 and Fig. 6.13). Except for pair 3, there was a 
fourfold or greater rise in VN titre between the acute (A) and 
convalescent (C) samples and there was an increase in slope of the 
ELISA curve from A to C. The change in ELISA antibody level from 
acute to convalescent was measured in three ways (Table 6.13): the 
estimated end point titres for each serum (i.e. the dilution at which 
the OD would be 0.10), the ratio 0DC /ODA and the arithmetic differ- 
ence 0DC -ODA at a given serum dilution. The ratio method was subject 
to high bias when the acute OD value was low. The best discrimina- 
tion between A and C was achieved with the arithmetic difference in 
OD at a dilution of 1 /100. 
The results of the second part of this study, in which 8 replicate 
blocks were tested for each of the 12 sera at 1 /100 dilution, are 
shown in table 6.14. The mean differences between sera A and C for 
each animal were significant (P <0.001) except for pair 3, which did 
not differ significantly in any of the tests. There was again evi- 
dence of clustering of OD values on the plate, in that the variance 
ratios (F) of the difference between blocks of the same serum in 
different areas of the plate, to that between duplicates within 
blocks was significant (Table 6.15). 
In the above experiment, all the replicate tests for any one serum 
were made from one bulk dilution of the sample. Thus the variation 
observed was due to plate effects. In order to assess the total 
variation within the whole assay procedure tests were carried out on 
three sera of which a bulk supply was available, with the intention 
that they could henceforth be used as standards for the assay. The 
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Fig. 6.13 The log dose - response in ELISA for three pairs of 
acute (A) and convalescent (B) sera from a natural 
outbreak of IBR 
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was seronegative to BHV1, one (SA38) had been immunised with intra- 
nasal BHV1 vaccine (Tracherine, Smith Kline Animal Health) and had a 
low antibody titre to the virus (VN titre 1/5), and the third (SA39) 
had been infected with virulent BHV1 and had a typical convalescent 
antibody titre (VN 1/16). Twenty four separate dilutions of each 
serum were tested, each serum occupying a microtitre plate, again 
using the system of 4 wells per block (2 virus and 2 control). Two 
plates were used on each of four days for each serum, making a total 
of 24 plates in all. The results are shown in table 6.16. The 
variation between days was greater than that between plates tested on 
the same day. The upper 99% tolerance limit (one sided) for the 
negative serum was 0.06, while for serum SA38 there was a chance of 
only 1 in 1000 of obtaining a reading lower than 0.16. On the basis 
of the least significant difference calculations, a value of 0.15 was 
set as the change in OD indicative of a significantly rising antibody 
response between acute and convalescent sera from the same animal. 
Paired sera from 105 cattle with respiratory disease, submitted to 
the laboratory for diagnostic purposes, were tested using a rise in 
OD of 0.15 as the criterion for a positive diagnosis, and comparing 
it with the conventional fourfold rise in VN titre. The two tests 
agreed in 103 of the serum pairs (98 %), of which 87 were positive 
(rising titre) and 16 negative (no change in titre). The remaining 
two pairs showed no change by VN, but a rise in OD in one case of 
just 0.15, and in the other 0.46. The latter animal was from a group 
experiencing clinical IBR in which other animals showed a rising 
titre by both tests. To give a margin of safety the OD value has been 
raised to 0.2 for routine diagnostic use. 
As well as diagnostic assays for clinical cases, serological tests 
for BHV1 are also used for screening purposes for animals prior to 
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entry to sero- negative herds such as bull studs or for export 
certification. A large group of such sera, of known VN status, were 
tested by the ELISA in order to establish a positive /negative cut 
off value. Six hundred and fifty two sera were from herds known to 
have been free of BHV1 infection for many years and therefore true 
negatives. Eighty eight were definitely sero -positive by VN, and 181 
were weak positives giving low titre reactions ( <10) in the VN test. 
119 of the latter group were subsequently retested by ELISA giving a 
total of 300 readings for the weak positive group. The results are 
summarised in Table 6.17. All the sero- negative samples gave results 
<0.10. 
The sero -positive group were all >0.10 with a mean OD of 1.21 (stan- 
dard error +/- 0.045). There was a less than 1 in 1000 chance of one 
of this group giving a result <0.10. The weak positive group could 
be divided into two populations (Table 6.17) based on VN titres of <4 
and 4 and above, with considerable overlap in OD values. A few of 
this group gave high OD readings (confirmed on retest) suggesting 
erroneous VN results (which were not repeated). 112 of the weak 
positives gave ODs <0.10, at least some of which may have been false 
positive results by VN (nonspecific neutralization). Thenceforth a 
negative /positive cut -off value of 0.10 was used, with the acceptance 
that a low number of sera would inevitably be misclassified, by this 
or any other system. The sensitivity of the assay for screening 
purposes was found to be slightly higher when sera were tested at 
1/50 dilution, rather than the 1 /100 which gave the best discrimina- 
tion between acute and convalescent sera for diagnosis of clinical 
disease. 
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DETECTION OF IgM -CLASS ANTIBODIES BY ELISA 
As described in Chapters 1 and 5 IgM -class antibodies to BHV1 appear 
early in the course of infection and are of short duration. Their 
detection should provide an adjunct to the rapid diagnosis of IBR, 
and could obviate the need for collection of convalescent serum 
samples in many cases. The immunoglobulin sub -class specific ELISA 
was described in Chapter 2, using viral antigen coated plates, heavy 
chain specific rabbit antisera to bovine immunoglobulins, and protein 
A enzyme conjugate. Conjugate controls, omitting the intermediate 
rabbit serum were used for all test samples to detect any binding of 
the protein A to bovine IgG. A goat anti -rabbit IgG peroxidase 
conjugate (Miles Scientific) was also assessed in the early trials, 
but was not pursued as it gave poorer signal /noise ratios. 
A standard serum for the IgM assays was prepared by killing and 
bleeding out a calf, 10 days after the intranasal inoculation of 107 
TCID50 BHV1. The assay was subsequently standardized by carrying out 
a titration of this serum on each occasion that a test was performed. 
To establish the immunoglobulin class specificity of the assays, 
purified IgG1 and IgG2 were prepared from a high titre bovine anti- 
serum to BHV1 by the methods of Fey and others (1976) for IgG1 and 
Butler (1983) for IgG2. IgM was purified from the standard serum 
containing high BHV1- specific IgM, by the method of Hudson and Hay 
(1980), using affinity chromatography with protamine sulphate fol- 
lowed by gel filtration on Sepharose 6B (Pharmacia). 
The results of the class specific assays for BHV1 antibodies in the 
resultant fractions are shown in Table 6.18. The protein A conjugate 
bound weakly to bovine IgG2 only. In practice this was found not to 
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cause any difficulties with the test samples, provided conjugate 
controls were used. 
The possibility that the fall in IgM in week 3 after inoculation 
(Chapter 5) was an artefact caused by competition for antigenic sites 
by IgG, which was rising at this time, was investigated by testing 
protamine sulphate purified IgM (Hudson and Hay, 1980) fractions of 
serial samplings from 2 of the animals in experiment 1C. Removal of 
most of the IgG from the samples did not greatly affect the shape of 
the IgM response curve, as compared with the whole serum assay. The 
same fall in IgM was observed during the third week after inoculation 
(Fig. 6.14). 
Paired acute and convalescent sera from natural cases of respiratory 
disease were obtained from the laboratory's diagnostic section. They 
were classified into three categories according to the results ob- 
tained with the VN test for BHV1 antibodies: 
a. both samples seronegative to BHV1; 
b. evidence of active BHV1 infection, fourfold or greater rise in 
VN titre between acute and convalescent sample; 
c. both samples seropositive, VN titre level or falling; 
The results from cattle (group a) with no evidence of BHV1 infection, 
indicated that there was a considerable variation in background colour 
reaction, with some animals giving much higher ODs in the IgM assay 
(with both control and virus antigens) than the IgG assays. The 
colour difference between virus and control antigen was also fre- 
quently as high as 0.25 OD units, so that a positive result for IgM 
could only be accepted for samples with an OD difference >0.25. The 
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Fig. 6.14 Comparison for two calves of IgM- specific 
ELISA responses 
on whole sera diluted 1 /100 and on purified 
IgM fractions 


















Fig. 6.15 BHV1 IgM responses in three groups of paired acute 
(a) and convalescent (c) sera from natural cases of 
respiratory disease 
in table 6.19 they are grouped according to the dynamic state of the 
IgM response. 
Elevated IgM was detected in 30/53 animals experiencing active in- 
fection as indicated by a rising VN titre. The animals with positive, 
but not rising, VN antibody can be divided into 2 groups: those with 
elevated IgM (often falling) which were considered to have experienced 
recent BHV1 infection but were past the phase of seroconversion; and 
those without detectable BHV1- specific IgM, which were considered to 
have VN (IgG) antibodies as a result of past (but not recent) infect- 
ion. 
Subsequent to the above studies a monoclonal antibody with specific 
activity to bovine IgM became available at the laboratory. The 
monoclonal antibody (of murine class IgGl, supplied as ascitic fluid) 
was used to evaluate the IgM response in two calves from experiment 
1C (Chapter 5), in comparison with the polyclonal IgM ELISA described 
above, in three different assay systems: 
Assay 1 (a) Microtitre plates coated with BHV1 and control cell 
antigens. 
(b) Test sera diluted 1 /100. 
(c) Monoclonal anti bovine IgM diluted 1/2000 
(d) Peroxidase conjugated goat anti -mouse IgGl, 1/2000 
(Nordic). 
(e) Chromogenic substrate OPD. 
Assay 2 (a) Microtitre plates coated with monoclonal anti -bovine 
IgM, 1/2000. 
(b) Test sera diluted 1 /100. 
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(c) BHV1 partially purified antigen (prepared by PEG 
precipitation as described in Chapter 4). 
(d) Peroxidase conjugated bovine antiserum to BHV1, 1 /1000. 
(e) Chromogenic substrate OPD. 
Assay 3 As assay 2 but using a conjugated rabbit antiserum to BHV1 
(diluted 1/500) at step (d). 
All buffers and diluents were as described before for the IgG ELISA, 
and plate washes were carried out as usual between each step of the 
assays. 
The results are show in figs 6.16 and 6.17. When the monoclonal was 
substituted for the polyclonal rabbit serum, as in assay 1, the 
response curve was very similar but the noise level in the post -con- 
valescent phase (after 21 days) was much lower. The IgM capture 
systems (assays 2 and 3) appeared to be of higher sensitivity and 
detected virus -specific IgM up till 28 days after inoculation. 
Thereafter they also had low noise levels. The potential of these 





















































































































































































































































































































































































































































































































































































































































TABLE 6.1 Detection of BHV1 antigen in washed cell smears from 
nasal secretions, experiment 1C, using direct 
fluorescent antibody (FA) or immunoperoxidase 
(PX) methods. 
Virus strain: ED1 ED2 ED3 ED4 ED5 ED6 
FA PX FA PX FA PX FA PX FA PX FA PX 
Days after 
inoculation: 
1 + + + - + + - - - + - - 
2 ++ ++ ++ ++ ++ ++ ++ ++ + + + + 
3 ++ ++ + ++ ++ ++ ++ ++ ++ ++ + - 
4 + ++ + - ++ ++ + ++ + ++ + + 
5 + ++ + + ++ ++ ++ ++ ++ ++ + + 
6 - + - - ( +) + + ++ ( +) + - +' 
7 - - - - + + + + - - - - 
8 - - - - ( +) - ( +) ( +) - - - - 
9 - - - - - - - 
10 - - - - - - - 
11 - - - - - - - 
Cusum score 7 10 6 5 11 11 9.5 11.5 6.5 9 4 4 
INTERPRETATION: 
++ (score 2) Strong positive, many infected cells in smear 
+ (score 1) Definite positive, but fewer infected cells 
( +) (score 0.5) Probable positive, but not sufficient on its 
own to establish a diagnosis 
(score 0) Negative 
PAIRED COMPARISON OF FA AND PX TESTS: 
Mean difference in cusum score (PX -FA) = 1.083 
Standard deviation = 1.625 
Student's t (5 d.f.) = 1.63 (P >0.10) 
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TABLE 6.2 Detection of BHV1 antigen in washed cell smears from nasal 
secretions, experiment 2, using direct immunofluorescence. 
Virus: ED1 ED2 
Calf: 9366 9414 
(in- contacts) 
9378 9408 9409 9416 9370 9411 
(in- contacts) 
9406 9407 9412 9415 
Days after 
inocula- 
tion: 1 - - - - - - - - - - - - 
2 - - + + + + - - - - ( +) - 
3 - - + + + + - - + + + - 
4 - - + + + + - - ( +) + + - 
5 ( +) + + + + + + + + + + + 
6 + + + + + + ( +) + + + + + 
7 + + + + + + + + + + + + 
8 + + ( +) ( +) + ( +) + + ( +) ( +) + ( +) 
9 + + + ( +) + + + + ( +) - ( +) - 
10 ( +) + ( +) + ( +) - ( +) ( +) - - - - 
11 ( +) + - - - - + ( +) - - - - 
12 - + ( +) ( +) - ( +) - + - - - ( +) 
13 ( +) - - - ( +) - - ( +) - - - - 
14 - ( +) - - - - - - - - - - 
15 - - - - - - - - - - - - 
Cusum 
score 
6 8.5 8.5 8.5 9 8 6 7.5 5.5 5.5 7 4 
NOTES: + Definite positive (score 1, not graded further) 
( +) Probable positive, but not of itself diagnostic (score 0.5) 
- No positive cells seen (score 0) 
PAIRED COMPARISON OF VIRUS STRAINS: 
Mean difference in cusum score (ED1 -ED2) = 2.17 
Standard deviation = 1.47 
Student's t (5 d.f.) = 3.606 (P <0.05) 
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TABLE 6.3 Proportion( %) of virus -positive cells in washed cell 
smears from nasal secretions, experiment 4, using 
direct immunoperoxidase. 
Calf: 1 2 3 
Days after 
inoculation: 1 - <1 <1 
2 32 44 29 
3 63 74 37 
4 48 62 22 
5 16 14 8 
6 4 12 11 
7 2 <1 4 
8 13 - - 
9 - - - 
10 <1 - - 
11 - - - 
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TABLE 6.4 Summary of bovine respiratory disease outbreaks 
investigated by VI centres in 1985, in which immuno- 
fluorescent examinations for BHV1 antigen were carried 
out. 
Month No. of outbreaks No. (and %) 
positive 
Expected No. 
positive at a 
diagnosis rate 
of 13.5% 
1 365 74 (20.3) 49 
2 251 47 (18.7) 34 
3 252 47 (18.7) 34 
4 209 26 (12.4) 28 
5 134 6 (4.5) 18 
6 123 11 (8.9) 17 
7 106 10 (9.4) 14 
8 78 4 (5.1) 11 
9 122 14 (11.5) 16 
10 237 25 (10.5) 32 
11 371 43 (11.6) 50 
12 278 34 (12.2) 38 
1985 Total 2526 341 (13.5) 
X2 513.4 41.16 
(P <0.001) (P <0.001) 
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TABLE 6.5. Summary of VI centre performance in 31 coded 
quality assessment trials. 
Year Correct positives ( %) Correct negatives ( %) 
1982 30/39 (77 %) 26/32 (81 %) 
1983 37/43 (86 %) 23/27 (85 %) 
1984 56/69 (81 %) 29/30 (97 %) 
TOTAL 123/151 (81 %) 79/89 (88 %) 
TABLE 6.6 Comparison of two types of polystyrene plate, 
and use of polyethylene glycol (PEG) to enhance 
antigen antibody interactions, in the ELISA for 
antigen detection. 
Plate type: 
4% PEG added: - 














1/500 .25 .08 .34 .04 .93 .65 .80 .64 
1 /1000 .16 .03 .18 .02 .38 .43 .74 .39 
1/2000 .05 .02 .11 .01 .32 .20 .41 .20 
1/4000 .04 .05 .04 .02 .48 .13 .35 .13 
NOTES: 1. Results are given in OD units 
2. Test samples were infected /non- infected cell culture 
harvests diluted 1/50 in PBS. This was taken as close 
to the virus detection limit for the assay and therefore 
a critical test of sensitivity. 
3. The results are extracted, for clarity, from the full 
chequerboard assay of coating antibody level and con- 
jugate dilution. The results shown are for the optimum 
coating level (414/ml). 
Continued ... 
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TABLE 6.6 (Contd) 
STATISTICAL ANALYSIS FOR PLATE M129A 
Tabulated values are (OD positive sample - OD negative sample) x 100 
Without PEG PEG added 
Coating 
antibody: 32 16 8 4 
(ug /ml) 
2 1 32 16 8 4 2 1 
Conjugate 
dilution 
1/500 4 26 25 17 13 12 57 27 32 30 20 17 
1 /1000 0 9 10 13 8 6 17 6 14 16 12 10 
1/2000 2 2 5 3 3 3 8 8 9 10 6 4 
1/4000 0 1 3 -1 4 -2 -3 4 -1 2 5 3 
ANOVAR 
Source of variation d.f. S.S. M.S. F ratios 
(a) PEG added or not 1 450 450 a/c=4.5(NS) a/e=5.92(NS) 
(b) Conjugate dilution 3 3323 1108 b/c=11.08(*) b/f=41.04(***) 
(c) PEG x conjugate 3 299 100 c/g=2.13(NS) 
(d) Coating antibody 
level 
(e) PEG x coating 
5 
5 
154 31 d/e=0.41(NS) 
378 76 e/g=1.62(NS) 
d/f=1.15(NS) 
(f) Conjugate x coating 




404 27 f/g=0.57(NS) 
709 47 
TOTAL 47 5717 
NS = not significant (P>0.05) 
* = P<0.05 
* ** = P<0.001 
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TABLE 6.7 The effect on non -specific background readings in the 
antigen detection ELISA, of 1% bovine serum albumen 
in the conjugate diluent. 
Sample Dilution 
10° 10 -1 10 -2 10 -3 10 -4 
Sample 
Without BSA C .12 .09 .11 .11 .11 
I >2.00 1.01 .16 .10 .13 
Difference (I - C) >1.88 .92 .05 -.01 .02 
With BSA C .12 .05 .05 .03 .04 
I >2.00 .99 .11 .06 .05 
Difference (I - C) >1.88 .94 .06 .03 .01 
NOTES: Sample C = non -infected cell culture harvest 
Sample I = BHV1- infected cell culture harvest 
Conjugate diluent incorporated 4% PEG 
Results shown are OD values, means of 2 replicates per sample. 
Plate type was Dynatech M129A. 
STATISTICAL ANALYSIS 
Wilcoxon signed rank sum test for the comparison of OD values with 
BSA treatment vs. no treatment: n = 8; t, T = 0, 36; P <0.05 
Mann -Whitney test for the comparison of (I - C) values with BSA teat - 
ment vs. no treatment: ni = n2 = 5; U = 10.5; P >0.10 
(note, insufficient values for a Wilcoxon test). 
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TABLE 6.8 Antigen- detection ELISA results (OD values) on swab 
supernatants from experiment 4. 
Treatment: BHV1 infected Control 
Calf: 1 2 3 Cl C2 C3 
Days after 
inoculation: 1 .06 .06 .06 .05 .03 .04 
2 .84 1.62 1.22 .08 .17 .08 
3 1.05 1.54 .67 .09 .07 .10 
4 .42 .43 .50 .05 .05 .09 
5 .74 1.13 1.19 .09 .06 .07 
6 1.07 1.41 1.76 .16 .16 .24 
7 .22 .55 .85 .11 .07 .12 
8 .33 .30 .37 .06 .06 .13 
9 .20 .27 .19 ND ND ND 
10 .17 .25 .14 .06 .07 .05 
11 .10 .25 .06 ND ND ND 
14 .12 .14 .06 .07 .07 .06 
NOTE: ND = no sample taken. 
Plate type was Dynatech M129A 
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TABLE 6.9 Comparison of polystyrene and polyvinyl assay plates 
in the ELISA for BHV1 antigen detection 











-1 1.53 .19 1.15 .16 .64 .14 
-2 .35 .20 .33 .21 .27 .21 
-3 .17 .16 .16 .15 .17 .15 
-4 .22 .15 .17 .17 .16 .17 
Dynatech -1 .88 .16 .89 .17 .61 .15 
M129A 
(polystyrene) -2 .21 .18 .24 .17 .22 .17 
-3 .14 .14 .15 .15 .14 .14 
-4 .15 .15 .15 .15 .13 .14 
NOTES: 1. Tabulated values are OD units 
2. Test samples were infected /non infected cell culture 
harvests. 
STATISTICAL ANALYSIS 
Wilcoxon signed rank sum test for the differences 
(Falcon plate - Dynatech plate) at each location: 
BHV1 positive sample: n = 12; t, T = 0, 78; P <0.001 
BHV1 negative sample: n = 10; t, T = 4, 51; P <0.05 
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TABLE 6.10 Effect of plate type and storage conditions after 







V C V -C 
Positive 
serum 
V C V -C 
Negative 
serum 
V C V -C 
Positive 
serum 
V C V -C 
Plate treatment 
after coating 
Wash and use same 
day .11 .08 .03 .96 .11 .85 .22 .16 .06 1.25 .20 1.05 
Wash, dry and use 
same day .11 .09 .02 1.03 .12 .91 .14 .12 .02 1.09 .15 .94 
Wash, dry and 
store 7 days 4 °C .09 .07 .02 .71 .07 .64 .11 .10 .01 .88 .11 .77 
Wash, dry and 
store 7 days 
-20 °C .10 .07 .03 .74 .07 .67 .12 .10 .02 .95 .11 .84 
Store wet 7 days 
4 °C then wash and 
use .10 .08 .02 .70 .07 .63 .15 .12 .03 1.12 .13 .99 
Store wet 7 days 
-20 °C then wash 
and use .09 .07 .02 .57 .08 .49 .14 .10 .04 1.12 .12 1.00 
NOTES: Sera used at 1:50 dilution, conjugate 1:500 
V = OD with viral antigen 
C = OD with control antigen 
ANOVAR FOR POSITIVE SERUM (V - C values) 
Source of variation d.f. Sums of 
squares 
Variance F P 
Plate treatments 5 .1019 .0204 1.36 >0.05 
Plate type 1 .1633 .1633 10.89 <0.05 
Error 5 .0749 .0150 
Total 11 .3401 
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TABLE 6.11. Effect of Arklone and n- butanol treatments on BHV1 
ELISA antigen, and effect of gelatin post- coating 
of microtitre plates. 
Serum: SA37 SA38 SA39 
Plate Treatment 
with gelatin after 
coating 
Antigen treatment V -C C V -C C V -C C 
+ NP40 .08 .18 .56 .13 1.34 .17 
+ NP40 + Arklone .02 .21 .18 .15 .49 .24 
NP40 .07 .16 .48 .16 1.41 .18 
NP40 + Arklone .03 .22 .14 .17 .43 .24 
NP40 + Arklone + 
n-butanol 0 .04 .12 
NOTES: Sera SA37 = BHV1 seronegative 
SA38 = BHV1 seropositive, low titre 
SA39 = BHV1 seropositive 
C = OD with control antigen 
V -C = Calculated OD value (virus antigen - 
control antigen 
STATISTICAL ANALYSIS (paired t- tests) 
n t 
Gelatin vs. no gelatin (all sera, V -C values) 6 0.83 
NP40 vs. NP40 + Arklone (SA38 & SA39, V -C values) 4 3.92 





n- butanol treated antigen lacked potency and was omitted from the 
analysis. 
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TABLE 6.12. ELISA for BHV1 antibody: identical dilutions in 96 wells on an 8 x 12 microtitre plate. Standardized row and column effects for two replicate plates. 
Plate 1 Plate 2 
Rows Columns Rows Columns 
A 1.9 1 -6.8 A 3.2 1 -0.5 
B 2.5 2 -3.3 B 0.9 2 -0.6 
C 0.3 3 2.7 C 0.1 3 1.8 
D -2.2 4 2.7 D -1.5 4 2.0 
E -3.0 5 2.0 E -1.3 5 2.1 
F 0.2 6 2.4 G -2.0 6 0.9 
G 0.5 7 2.3 G 0.3 7 -0.4 
H -0.2* 8 0 H 0.2 8 2.0 
9 1.0 9 1.2 
10 1.1 10 0.9 
11 1.3 11 -2.6 
12 -5.5 12 -6.8 
P<0.01 P<0.001 P<0.05 P<0.001 
*Replicate 1 Row H, Column 1 was an estimated value 
since no colour developed in this well. 
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TABLE 6.13. ELISA for BHV1 antibody: regression of corrected mean 






















OD C/A C-A 
1 lA <1 50 -3200 0.125 +0.023 0.42 0.17 4.8 0.64 
1C 8 50 -3200 0.466 +0.024 1.74 0.81 
2A <1 50 -3200 0.089 +0.016 0.29 0.11 8.6 0.84 
2 2C 24 50 -6400 0.524 +0.033 2.00 0.95 
3A 24 50 -3200 0.454 +0.025 1.66 0.75 1.1 0.06 
3C 8 50 -6400 0.478 +0.040 1.77 0.81 
3 4A <2 50- 6400(e) 0.170 +0.009 0.63 0.29 2.6 0.46 
4C 16 50 -6400 0.380 +0.026 1.51 0.75 
5A <2 50 -400 0.060 +0.018 0.15 0.03 18.3 0.52 
4 5C 24 50 -6400 0.328 +0.029 1.21 0.55 
6A <1 50 -3200 0.095 +0.013 0.34 0.15 7.9 1.04 























Notes (a) Serum A = acute, C = convalescent. 
(b) Reciprocal dilution range over which log dose -response 
curve was linear in the ELISA. 
(c) Regression coefficient and its standard error. Equation 
has the form: 
1 
OD = Intercept - (Gradient x Log10 dilution ). 
(d) Dilution at which OD = 0.10, assuming linearity holds. 
(e) Serum 4A: OD values at 1/200 and 1/1600 omitted due to 
significant deviations from linearity. 
(f) Outside the linear part of the respective curves. 
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TABLE 6.14 ELISA for BHV1 antibody: mean optical density 
(OD) readings of six pairs of sera tested at a 
dilution of 1 /100. 
Mean corrected OD values for 4 blocks of 
2 replicates. 
Serum* 
Plate lA 1C 2A 2C 3A 3C LSD+ 
1 0.136 0.792 0.106 0.850 0.703 0.771 0.096 
2 0.183 0.783 0.099 0.832 0.671 0.746 0.091 
Serum* 
4A 4C 5A 5C 6A 6C 
3 0.299 0.844 0.049 0.589 0.174 0.987 0.114 
4 0.350 0.956 0.040 0.721 0.134 1.090 0.152 
*A = Acute, C = convalescent. 
+LSD = Least difference between two means necessary to show 
significance at the 5% level. 
TABLE 6.15 ELISA for BHV1 antibody: variability between blocks/ 
within blocks of sera. 
Plate Number 
1 2 3 4 






Notes: Plates 1 and 2 were replicates, as were plates 3 and 4. 
Sera were each allocated to 4 blocks at random per plate. 
(plates 1/2: sera 1A, 1C, 2A, 2C, 3A, 3C 
plates 3/4: sera 4A, 4C, 5A, 5C, 6A, 6C). 
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TABLE 6.16 ELISA for BHV1 antibody: Mean optical density (OD) 
readings of 24 separate dilutions per plate for each 
of three sera 
Serum SA37 Serum SA38 Serum SA39 
Negative Weak positive Medium positive 
Plate Number: 1 2 1 2 1 2 
Day of ( 1 0.027 0.050 * ** 0.254 0.216 * ** 0.685 0.698 
test ( 2 0.027 0.020 0.292 0.262 ** 0.672 0.596 ** 
( 3 0.010 0.013 0.275 0.333 * ** 0.762 0.746 
( 4 0.016 0.012 0.238 0.247 0.739 0.723 
SEM of 
24 values 0.0032 0.0066 0.0112 
Overall mean OD 0.022 0.265 0.703 
LSD-F(5% level) 0.043 0.090 0.152 
LSD-F(1% level) 0.057 0.119 0.200 
95% CL of a 
single result +0.031 +0.064 +0.108 
Significant difference between plates, ** = P <0.01, * ** = P<0.001. 
+ LSD = least difference necessary for significance between 
individual dilutions within a plate. 
+ +CL = Confidence limit. 
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TABLE 6.17 Frequency distribution of corrected optical density (OD) 
readings of sera assessed as positive or negative according to the virus neutralization test. 
652 Known 
300 weak positive sera negative 
sera 
88 VN positive 
sera 
OD VN < 4 
n 






0 31 6 0.00 157 
0.01 -0.04 35 9 0.01 68 0.10 -0.19 5 
0.05 -0.09 24 7 0.02 75 0.20 -0.29 2 
0.10 -0.14 10 26 0.03 74 0.30 -0.39 0 
0.15 -0.19 3 33 0.04 64 0.40 -0.49 2 
0.20 -0.24 2 21 0.05 67 0.50 -0.59 1 
0.25 -0.29 0 17 0.06 58 0.60 -0.69 2 
0.30 -0.39 2 33 0.07 53 0.70 -0.79 4 
0.40 -0.49 18 0.08 35 0.80 -0.89 1 
0.50 -0.59 11 0.09 1 0.90 -0.99 2 
0.60 -0.69 4 1.00 -1.09 3 
0.70 -0.79 1 1.10 -1.19 9 
0.80 -0.89 3 1.20 -1.29 7 
0.90 -0.99 1 1.30 -1.39 15 
1.00 -1.09 0 1.40 -1.49 14 
1.10 -1.19 1 1.50 -1.59 12 
1.20 -1.29 0 1.60 -1.69 7 
1.30 -1.39 2 1.70.1.79 2 
Total 107 193 652 88 
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TABLE 6.18 Optical density readings of purified immunoglobulin 




IgGl IgG2 IgM 
IgG1 1.35 0.08 0.09 
IgG2 0.12 0.87 <0.01 
IgM 0.07 0.05 0.59 
Protein A Conjugate control <0.01 0.17 <0.01 
TABLE 6.19 Classification of paired serum samples from outbreaks of 
natural respiratory disease in cattle, according to IgM 
and VN antibody assays for BHV1. 
The values given are the number of serum pairs in each category. 
VN negative VN rising 
titre 
VN positive (static 
or falling titre) 
IgM negative ( <0.25) 18 23 18 
IgM rising 16 
IgM static positive 6 6 
IgM falling 8 13 





The theme of the dissertation has been the changing pattern of disease 
associated with bovid herpesvirus 1 in Great Britain, with particular 
focus on the decade 1977 -1986. From an evaluation of field data in 
Chapter 3, it has proceeded to detailed studies of viral isolates in 
vitro (Chapter 4) and in vivo (Chapter 5). Finally, the availability 
of experimentally infected animals for these studies has enabled a 
thorough evaluation of existing and new diagnostic tests (Chapter 6). 
EVIDENCE FROM THE FIELD 
There is a danger when a "new disease" is first reported, as happened 
with severe IBR in 1977 -1978, that the phenomenon becomes an artifi- 
cially self- sustaining epidemic fueled by positive feedback from 
anecdotal clinical reports (Thrusfield, 1986b). It was important 
therefore to seek unbiased sources of data to substantiate the claim 
that a virulent strain of virus had appeared, and that alternative 
explanations, such as the effect of husbandry changes on host -virus 
equilibria, were considered. Unfortunately, such unbiased data were 
not readily available as has been shown in Chapter 3. 
The first questions to be addressed were, "Did the disease incidence 
suddenly increase in 1977 -1978 ?" and "Was the disease at that time 
more virulent than had been seen thitherto ? ". Very definitely affir- 
mative responses to both questions have been expressed to the author 
on many occasions at scientific and clinical meetings as well as in 
the VI reports and correspondence columns of the Veterinary Record 
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(Cuthbertson and Wood, 1979; Imray, 1979; Wiseman and others, 1979). 
Such views although lacking support from quantitative data should not 
be dismissed lightly, arising as they did from many astute and 
experienced practitioners and veterinary investigation officers who 
were well versed in the art of clinical and pathological observation. 
The true population incidence of this or any other disease is almost 
impossible to determine. Many cases are not referred to a veterina- 
rian and of those that are only a proportion are referred on to the 
VI Service. It is only at this point that a comprehensive record 
begins to be maintained. The cases so referred are likely to include 
a disproportionately high percentage of severe incidents. The VIDA 
II system provides a huge database of farm animal disease information 
for Great Britain but because it is elective, by submission from the 
field, rather than randomly selective as an unbiased population 
sample would be, it cannot offer information on absolute incidence 
(Thrusfield, 1986c). Providing certain precautions are taken, it can 
give useful information on changes in relative incidence as has been 
shown in Chapter 3. In particular, as advised in the preface to the 
annual VIDA II reports (MAFF and others, 1987), specific disease data 
should be related to total submissions for that species. This should 
even out the effects on submissions, of changes in general farming 
prosperity, the value of cattle and the charging policies of diag- 
nostic laboratories. It does not compensate for an increase in 
specific submissions when a disease is at the forefront of attention 
in the veterinary and farming press. VIDA II is also weak for the 
recording of new diseases (Hall and others, 1980), and in the case 
of 
IBR this did not become a specifically coded category until 1980. 
It 
therefore captured only the tail end of the rising phase 
of the 
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putative epidemic curve. IBR incidence appeared to be entering a 
declining phase in the mid 1980s (Fig 3.1). This would be expected 
as the population immunity rose (Fig 3.3, Table 3.5) in response to 
a higher incidence of infection (Thrusfield, 1986a). A similar 
trend for BHV1 on a herd basis was reported by Van Nieuwstadt and 
Verhoeff (1983). 
Samples submitted to the CVL for diagnostic virology offer a yet more 
biased set of data. They arise from disease outbreaks where viral 
aetiology is suspected in any case, and there are generally no con- 
trols for comparison with the cases. An attempt was made at statis- 
tical evaluation by relating BHV1 diagnoses to the total bovine sample 
submission rates (Table 3.3, Fig 3.2). The data have the particular 
merit of extending back to the early 1970s. There was a clear, and 
statistically significant, rise in the proportional diagnosis rate 
for IBR from 1975 to 1978. The trend was even more marked when 
expressed as the absolute number of diagnoses made at the CVL (Table 
3.3). Other factors which could have influenced these results were 
changes in laboratory methods, such as from tube VN tests to micro - 
titre systems, then subsequently to ELISA. A useful control in this 
case is provided by paired sera from reproductive disease cases 
(mainly abortion) which did not show any significant rise (Fig 3.2) 
in BHV1 diagnoses. This in turn supports the view that whilst BHV1 
abortions do occur they have not been a prominent feature of the wave 
of severe IBR from 1976 onwards. 
The absolute and proportional diagnosis rates by BHV1 isolation 
declined at the end of the study period (Table 3.3) and continued to 
fall in 1987 -88. Although there may be an underlying population 
trend this was considered to be principally due to the development 
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work on antigen detection tests described in Chapter 6. Most VI 
Centres now diagnose IBR by immunofluorescence on smears or frozen 
sections without recourse to virus isolation or to the CVL. At this 
stage therefore the VIDA II data (Table 3.2), which record all VI 
Centre diagnoses, are more informative. 
The hypothesis that the host -virus relationship for BHV1 was not in 
equilibrium in the study period was further supported by the rising 
seroprevalence both in diagnostic submissions (Table 3.5) and in 
export and AI tests (Table 3.4, Fig. 3.3). These indicate that 
between 13 and 31% of cattle were seropositive in 1986, compared with 
the earlier figures of 11 -12% (Msolla and others, 1981; Peters and 
Perry, 1983) and less than 10% (Dawson and Darbyshire, 1964; Kirby 
and others, 1978). 
Although there was a significant variation in IBR incidence from 1980- 
86 between counties (Fig. 3.4) it was not possible to identify the 
reasons for this. It was concluded that a much more detailed study 
would be required relating disease incidence and severity to herd 
types, sizes, stocking densities, husbandry practices and cattle 
movements. 
The case records file showed that IBR affected cattle of all age 
groups (Table 3.7). The rising incidence in calves at the end of the 
study period corresponds with reports from Holland (Van Nieuwstadt 
and Verhoeff, 1983) which suggested an increasing role for BHV1 in 
the less well defined calf pneumonia complex. This may in part be 
accounted for by the rising seroprevalence (and the concommitant rise 
in prevalence of latently infected carriers) in the adult popula- 
tion, so that calves are increasingly likely to be exposed to BHV1 
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infection in their first 6 months of life. Both VIDA II and the case 
records analysis showed that IBR had a pronounced, and statistically 
significant, winter peak of incidence (Fig 3.1). The only exception 
to this trend was in adult cattle, in which a secondary peak in August 
reflected the high proportion of animals in mid gestation at that time 
of year. This was reflected in the August peak of BHV1- associated 
abortions (Table 3.10) which was the only clinical sign which differed 
statistically from the seasonal trend. 
Five clinical signs showed trends over the 10 year period which 
differed significantly from the overall pattern (Table 3.9). The 
rise in abortions may indicate the rising prevalence of BHV1 infec- 
tion in adult cattle, while the rise in pulmonary disease may reflect 
the consequent exposure of younger calves as discussed above. In 
contrast one factor leading to a decrease in the more severe signs of 
IBR (mortality and tracheitis) may be the control by vaccination of 
frank clinical disease in the herds most at risk, while the generally 
rising trend in population immunity may also have contributed. The 
fall in ocular signs may have been affected by similar factors al- 
though, like much of the above discussion, these hypotheses are 
speculative attempts to explain observed trends. 
VIRUS CHARACTERISTICS 
When the epidemic of severe IBR began in the late 1970s investigators 
were limited by the lack of sufficiently precise techniques with 
which to compare different isolates of the virus. Nevertheless, 
workers at Glasgow University were able to show that severe IBR was 
reproducible experimentally (Msolla and others, 1983c) which suggested 
that virulence was an attribute of the virus rather than an effect of 
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husbandry conditions. The latter no doubt contributed to the worst 
effects of the disease seen in intensive beef units in north -east 
Scotland (Wiseman and others, 1978). 
It was first shown for human herpesviruses (Hayward and others, 
1975) that RE fingerprints could reveal both major and minor diff- 
erences between strains, and that the technique could be used for 
epidemiological studies (Buchman and others, 1979). This concept was 
extended to veterinary virology, for example with equine herpesvirus 
1 (Allen and others, 1983), SHV1 (Paul and others, 1982) and BHV1 
(Engels and others, 1981). 
Misra and others (1983) first reported RE fingerprints from British 
strains of BHV1 and classified them as DNA types I1 and IIID, which 
correspond to types 1 and 2b of Metzler and others (1985) as used in 
the present work. According to Misra and others (1983) the enzyme 
Hpa I did not distinguish between these two genotypes of BHV1. This 
is surprising because the present studies, supported by Mayfield and 
others (1983) and Kennedy and others (1986), indicate that this enzyme 
gives one of the clearest and most consistent distinctions between the 
two viral types (Fig 4.6). This clarity is facilitated by the small 
number of cleavage sites for the enzyme and the fact that none of 
them are in the short region of the genome so that the digestion 
fragments are all equimolar (Fig 1.2). 
Eco RI and Hind III have been more widely used, and Hind III in par- 
ticular distinguishes type 1 from type 2 viruses by the bands in the 
7 -11kbp range (Fig 4.5). Allowing for some discrepancies in molecu- 
lar weight calibration, the patterns found with UK strains (Figs 4.4- 
4.7) agree closely with the genome maps of American strains of BHV1 
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(Mayfield and others, 1983). Neither the type 2a nor the encephali- 
tic strain (type 3) patterns (Metzler and others, 1985; Brake and 
Studdert, 1985; Metzler and others, 1986; Engels and others, 1986) 
were found among UK field isolates. This conflicts with the assertion 
of Metzler and others (1985) that IBR and abortion isolates are of 
types 1 and 2a, and IPV and IPB of types 2a and 2b. In Britain type 
2b was more frequently isolated from respiratory than from genital 
disease (Tables 4.2 and 4.3). In Northern Ireland (McFerran, personal 
communication; Table 4.4) and Australia (Brake and Studdert, 1985) 
type 2b strains predominate and are frequently found in association 
with respiratory disease. Both of the vaccine strains in use in 
Great Britain appear to be variants of type 1 virus. Although 
Nasalgen somewhat resembled type 2a when digested with Hind III, its 
Hpa I fingerprint placed it in type 1. This has been confirmed by 
Dr Engels (personal communication) who has studied our results (Figs. 
4.10- 4.12). She indicated that type 2a was more common than 2b in 
Switzerland and that both gave type 2 patterns with Hpa I. The 
vaccine strains could thus be uniquely identified by their digestion 
fragments with Hind III and Hpa I. This should facilitate epidemiol- 
ogical studies and diagnostic investigations in herds where vaccines 
have been used. 
Workers at the Moredun Institute first obtained evidence for a change 
in the predominant genotype in Scotland coinciding with the emergence 
of more severe disease in the field (Nettleton, 1986). This was con- 
firmed by the present studies, covering English and Welsh isolates. 
Although few isolates from the 1960s and early 1970s were available, 
neither we nor the Moredun team have found any evidence of type 1 
strains in Britain before the mid 1970s. The emergence of severe 
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IBR has also been reported from other European countries (reviewed in 
Chapter 1) although an association with type 1 virus has not been 
documented. Metzler and others (1985) commented on the remarkable 
homogeneity within type 1 isolates by monoclonal antibody typing, and 
the present RE studies (Chapter 4) suggest that there is less genetic 
variability among type 1 than type 2. A plausible explanation (though 
lacking incontravertible proof) is that a variant or mutant of BHV1 
emerged in the early 1950s in the USA (McKercher, 1959). This was 
the type 1 genotype which had an enhanced affinity and virulence for 
the respiratory tract, grew to higher titre (Gillespie and others, 
1959) and was therefore able to spread rapidly through the intensive 
feedlots. At some stage, and probably on more than one occasion, 
this new virus type returned to Europe by means of latently infected 
cattle purchased for genetic improvement programmes. It spread 
rapidly, expressing its enhanced virulence whenever the epidemio- 
logical circumstances permitted. In the case of Great Britain this 
was in the mid 1970s, and may have been a consequence of the consid- 
erable number of imported cattle brought in for restocking following 
the foot and mouth disease epidemic of 1968 -69. The possible asso- 
ciation of higher prevalence of BHV1 with the presence in herds of 
imported Holstein cattle (Msolla and others, 1981) supports this 
hypothesis. Whether or not this historical view is correct, the 
present studies indicate the need for continued vigilance on new 
importations of cattle in that Britain appears to be free of both the 
wild -type 2a and type 3 strains of the virus. 
It would be expected that the genetic differences demonstrable by 
RE fingerprinting would be reflected in the viral proteins. Studies 
at the CVL (White, 1985) with representative UK strains of DNA types 
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1 and 2b (strains ED1 and ED2, Table 4.1) showed small but consistent 
differences in the PAGE mobility of a number of viral proteins, as 
also reported by Pastoret and others (1980b), Misra and others (1983) 
and Gregersen and others (1985). Neither Gregersen and others (1985) 
using immunoprecipitation nor White (1985) using immunoblotting could 
detect antigenic differences between BHV1 types with rabbit antisera. 
White (1985) also showed extensive cross reactions with convalescent 
calf sera from experiment 2 of the present studies, reacted with 
electroblotted proteins from both virus types. Furthermore the cross 
reactivity extended to clinical protection (Table 5.8). It appears 
that only with the narrow epitope specificity of monoclonal antibodies 
will it be possible to demonstrate distinguishing antigenic features 
between BHV1 genotypes (Metzler and others, 1985). The application 
of such distinguishing monoclonals will provide a tool for the typing 
of isolates which is simpler than the rather specialised and elaborate 
RE method. 
EXPERIMENTAL PATHOGENICITY 
Ideally the relationship between viral genotype and virulence would 
be explored by comparing a large number of isolates, representing the 
different DNA types, in similar host groups under identical condit- 
ions. Practical considerations, not least the cost of experimental 
work in cattle and the time involved in clinical assessments, impose 
severe constraints on this approach. Although small animal models of 
IBR have been described (Lupton and others, 1980) they could not be 
used as indicators of strain virulence for cattle without first doing 
comparative studies in cattle and the model species. Possible con- 
founding factors of the calf experiments include individual animal 
variation in an outbred population, and the difficulty with purchased 
-227- 
calves of obtaining animals of a uniform genetic makeup. There was 
evidence in experiment 2 of an age -related susceptibility to BHV1 
(Fig. 5.4) which supported the findings of Msolla and others (1983a). 
Although not conclusive the results of experiments 3 and 5 suggested 
a possible host breed variation in susceptibility, which could be 
investigated by a breed comparison in age matched groups of calves 
using a standard viral inoculum. Studies in cattle would be unlikely 
to achieve the precision of Shanley (1984) who showed with inbred 
mouse strains that susceptibility to pulmonary infection with murine 
cytomegalovirus was inherited as an autosomal dominant associated 
with the H -2 locus. Further problems in the present studies may have 
arisen because of the practical necessity of extending the primary 
comparisons (experiment 1) over a period of time, with the possible 
effects of weather or other seasonal factors on the clinical express- 
ion of the experimental disease. This was controlled by the use of a 
randomized block design, although the results showed that there was 
not in fact any significant variation attributable to blocks (Table 
5.5). 
It was essential, in order to make statistical comparisons between 
viral strains, that a quantitative system of clinical assessment was 
developed. The recording system described for calf respiratory 
disease by Thomas and others (1977) was used, but adapted to the 
clinical signs expected in IBR. Essential elements were that the 
clinician was unaware of treatment allocations, that the same clinic- 
ian did all the examinations, and that each calf was specifically 
examined and scored daily for each item on the check list of clinical 
signs. Strict attention to personal disinfection between pens was 
essential to prevent cross- infection and the lack of transmission to 
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the control calves (experiment 1) confirmed that this was effective. 
No significance can be attached to the absolute values of clinical 
score produced, as they were dependent on the clinician's personal 
criteria of severity for each sign, and on the weighting system used 
in the calculation. Nevertheless they should provide a reliable 
measure of relative virulence within the parameters of the experi- 
ments. Although the endeavour was always to maintain objectivity of 
clinical scoring one possible source of bias, notably in experiment 
2, was that it was obvious to an experienced clinician that one group 
of calves was more severely affected than the other, and it was 
guessed (later proved correct) what the treatment allocations were. 
Thomas and others (1977) emphasised the importance of a period of 
pre- inoculation monitoring of experimental calves in order to deter- 
mine an individual baseline for the clinical scores. This procedure 
was followed in the present studies but their use of individual means 
and tolerance limits for rectal temperature was found to be unnecess- 
arily elaborate. The practical alternative of scoring temperature 
above 39 °C gave a satisfactory measure of the febrile response. 
Thomas and others (1977) used a combination of mean scores for clin- 
ical signs and cumulative scores for rectal temperature and haemat- 
ological values. The latter two were also divided by their standard 
deviations. The rationale for these calculations is not clear and is 
not explained in their paper. For the present studies the scores 
were originally calculated from the raw data by Thomas and others' 
method but this was subsequently changed to a uniformly cumulative 
method. This was considered more representative of the total virul- 
ence of the strain and, unlike values based on means, was independent 
of the length of the monitoring period provided monitoring continued 
until clinical recovery occurred. Thomas and others also included 
-229- 
values derived from weekly haematological measurements. This would 
not be very informative for an acute disease of short duration. As 
the preferred alternative of daily haematology was beyond the resourc- 
es available it was omitted altogether. 
There was no reason to suppose that the clinical score values for 
individual calves with any one virus inoculum would be anything but 
normally distributed. The use of analysis of variance and Student's 
't' test was therefore considered appropriate as they are generally 
more powerful than non -parametric tests for normal data (Snedecor and 
Cochran, 1967). Non -parametric tests were also done (Tables 5.5 -5.9) 
to support and confirm the validity of the conclusions of the para- 
metric analyses. This was simpler than attempting the tedious pro- 
cedures involved in testing for normality in data. A particular 
problem arose with experiment 1 in the need to use an estimated value 
to produce a balanced table for the anovar. The necessary correction 
factor reduced the treatment variance thereby lowering the F value 
and raising the significance above 5 %. Friedmann's test did not 
require use of the estimated value and showed that there was in fact 
evidence of significant variation attributable to treatments (virus 
strains). Taken together, the clinical score results from experiments 
1, 2 and 3 indicate that not only is there a variation in virulence 
between strains of BHV1 but that, at least within this limited series 
of experiments, it could be related to the genomic type as determined 
by RE fingerprinting. Type 1 strains produced more severe clinical 
signs of IBR, which observation fits the hypothesis propounded above 
that type 1 virus was imported to Britain in the 1970s and led to an 
epidemic of severe disease in the field. 
For statistical analysis of the virus titres in extracted swab samples 
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from the experimental calves (Table 5.11 -5.18) non -parametric tests 
were used in order to avoid distortion due to the large number of 
negative samples, whose titre could properly only be described as 
" <1" where there was no detectable growth from the undiluted sample. 
As with the clinical scores cumulative virus scores derived from 
the logarithms of the titres were used to facilitate comparisons 
between strains. The virus score was affected by both the height and 
duration of the virus shedding curve (Fig 5.6) but as both of these 
are relevant to the risk of cross infection between animals it was 
considered a pertinent measure. 
In experiment 1 there was a significant variation in virus score 
attributable to strains and this appeared to be related to viral 
genotype when the strains were grouped according to their RE profiles 
(Table 5.11). The analysis was further supported by a detailed analy- 
sis of individual titres using the Kruskal Wallis method (Table 5.12) 
which showed significant variation attributable to strains, genotype 
group, and (not surprisingly) days post -inoculation. The same pattern 
of virus excretion was repeated in the age- matched pair comparison 
(Table 5.14) in which calves inoculated with DNA type 1 virus had 
significantly higher cusum titres in the nasal mucus as shown both by 
the paired Wilcoxon test and by a Mann Whitney comparison of the 
medians. The differences were significant individually for only two 
of the pairs, while an overall comparison of daily titres was not 
significant. These analyses emphasise the importance of careful 
selection of statistical methods which will highlight the differences 
between treatments and distinguish them from the confounding effects 
of other variables. In experiment 3 the differences in virus shedding 
between the two strains of DNA type 1 were not significant, but in 
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view of the very limited number of observations this can only be 
regarded as a provisional conclusion (Table 5.18). 
The measurement of viral titres in the swab extraction media gave 
a reasonable estimate of the infectious titre per gram of nasal 
mucus, in view of the consistent amount of mucus collected on the 
swabs (Table 5.10). Virus shedding into the environment would 
also be affected by the total mucus production which tended to be 
higher with type 1 strains (Table 5.7). Less consistent sampling 
was achieved by ocular swabbing (Table 5.10) and a larger sample was 
likely to be obtained from eyes with frank discharge than from 
clinically normal ones. Accordingly, although some differences in 
virus titres were shown (Tables 5.13, 5.15), the results were ascribed 
less importance than those from the nasal swabs. 
It is evident from Table 5.16 that recrudescent infections of the 
genital tract can follow a primary respiratory infection. This is of 
importance when selecting bulls for breeding or AI purposes and 
supports the view that any serological reactor is a potential risk 
for spread of virus in semen. In the context of control of BHV1 
another important finding is that recovered cattle, whilst immunolog- 
ically protected against clinical disease (Table 5.8), can still 
become infected with BHV1 of another genotype, and be an infective 
risk for other cattle (Table 5.17). The pattern of excretion was 
similar to that shown by vaccinated calves (Frerichs and others, 
1982). 
One of the major features of IBR in the field in Britain in the study 
period was the apparent increase in incidence. These virological 
studies offer an explanation for the phenomenon in that animals in- 
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fected with the "new" strain (DNA type 1) excrete much higher titres 
of virus (1 to 2 logs at the peak in some cases - Table 5.14) and are 
therefore more likely to transmit infection than are animals infected 
with type 2 strains. 
This provides a parallel with earlier comparisons of IPV and IBR 
strains (Gillespie and others, 1959) where a 100 -fold difference 
in titre was noted. It is probable (as indicated in Table 4.4) that 
they were also studying viruses of types 1 (IBR) and 2 (IPV). 
ANTIBODY RESPONSES 
The development of the ELISA (described in chapter 6), initially for 
measurement of IgG responses and subsequently for immunoglobulin class 
and subclass specific assays, enabled a more detailed study of the 
serological responses to experimental infection than had previously 
been possible. The calves showed a classic sequence of antibody 
responses with an early rise in IgM (day 8) followed within a few 
days by IgG1 and IgG2 (from days 9 -10) which rose to a peak or a 
plateau as the IgM fell from its peak at day 14. IgA responses were 
detected only weakly in nasal secretions and not at all in serum. 
Although IgG1 is present in considerable amounts in bovine respiratory 
tract secretions, IgA is the dominant immunoglobulin especially in 
the upper respiratory tract (Butler, 1983). A strong secretory IgA 
response would therefore be expected following an upper respiratory 
infection such as BHV1 (Gerber and others, 1978). The lack of known 
positive standards for the IgA assay led to difficulties in calibrat- 
ion of the test. It is possible that the commercial antiserum used 
was insufficiently potent for the purpose, although the antisera for 
IgM, IgG1 and IgG2 from the same manufacturer appeared to have ade- 
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quate specificity and potency, as shown in Chapter 6. Further devel- 
opment and characterisation of the IgA assay is needed before it can 
be used to study this aspect of the immune response. 
DIAGNOSIS 
Because IBR is principally a disease of the upper respiratory tract, 
samples for diagnosis are readily collected and the confirmation of 
BHV1 is generally easily achieved. As shown in Chapters 5 and 6 the 
virus is present in high titres in the nasal secretion during the 
first week after infection. Although elaborate sampling techniques 
have been described for bovine respiratory disease diagnosis (Thomas 
and Stott, 1975; Kimman and others, 1986), and may be necessary for 
pneumonic infections, a simple nasal swab technique as described in 
Chapter 6 was quite adequate in the case of IBR. The addition of a 
liquid transport medium facilitated transport to the laboratory and 
improved the quality of cytological smears for direct immunofluor- 
escence compared with unwashed nasal mucus smears, even though the 
latter have been very successfully employed (Nettleton and others, 
1983). It is clear from the experimental infections that nasal 
secretion samples for antigen detection must be taken early in the 
course of the disease - ideally within a week of first exposure to 
the virus, which probably corresponds in field cases to a 4 -5 day 
window from the first detection of clinical signs. The use of a 
rectal thermometer to detect in- contact animals in the prodromal 
febrile phase would be of benefit in the investigation of outbreaks 
in groups of cattle. 
The choice of antigen detection system appears to matter little 
provided that the test conditions are optimised. Direct immunofluor- 
escence was selected for routine IBR diagnosis in the MAFF laboratory 
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service on the grounds that it was technically simple and familiar to 
the staff. For the labelling of cytological smears immunoperoxidase 
could be used but its advantages (visible light microscopy, permanent 
preparations) were outweighed by the drawbacks (high noise levels, 
endogenous enzyme problems, a longer test with more steps). The 
immunoperoxidase method has a particular advantage for frozen or para- 
ffin embedded tissue sections where it can be used to relate the 
presence of viral antigen to tissue pathology (Higgins and Edwards, 
1986). 
For other laboratories, methods aimed at the detection of soluble 
viral antigen may be preferred. ELISA could be amplified to a high 
sensitivity by using the biotin -avidin system, but even so it only 
equalled the technically much simpler RPHA system. An advantage of 
these methods is the facility with which large batches of samples can 
be processed. This may be of little benefit to many laboratories. 
The methods also avoid the need, inherent in cytological techniques, 
for skilled staff to read and interpret the test, although this could 
be considered a drawback which might lead to a higher risk of false 
positives when relying on a purely mechanical determination of 
positivity. 
Future developments in antigen detection systems (whatever the label) 
are likely to involve virus specific monoclonal antibodies (Collins 
and others, 1985a). The high specificity of these reagents leads to 
low noise levels in the assays and hence to high sensitivity. Never- 
theless the low noise and high signals obtained with polyclonal 
gnotobiotic calf sera in the present studies will prove hard to beat. 
Monoclonals also have a potential for use in virus sub -typing where 
this is thought desirable (Metzler and others, 1985). 
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DNA hybridization has been heralded as the answer to highly sensitive 
detection of the virus (Petterson and Hyypia, 1985). At present the 
technique is more lengthy and elaborate than antigen detection, while 
the reliance on radio labels (Pacciarini and others, 1986) for all 
the most sensitive protocols rules it out for practical diagnostic 
applications. Furthermore, problems may arise in clinical samples 
from the high proportion of non -viral material present leading to 
reduced sensitivity of virus detection with DNA probes (Dorman and 
others, 1985). 
Serology continues to provide a useful tool for the diagnosis of 
BHV1. The VN test is simple to perform, provides a high degree of 
specificity and is likely to remain the standard against which other 
assays are evaluated (Office International des Epizooties, 1986). 
The ELISA is an economical alternative which permits more rapid 
screening of sera for regulatory and diagnostic purposes. Its 
sensitivity approaches that of the enhanced VN test using a 24 hour 
neutralization time (Bitsch, 1978; Edwards and others, 1986b). It is 
difficult to purify herpesvirus antigens so as to be completely free 
of host cell proteins (Spear and Roizman, 1972). It was shown in 
this study that satisfactory and specific results were obtainable 
using a crude detergent- extracted antigen from BHV1- infected cell 
cultures. The incorporation of a control cell antigen as part of the 
test provides an internal baseline for each individual serum. The 
value of this was shown by the considerable variation among field 
sera in the background OD obtained with the control antigen. 
The results of serological ELISAs can be expressed in a variety of 
ways, none of which is completely satisfactory (de Savigny and Voller, 
1980). Both end -point titrations and OD measurements at a single 
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dilution are influenced in a complex manner by the concentration and 
the affinity of the antibodies present in the test sample (Butler and 
others, 1978; Lehtonen and Eerola, 1982; Lew, 1984). For diagnostic 
purposes, the mathematical form of the result is of little importance 
provided some sort of quantitative expression is available which can 
be evaluated against established parameters. The OD result at a 
fixed dilution provides such a measure, and is easily calculated. 
The extensive calibration of the test described in Chapter 6 provided 
the necessary parameters. 
Diagnostic serology should be considered from two distinct points of 
view. In the first instance the test is used for regulatory purposes 
(pre- export tests, AI health controls, other herd health control 
schemes and surveillance work). For such applications only a qualit- 
ative result is required, but the test sensitivity should be maximised 
and the positive /negative cut -off point determined with the greatest 
possible precision. This was achieved by testing sera at a dilution 
of 1/50, and by calibrating the assay with a large population of 
known negative samples. It is important that those using such test 
results appreciate that a fixed cut -off value such as 0.10 OD units, 
as used here, is arbitrary and inevitably a few sera will be 
misclassified by such a system. Although in population terms this 
may not matter it could cause problems particularly when dealing with 
individually valuable animals. 
The second main application for serology is in disease diagnosis. A 
single sample from an affected case is uninformative as positive 
results indicate past infection but not how recent it was, while 
negative results can mean either no exposure, or that an acutely 
affected animal has not yet seroconverted. Paired acute and convales- 
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ent sera are therefore essential for diagnosis, a concept that is 
well known. Conventionally, a fourfold rise in titre is considered 
the minimum criterion for diagnosis of active infection. For the 
ELISA using OD values as the quantitative result it was necessary 
to establish equivalent parameters for a diagnostic rise, for which 
purpose the "least significant difference" method was used. The 
chosen criterion of a 0.20 rise in OD value was shown to compare well 
with a fourfold rise in VN titre. 
Further development of serological diagnosis should focus on the 
detection of viral- specific IgM class antibody. It was established 
in Chapter 5 that IgM is detectable 8 days after infection, peaks at 
12 -14 days then falls to low or undetectable levels by 3 -4 weeks. 
The finding of high IgM would therefore provide a useful diagnostic 
indicator of recent active infection with the virus, and could obviate 
the need for collection of convalescent sera for the demonstration of 
rising titres. Similar findings have been reported for bovine respir- 
atory syncytial virus (Westenbrink and Kimman, 1987) and vesicular 
stomatitis virus (Vernon and Webb, 1985). IgM assays are particularly 
prone to difficulties caused by high non -specific background reactions 
(Tedder, 1984), as was encountered in the study of field sera described 
in Chapter 6. Although the inversion of the assay to an antibody 
capture system (Tedder, 1984) provided some improvment, it remains 
difficult to find or prepare polyclonal antisera of adequate specif- 
icity against IgM. (Butler, 1983). Monoclonal antibodies are the 
obvious answer. They have already been applied in a respiratory 
syncytial virus IgM assay in cattle (Kimman and others, 1987; 
Westenbrink and Kimman, 1987) and the preliminary studies reported 
here show their potential for a sensitive and specific assay for 
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bovine IgM applicable to BHV1 diagnosis. 
The studies reported here have shown that a variety of immunoassays 
may be employed in BHV1 diagnosis, using fluorescent, enzymic or 
erythrocyte labels and applying them to both antigen and antibody 
detection. The choice of method for an individual laboratory depends 
on the facilities available, the experience of the personnel, the 
nature and the number of diagnostic submissions. All the methods 
depend upon the availability of high quality monospecific antisera, 
and this is an area where monoclonal antibodies should play a promin- 
ent role in future. 
PRINCIPAL CONCLUSIONS 
1. Infectious bovine rhinotracheitis was first described in Great 
Britain in 1961 although there is no reason to suppose it was not 
present before that date. In the late 1970s it appeared in 
epidemic form with greater virulence and a stronger propensity 
to spread. In this respect it resembled IBR as described in the 
USA rather than the milder form seen previously in Britain. 
2. The incidence of severe IBR appears to have declined in recent 
years. This may reflect the successful application of health 
control regimens (including vaccination) and also a rising bovine 
population immunity, which is reflected in the data for sero- 
prevalence. 
3. Molecular genomic studies of viral isolates indicated that 
severe IBR was associated with BHV1 of genotype 1 which closely 
resembles American IBR isolates. The evidence suggests that 
virus of this genotype, although now predominant, was absent 
from Great Britain before the mid 1970s. It may still be absent 
-239-- 
from Northern Ireland. 
4. Experimental infections in calves showed that genotype 1 viruses 
were more virulent than genotype 2 isolates of BHV1. Calves 
infected with genotype 1 also shed significantly higher titres 
of virus, which may explain the propensity of this virus to 
spread to other cattle. Calves recovered from infection with 
either genotype were clinically resistant to challenge with the 
other type. 
5. The serological responses of experimentally infected calves 
followed a consistent pattern. ELISAs were developed to measure 
the immunoglobulin classes of the responses. IgM was detected 
from day 8 after infection, peaked at days 12 to 14, then fell 
to low or undetectable levels by 3 to 4 weeks after infection. 
IgG (sub classes 1 and 2) and neutralizing antibody responses 
appeared at days 9 or 10 and rose to a high level by 2 to 3 
weeks. This persisted for at least several months. Recovered 
calves given dexamethasone to reactivate latent virus showed 
anamnestic rises in IgG and neutralizing antibody, as did calves 
challenged with virus of a heterologous genotype. 
6. Diagnostic test procedures were developed using samples from 
the experimentally infected calves. The most promising of the 
tests were evaluated on field materials then brought into routine 
use at the laboratory. These included antigen detection proced- 
ures (immunofluorescence, enzyme immunoassays) and serology 
(ELISA). Other assays showed potential which might be best 
exploited by the application of monoclonal antibodies (reverse 
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APPENDIX 3 (iii) Distribution of VIDA II records and CVL case 
records by VI Centre 
VI Centre Total IBR /IPV 







Aberystwyth 10 2 5 
Bangor 90 3 22 
Bristol 299 19 4 
Cambridge 190 3 8 
Cardiff 62 4 6 
Carmarthen 73 7 49 
Chester 32 3 19 
Gloucester 335 9 9 
Leeds 203 9 23 
Lincoln 64 12 36 
Liverpool 441 16 16 
Newcastle 41 4 22 
Northampton 65 5 58 
Norwich 76 4 13 
Penrith 238 7 8 
Reading 92 - 7 
Shrewsbury 339 40 16 
Starcross 260 10 18 
Sutton Bonington 134 17 60 
Thirsk 283 12 93 
Truro 43 - 18 
Weybridge 24 4 9 
Winchester 177 3 11 
Worcester 229 14 133 
Wye 90 3 9 
Aberdeen 95 - - 
Auchincruive 89 - - 
Dumfries 115 - 1 
Edinburgh 81 - 1 
Inverness 85 - - 
Oban 4 - - 
Perth 150 - 2 
St Boswells 120 - - 
Thurso 83 - - 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Antibodies to BHV1 in nasal mucus measured by virus neutralization (VN) 
(end point titre) or immunoglobulin class -specific ELISA (OD values, for 
mucus diluted 1/20), Experiment 1C 
Days after inoculation 
Antibody Virus 1 5 8 12 16 21 
EDI <1 <1 <2 1 3 3 
ED2 <1 <4 <4 <4 2 1.5 
VN ED3 <1 <1 <1 5 >8 3 
ED4 <1 <1 <1 3 6 3 
ED5 <1 <1 <1 <1 1 1.5 
ED6 <1 <1 <1 1 1.5 2 
ED1 .02 .01 .07 .81 1.02 .25 
ED2 .02 .02 .12 .42 .32 .20 
IgM ED3 0 .04 .18 1.79 1.02 .36 
ED4 .01 0 .14 1.58 .99 .50 
ED5 .01 0 .12 .50 .31 .14 
ED6 .01 .01 .32 .62 .42 .20 
ED1 .03 .01 .02 .41 .34 .24 
ED2 .04 .01 .03 .10 .09 .07 
IgA ED3 .02 0 .06 .28 .23 .41 
ED4 .02 .01 .03 .28 .46 .76 
ED5 .02 .01 .02 .21 .07 .19 
ED6 0 .01 .06 .40 .31 .10 
ED1 .03 .02 .02 .20 .85 .77 
ED2 .02 .02 .03 .12 .26 .41 
IgGl ED3 .02 .02 .03 .51 .71 .69 
ED4 .02 .02 .04 .20 .67 .78 
ED5 .02 .02 .03 .29 .64 .48 
ED6 .01 .02 .03 .20 .46 .62 
EDI .04 .01 .01 .17 .91 .65 
ED2 .02 .03 0 .08 .26 .49 
IgG2 ED3 .02 0 .02 .30 .73 .66 
ED4 .01 .01 .01 .26 .92 .90 
ED5 .03 .02 .01 .25 .71 .62 
ED6 0 .01 .02 .22 .49 .57 
-293- 
APPENDIX 5(xiv) 
IgG1 antibodies detected by ELISA (OD values) in nasal mucus in experiment 2 
Pair Treatment* Virus Strain 
Days after inoculation 
0 14 21 32 42 56 63 70 88 102 
1 C ED1 .06 .23 .63 .91 .76 1.00 .68 .65 
C ED2 .03 .19 .81 .66 .34 .41 .34 .29 
5 C ED1 .03 .18 .79 .85 .96 1.23 .80 1.29 
C ED2 .01 .14 .42 .67 .44 .69 .44 .59 
2 IH ED1 .03 .86 1.00 .72 1.05 .72 .52 .38 1.16 
IH ED2 .06 .47 .73 .91 .93 1.03 .42 .74 1.16 
3 IH ED1 .03 .30 .40 .27 .32 .68 .97 .69 1.28 
IH ED2 .04 .44 .47 .35 .48 .54 .33 .37 .92 
4 ID ED1 .03 .51 .52 .46 .29 .53 .67 1.16 1.19 
ID ED2 .15 .40 .34 .42 .40 .85 .66 1.49 1.34 
6 I ED1 .02 .53 .69 .61 .72 .82 .67 .57 
ID ED2 0 .25 .44 .47 .45 .63 .35 .59 .42 
* Treatments: I = inoculated on day 0 
C = in- contact from day 0 
D = dexamethasone on days 56 -60 inclusive 
H = heterologous virus strain challenge on day 88 
-294- 
APPENDIX 5(xv) 
IgG2 antibodies detected by ELISA (OD values) in nasal mucus in experiment 2 
Days after inoculation 
Pair Treatment* Virus strain 0 14 21 32 42 56 63 70 88 102 
1 C ED1 .04 .13 .38 .72 .68 .96 .69 .56 
C ED2 .05 .09 .31 .34 .23 .33 .25 0 
5 C ED1 .01 .09 .36 .61 .76 1.04 .99 1.11 
C ED2 0 .07 .26 .46 .32 .46 .36 .49 
2 IH ED1 .01 .32 .36 .34 .57 .48 .43 .39 1.18 
IH ED2 .03 .19 .32 .41 .44 .49 .20 .42 .85 
3 IH ED1 0 .22 .33 .27 .38 .93 1.14 .91 1.29 
IH ED2 .03 .36 .38 .34 .48 .60 .36 .43 .90 
4 ID ED1 0 .26 .31 .38 .29 .65 .89 1.25 1.28 
ID ED2 .01 .17 .20 .29 .27 .60 .48 1.02 1.06 
5 I ED1 .02 .32 .43 .53 .70 .88 .81 .60 
ID ED2 .01 .25 .33 .47 .47 .73 .48 .79 .56 
* Treatment I = inoculated on day 0 
C = in- contact from day 0 
D = dexamethasone on days 56 -60 inclusive 
H = heterologous virus strain challenge on day 88 
-295- 
APPENDIX 5(xvi) 
IgM antibodies detected by ELISA (OD values) in nasal mucus in experiment 2 
Pair Treatment* Virus Strain 
Days after inoculation 
0 14 21 32 42 56 63 70 88 102 
1 C ED1 .08 .51 .22 .20 .16 .18 .14 .08 
C ED2 .02 1.15 .39 .14 .46 .15 .05 .06 
5 C ED1 .10 .60 .27 .19 .22 .34 .18 .35 
C ED2 .02 .69 .28 .19 .28 .17 .06 .09 
2 IH ED1 .04 .69 .34 .14 .15 .09 .09 .04 .38 
IH ED2 .05 .53 .29 .24 .24 .24 .06 .12 .34 
3 IH ED1 .03 .50 .17 .09 .11 .15 .17 .13 .37 
IH ED2 .04 .28 .10 .07 .10 .07 .08 .10 .36 
4 ID ED1 .01 .65 .19 .06 .04 .09 .13 .37 .18 
.64 .19 .10 .06 .12 .11 .45 .19 
6 I ED1 .02 .63 .21 .14 .15 .18 .18 .12 
ID ED2 0 .34 .12 .14 .09 .19 .11 .22 .11 
* Treatments: I = inoculated on day 0 
C = in- contact from day 0 
D = dexamethasone on days 56 -60 inclusive 
H = heterologous virus strain challenge on day 88 
-296- 
APPENDIX 5(xvii) IgA antibodies detected by ELISA (OD values) in nasal 
mucus in experiment 2 
Pair Treatment* Virus strain 
Days after inoculation 
0 14 21 32 42 56 63 70 88 102 
1 C ED1 .02 .08 .04 .03 0 0 .03 0 
C ED2 0 .15 .07 .05 .06 .04 .06 .04 
5 C ED1 .03 .12 .05 .10 .13 .04 .06 .07 
C ED2 .09 .09 .08 .10 0 .11 .05 .09 
2 IH ED1 .02 .19 .06 .08 0 .02 .06 .13 .41 
IH ED2 .01 .13 .05 .04 .02 0 .03 .04 0 
3 IH ED1 0 .26 .08 .14 .09 .08 .03 .04 .74 
IH ED2 0 .07 .06 .06 .05 .10 .10 .04 .50 
4 ID ED1 0 .08 .11 .09 .05 .04 .07 .61 .51 
ID ED2 .03 .09 .06 .30 .12 .08 .06 .22 .15 
6 I ED1 .02 .13 .09 .09 .06 .09 .17 .09 
ID ED2 0 .03 .05 .07 .16 .21 .15 .30 .23 
* Treatments: I = inoculated on day 0 
C = in- contact from day 0 
D = dexamethasone on days 56 -60 inclusive 
H = heterologous virus strain challenge on day 88 
-297- 
APPENDIX 6 (i) Results of virus isolation, amplified ELISA and 
reverse passive haemagglutination for BHV1 antigen 





Test (a) Calf 
No. 
35 58 88 41 54 44 68 2 43 47 
2 V 2.25 3.5 1.25 2.5 3.0 0.75 - - - 1.75 
E - - - 0.03 0.02 - - - - - 
- - - - - - - - - 2 
3 V 1.0 3.25 1.25 3.5 2.75 0.75 2.0 - 3.25 - 
E - - - 0.02 0.01 - - - 0.02 - 
R - - 1 - - - - 1 - 2 
4 V 3.25 2.5 0.75 5.0 4.25 0.75 0.75 0.75 1.75 1.0 
E - 0.05 - 0.22 0.03 - - - - - 
R - 2 2 6 1 1 NA 2 - 2 
6 V 1.5 1.5 - 4.5 - 1.75 1.25 2.0 3.5 1.0 
E - - - 0.07 0.01 - 0.04 - - - 
R - - - 2 - - - - 2 - 
7 V 0.75 - - 3.0 - 3.0 1.25 - - 1.5 
- - - - - - - - - - 
- - - - - - - - - 2 
8 V - - - 0.75 - - - 0.75 - - 
- - - - - - - - - - 
R - - - - - 2 1 2 - - 
9 V - - - - - - - - - - 
- - - - - - - - - - 
- - - - - - - - - 1 
10 V - - - - - - - - - - 
- - - - - - - - - - 
- - - - - - - - - - 
Notes (a) V = Virus isolation, log10 TCID50 /90 ul 
E = BAB ELISA, optical density (test well - control well). 
R = RPHA, logt end -point titre 
- = no virus isolated, or OD < 0, or no haemagglutination 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































614 The Veterinary Record, December 101988 
Papers and Articles 
Changing trends in infectious bovine 
rhinotracheitis in Great Britain 
S. Edwards 
Veterinary Record (1988) 123, 614 -618 
The incidence and severity of infectious bovine rhinotracheitis 
in Great Britain increased markedly in the mid to late 1970s. 
Data available in MAFF records have been used to analyse the 
changing trends in disease incidence and serological preval- 
ence, with particular emphasis on the most recent decade. 
EPIDEMIOLOGICAL data on infectious bovine rhino- 
tracheitis (IBR) and related diseases in Great Britain are in- 
complete. Early papers were presented as case reports of IBR 
(Dawson and others 1962, Darbyshire and Shanks 1963) and 
infectious pustular vulvovaginitis/balanoposthitis (Huck and 
others 1971, Collings and others 1972). Serological surveys 
gave an estimated seroprevalence for the virus as 2.1 per cent 
(Dawson and Darbyshire 1964), 6.8 per cent (sampled in 
1974) (Kirby and others 1978) and 12 per cent (sampled in 
1977) (D. H. Roberts personal communication, summarised 
by Anon 1978); however, these three studies used different 
methods of antibody assay, virus neutralisation in tube cul- 
tures, indirect haemagglutination and virus neutralisation in 
microplates, respectively. 
Beginning in the winter of 1977 to 1978, widespread reports 
(summarised by Anon 1979) indicated a sudden rise in the 
incidence and clinical severity of IBR, typically associated with 
high herd morbidity and variable but significant mortality. 
The evidence for this rise in incidence was supported by clini- 
cal and pathological studies by Wiseman and others (1978, 
1980) and Allan and others (1980). Subsequently, Msolla and 
others (1981) suggested that the seroprevalence of bovine 
herpesvirus 1 (Bxv1) in Scotland had increased to 12 per cent, 
notably in herds which had introduced Holstein cattle. They 
did not state the year in which the samples were collected. A 
similar prevalence (11.4 per cent) was reported by Peters and 
Perry (1983) for bulls at performance testing stations in the 
period 1979 to 1981. Further developments, likely to influ- 
ence the epidemiology of the disease, occurred in 1979 and 
1981 with the announcement of product licences and the com- 
mercial availability of the live attenuated intranasal IBR 
vaccines Tracherine (Smith Kline Animal Health) and 
Nasalgen (Wellcome). 
In an attempt to gain an overall view, particularly for the 
period 1970 to 1986, data from the records of the veterinary 
laboratories of the Ministry of Agriculture, Fisheries and 
Food (MAFF) and the Scottish Agricultural Colleges have 
been further analysed. 
Materials and methods 
Three sources of data were used. None represents an un- 
biased sample of the cattle population and two were derived 
from the same source material - namely clinical incidents pre- 
S. Edwards, MA, VetMB, MSc, MRCVS, Ministry of Agriculture, 
Fisheries and Food, Central Veterinary Laboratory, New 
Haw, Weybridge, Surrey KT15 3NB 
sented to the veterinary investigation (vi) service for disease 
investigation and diagnostic laboratory testing. 
VIDA II 
The veterinary investigation diagnosis analysis - Mark II 
(VIDA II) commenced in 1975 and comprised over 2.2 million 
computerised records by the end of 1986 (MAFF and others 
1987). The data were supplied by vi centres in England, Scot- 
land and Wales. 
Diseases caused by bovine herpesvirus 1 (Bxv1) were not 
recorded as specific diagnoses on VIDA II until 1980, when 
they appeared under `Group 1: Systemic diseases of cattle and 
those not readily classified organically' as 'IBR/infectious pus- 
tular vulvovaginitis (Irv)' and `Group 9: Diseases of the re- 
productive and mammary systems of cattle' as `Fetopathy due 
to IBRJIPV. The data were analysed by month and year and by 
county or region. 
Central Veterinary Laboratory diagnostic testing 
Materials for diagnostic testing were received at the 
virology department, Central Veterinary Laboratory, Wey- 
bridge (cvi,) via the vi service. All incidents investigated at 
the CVL were therefore also recorded on VIDA. Nevertheless, 
more detailed records were available at the CVL than were 
entered on VIDA and a separate analysis was carried out. Con- 
versely, not all VIDA incidents were investigated at the cvi. - 
during the study period, an increasing number of diagnostic 
tests for BHV1 were carried out in vi centres without further 
referral, while in Scotland most tests were carried out at the 
Moredun Institute in Edinburgh. Nevertheless, sufficient test- 
ing was done at the cvi, to warrant analysis of the data. 
Information on the number of tests done and number of 
positive diagnoses was available, through the virology depart- 
ment's annual reports, from 1969. In addition, from 1977 on- 
wards detailed case records were kept of all incidents in which 
a diagnosis of active BHVI infection was considered to have 
been established, either by virus isolation and antigen detec- 
tion or by seroconversion. These records included the labora- 
tory reference numbers, the date, the vi centre of origin, the 
basis of the laboratory diagnosis, and as much of the clinical 
and pathological history as was supplied on the sample sub- 
mission document. The history varied from nothing to a full, 
detailed account of the incident. The data in these case re- 
cords were subsequently reduced to a codified form and ente- 
red into a computer database for analysis. 
CVL, virology department statutory and export testing 
Serum samples were submitted directly to the cvi. by veter- 
inary practitioners and by artificial insemination (AI) or- 
ganisations for screening for BHV1 antibodies. The samples 
were from healthy animals, either before export or before 
entry to AI studs. The data were not recorded on VIDA and 
represented a section of the cattle population different from 
Rt cvz 
The Veterinary Record, December 101988 613 
case there were milking machine defects 
but in the other instance the problem re- 
mained undiagnosed. 
Sheep 
Nervous system diseases 
Diagnoses of cerebrocortical necrosis 
were made at Auchincruive, Dumfries 
and Edinburgh. Dumfries and St 
Boswells also saw listeriosis. 
At Dumfries three ewes were submit- 
ted from a farm where signs of ill -thrift, 
weight loss, skin irritation and nervous 
signs had been noted. Scrapie was sus- 
pected and post mortem examination of 
a South Country Cheviot gimmer was 
diagnosed on brain histopathology as 
suffering from scrapie. One other ewe 
was found to be hypomagnesaemic and 
another was confirmed as having cer- 
ebrocortical necrosis. Other ewes were 
examined which were showing signs of 
pruritus and orf and Dermatophilus 
species was recovered. It would appear 
that several different conditions were 
contributing to the problem. 
On another farm, a four -year -old 
greyface ewe showing central nervous 
system signs, a suppurative meningeal 
encephalitis and choroiditis indicative 
of bacterial infection was diagnosed. P 
haemolytica was also recovered in sep- 
ticaemic form and a necrotic suppurat- 
ive pneumonia was also present. 
Generalised and systemic diseases 
All centres commented on occasional 
incidents associated with low levels of 
trace elements while Edinburgh also 
saw copper poisoning. Sporadic cases of 
enterotoxaemia and pasteurellosis were 
also reported. 
Alimentary system diseases Parasitic 
gastroenteritis was diagnosed at all cen- 
tres. Ayr saw a four -month -old lamb 
with a worm egg count of 9700/g. Perth 
reported a few cases of coccidiosis. 
Thurso saw 12 lambs which died as a re- 
sult of damage caused by the use of a 
dosing gun. A further similar case was 
reported from Aberdeen. There were 
two cases of Johne's disease from Shet- 
land. 
Respiratory system diseases A few ases 
of Pasteurella haemolytica pne onia 
were seen at Aberdeen an Perth. 
Single cases of pulmonary ade omatosis 
were reported from Perth a Ayr. Ayr 
saw several cases of pn monic pas - 
teurellosis. Dumfries <w pneumonia 
and purulent pleurisy blackface ewes 
associated with C p ogenes. 
Musculoskeleta system diseases Ery- 
sipelas rhusioiathiae was isolated from 
the joint of a stiff lamb where problems 
have been occurring with stiffness and 
lameness in four -month -old lambs. A 
serological response of 1/5120 was also 
noted from this animal. 
Reproductive system diseases Ayr, 
Edinburgh and Dumfries commented 
upon various abnormalities found dur- 
ing tup testing. 
Pigs 
At St Boswells Mycoplasma hyosyno- 
viae was identified as the cause of joint 
swellings in a minimal disease pig unit. 
Serological examination of gilts at entry 
to the unit and two weeks later revealed 
high titres to M hyosynoviae with no evi- 
dence of seroconversion. It was conclu- 
ded that infection was well established 
in the gilts before arrival on the unit. 
An outbreak of red gut was seen in a 
12 sow unit where two of 28 three - 
month -old pigs died suddenly. No sat- 
isfactory dietary cause was identified. 
The condition had not been seen before 
on the farm. 
Perth saw streptococcal septicaemia 
in young pigs and Pasteurella multocid 
pneumonia in a fattening pig. 
Birds 
Gamebirds 
Several batches of intestines were 
submitted from grouse on Perthshire 
moors. Very high worm burdens were 
present despite the use of medicated 
grit. 
Aberdeen isolated Yersinia seudo- 
tuberculosis in eight- week -old red leg- 
ged partridges and diagnosed col - 
isepticaemia in nine -wee -old grey 
partridges. 
Fowl Broiler ascites 
ported from Thurs 
Coccidiosis was se 
infestation wit 
linarum was the 
duced egg pro 
free range he 
the same ce 
seen in ass 
hens. 
s drome was re- 
and Aberdeen. 
at Perth. Severe 
Dermanyssus gal - 
ause of death and re- 
ction in a small flock of 
s seen at St Boswells. At 
tre H gallinarum was also 
ation with histomoniasis in 
Geese erth saw gizzard worms as the 
caus of death of several birds on one 
un 
Gamebird submission constituted 
the bulk of avian work ring August. 
At Dumfries losses curred mainly 
among eight- week -ol pheasants from a 
variety of sources. 1 were found to be 
badly feathered along backs and wings 
due to severe fea er picking, and often 
there was a lack of food in the intestinal 
tract. While %scherichia coli was re- 
covered in s ticaemic form, it seemed 
likely tha stress factors including 
marble sp en disease were contributing 
to deat in these situations. 
The most serious problem encoun- 
tere at Edinburgh was an almost corn - 
ple wipe out - mainly over a weekend 
- f 10- to -1l- week -old pheasants in one 
elease pen. Yersiniasis was the prin- 
cipal diagnosis. 
At St Boswells Heterakis isolonche in- 
festation associated with histomoniasis 
was seen in a batch of pheasants. This 
worm, which is far more pathogenic 
than H gallinarum, was seen despite 
earlier successful treatment for Syn- 
gamus trachea. 
There was a steady intake of pheasant 
material to Perth throughout August. 
Diagnosis included trichomoniasis 
(two), coccidiosis (three), rotavirus 
(one), colisepticaemia (one) and ex- 
posure (one). One bird had gapeworms, 
staphyloccal joint infection and a group 
E salmonella. 
Mycotic air sacculitis was seen at 
Aberdeen. 
Pigeons 
Edinburgh found that submissions 
from racing pigeons continued at a mod- 
erate level with viral hepatitis being the 
diagnosis of the month in young birds 
which were scouring or going light. Tri- 
chomoniasis was also seen as a problem 
in young birds showing typical liver 
lesions. 
Deaths among wild sparrows and pig- 
eons in a Dundee factory caused con- 
cern. Post mortem examination re- 
vealed a miscellany of different, 
apparently unrelated conditions and it 
was concluded that the death represen- 
ted normal wastage among a very large 
avian population in the area. 
Paramyxovirus infection was dia- 
gnosed in unvaccinated doves in an 
aviary at Aberdeen. 
Miscellaneous mammals 
Strangles was confirmed in horses at 
Dumfries and St Boswells; Auchincru- 
ive and Edinburgh diagnosed ringworm 
in horses caused by Trichophyton 
equinum and Microsporum equinum, 
respectively. St Boswells saw D arnfi- 
eldi infestation in an adult Arab cross. 
Edinburgh saw an outbreak of der - 
matophilus infection in goats. 
Auchincruive isolated Campylobacter 
jejuni from a diarrhoeic pup. 
Carbamate poisoning was confirmed 
by Edinburgh in two cats from an area 
where two other cats had also died in 
suspicious circumstances. Perth repor- 
ted cases of ringworm (all Microsporum 
canis) involving two cats and a dog. 
Cryptosporidiosis continued to cause 
deaths in red deer calves up to a week 
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1969 x 0 3 x x x 
1970 x 1 3 x x x 
1971 2 2 0 x x x 
1972 5 0 1 x x x 
1973 5 5 o x x x 
1974 2 3 o x x x 
1975 4 4 0 x x x 
1976 11 8 1 x x x 
1977 21 9 5 17 x x 
1978 41 10 30 81 x x 
1979 50 18 58 112 x x 
1980 26 17 73 107 517 14 
1981 37 7 97 111 602 13 
1982 44 13 92 111 705 30 
1983 56 16 55 96 780 52 
1984 45 7 44 85 631 72 
1985 46 20 34 94 654 86 
1986 31 18 17 74 483 85 
x Data not available 
the previous analyses, ie, predominantly pedigree breeding 
herds and, in the case of the AI samples, males only. 
Two major changes in serological procedures for BHV1 dia- 
gnosis were made at the CVL during the study period, in each 
case involving an increase in test sensitivity and therefore the 
possibility that more seropositive animals would be detected. 
Until April 1976 the virus neutralisation test was carried out 
in test tube cell cultures using 0.1 ml per tube of serial serum 
dilutions mixed with an equal volume of medium containing 
100 TCID50 BHV1 as described by Dawson and others (1962). 
From April 1976 until August 1985 the virus neutralisation 
test was carried out in the microtitre plate system using 0.025 
ml of serum dilution and 100 TCID50 of virus per test well fol- 
lowing the procedure described by Frerichs and others (1982). 
The method is still in use for most export tests. Some export 
tests and all AI and routine diagnostic tests have been per- 
formed by enzyme immunoassay ( ELISA) since August 1985, 
as described by Hebert and others (1985) and Edwards and 
others (1986). 
Statistical analysis 
Frequency distributions of the incidence and prevalence of 
BHV1 infections were analysed by the X2 technique for one or 
two dimensional tables as appropriate. 
25 - Respiratory disease 
Reproductive disease 
0 
N co V' u) co r co O) O CJ (+) a ir) CO 
N- n N. r n GD co a0 a0 CD CD CD 
o) 0) 0) 0) 0) 0) 0) 0) 0) a) 0) 0) 0) 0) 0) 
Year 
FIG 1: IBR incidence diagnosed at the Central Veterinary Labora- 
tory. (Points on the graph represent the mean of the year shown and 




During the period 1980 to 1986, 4724 incidents of IBR/IPV 
were recorded on VIDA II, 4372 under the heading of systemic 
diseases and 352 as fetopathies. At the cvL, serological 
investigations for BHV1 were carried out on paired sera from 
2656 incidents of respiratory disease in the period 1971 to 
1986. Rising antibody titres to BHV1 were shown in 426 (16 per 
cent) of the incidents. Similar figures for reproductive disease 
for 1970 to 1985 were 2086 incidents investigated, of which 
158 (7.6 per cent) had rising titres to BHV1. Submission of 
tissues and swabs for virus isolation could not be separated by 
disease category but BHV1 was isolated from 513 of the total 
19,189 disease incidents investigated in the period 1969 to 
1986. An unquantifiable proportion of these incidents were 
also investigated by serology and therefore included in both 
totals. Separate successive submissions of samples to the CVL 
from the same disease incident in any one herd could not be 
identified from the available data. Such submissions were 
therefore recorded as separate incidents for the CVL analysis 
although recorded only once in the VIDA II analysis. Evidence 
from the CVL case records analysis, for which this information 
was available, suggested that there was little over- reporting. 
The case record analysis included 888 BHV1 associated clinical 
incidents in the decade 1977 to 1986. 
Testing of bulls for BHV1 antibody before entry to AI centres 
commenced in 1970. Up to the end of 1986, 26,585 animals 
were tested, of which 2716 (10.2 per cent) were positive. Dur- 
ing the period 1969 to 1986, 61,257 cattle were tested for BHV1 
antibody for export certification purposes and of these 5447 
(8.9 per cent) were positive. 
Temporal analysis 
The number of herd incidents each year, extracted from the 
various record sources, is shown in Table 1. There is evidence 
of a marked increase in incidence in the late 1970s, and the 
beginnings of a decline in incidence in the mid- 1980s. When 
the figures were expressed as a proportion of all incidents tes- 
ted for IBR (CvL data) or of all cattle incidents (vIDA II data) 
the X2 test indicated a significant annual variation (P<0.001) 
for all categories except reproductive disease serology 
(P >0.10). The trends in proportional incidence are shown in 
Fig 1, in which year to year fluctuations have been smoothed 
by plotting three year rolling mean values. 
The prevalence of serologically positive animals among 































FIG 2: IBR seroprevalence in healthy cattle. (Points on the graph 







FIG 3: Monthly data for IBR/IPV on VIDA II, 1980 -1986 
(P <0.001) during the study period, as illustrated in Fig 2, 
from below 5 per cent in the early 1970s to 10 to 12 per cent in 
the mid- 1980s. In contrast, among samples submitted from 
diseased cattle (not necessarily suffering from IBR) the preval- 
ence rose from 9.1 per cent in the period 1969 to 1973 to 34.7 
per cent for 1984 to 1986 (data for the intervening years were 
not accessible). To estimate the prevalence of herds with sero- 
logical reactors, it was calculated that 17.6 per cent of sub- 
missions from disease outbreaks tested for IBR in 1970 to 1973 
had one or more seropositive animals. This figure had risen to 
48.0 per cent of submissions in 1984 to 1986. 
All the record systems indicated a marked seasonal trend 
(P <0.001) in IBR incidence, which is illustrated in Fig 3 using 
VIDA II data. Systemic (respiratory) IBR peaked in the winter 
period, November to February, whereas fetopathy incidents 
were highest in July and August. 
Geographical analysis 
The frequency distribution of IBR/IPV incidents by county, 
from the VIDA II records, was related to cattle populations 
recorded in the agricultural census for England (MAFF 1983), 
Wales (Welsh Office 1984) and Scotland (DAFS 1985). There 
were no consistent geographical patterns for IBR/IPV incidence 
(Fig 4). There was no significant correlation between the inci- 
dence rate per 100,000 cattle and either the cattle density per 
hectare for the county or the average number of cattle per 
farm for the county. The only significant correlation found 
was between the actual number of cases of IBR/IPV per county 
and the total number of cattle per county. Nevertheless, x2 
tests indicated a significant variation in incidence per 100,000 
cattle between counties. It was concluded that in the absence 
of a more detailed breakdown of the figures according to size 
and type of farm, the reasons for this variation could not be 
deduced. It could not be linked simply to geographical loca- 
tion. 
Case records 
The age structure of the case records is shown in Table 2. 
No information on age was provided for 337 (38 per cent) of 
TABLE 2: Analysis of AMR case records by age and year 
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FIG 4: IBR (systemic) incidents recorded on VIDA II, 1980 -1986, as 
proportions of county cattle populations 
the incidents. The x2 test indicated a significant variation from 
the expected distribution. Notable trends in the yearly analy- 
sis were an increase in the number of calf incidents in later 
years and a decrease in the number of adult incidents in the 
early 1980s with a subsequent rise at the end of the study 
period. 
Table 3 shows the case records distribution according to 
clinical signs; x2 was calculated for clinical signs with a total of 
more than 20 observations. In the yearly analysis abortion, 
ocular disease, pneumonia, tracheitis, mortality, and `no his- 
tory', differed significantly from the expected distribution. 
The proportion of cases involving abortion rose in later years. 
The proportion of pneumonia cases was high in the last two 
years of the study whereas tracheitis and mortality were both 
relatively more frequent in 1978 to 1979. 
The data from case records were also analysed by month. 
Only abortion differed significantly from the general winter 
distribution. It was lower than predicted in the winter period 
(December to April) and higher from July to September. 
Of the 888 cases analysed, laboratory tests used to confirm 
the diagnosis of BHV1 infection were: serology 460 incidents 
(417 by serology alone); virus isolation 460 incidents (409 by 
virus isolation alone); antigen detection 22 incidents (eight by 
Year 
Age group 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 Total 
> 2 years 9 31 31 26 22 15 30 25 43 40 272 
0.5 -2 years 4 13 21 21 18 21 15 14 13 7 147 
< 0.5 years 2 7 9 10 9 14 16 18 25 22 132 
Unknown 2 30 51 50 62 61 35 28 13 5 337 
Total 17 81 112 107 111 111 96 85 94 74 888 
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TABLE 3: Analysis of 1BR case records by clinical sign and year; the tabulated values are the number of incidents recorded 
617 
Year 
Clinical sign 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 Total P t 
Deaths 1 13 16 9 6 5 4 8 5 9 76 * 
Fever 2 23 37 36 39 38 29 28 18 10 260 NS 
lnappetence 2 7 11 13 14 7 5 7 6 3 75 NS 
Nasal discharge /unspecified 14 50 61 66 62 60 45 41 45 
respiratory signs 
22 466 NS 
Eye discharge/ 5 22 42 51 49 51 35 26 27 
conjunctivitis 
11 319 ** 
Cough 1 6 15 10 16 11 10 6 4 1 80 NS 
Tracheitis 1 8 14 5 7 3 3 1 7 4 53 * 
Pneumonia 1 12 21 11 12 16 10 12 28 27 150 *** 
Diarrhoea 2 2 8 3 2 6 4 4 1 2 34 NS 
Gastrointestinal lesions 4 4 3 2 1 3 1 3 21 NS 
Salivation 8 7 8 5 4 2 5 3 1 43 NS 
Milk drop 3 11 12 6 8 4 11 5 5 7 72 NS 
Abortion 2 6 10 11 6 5 12 11 21 23 107 *** 
Vaginitis 1 2 1 1 1 6 
Infertility 2 1 3 
Haemorrhagic lesions 2 2 1 5 
Skin lesions 3 1 4 
Nervous signs 2 2 4 
No history 5 14 6 8 13 16 8 3 5 78 * 
t Probability that annual values differed from expected based on proportion of total records. X2 test NS >0.05, 
* <0.05, " <0.01, "' <0.001 
$ Clinical records based on information supplied at sample submission 
antigen detection alone). Antigen detection by the fluores- 
cent antibody technique was widely used by the vi service 
(Edwards and others 1988) to diagnose IBR by testing nasal 
mucus smears, but suitable samples were only occasionally 
submitted to the cvL; hence the low figure in this category. 
The distribution of samples in which BHV1 or its antigen were 
detected is shown in Table 4. This indicates the predominance 
of the respiratory form of BHV1 infection. 
Discussion 
It is surprisingly difficult to obtain unbiased information on 
disease incidence. Data from submissions to diagnostic lab- 
oratories, as used here, are subject to the selection of cases by 
the farmer in choosing to consult his veterinary surgeon 
and by the veterinary surgeon in deciding to submit samples 
to the laboratory. Such biases may not be consistent because 
more samples may be submitted when a disease first becomes 
more widely recognised, as with IBR in the late 1970s, and 
fewer samples may be submitted as practitioners become 
more confident in clinical diagnosis in the light of experience. 
Further confusion arises because of the changes in technical 
procedures used in the laboratories. 
Nevertheless the data are all indicative of a sharp rise in IBR 
incidence in the period 1977 to 1979 although the serological 
results (Table 1) suggest that this rise may have begun in 1976. 
The data thus support both anecdotal and published reports 
(Anon 1979, Wiseman and others 1980) of a wave of virulent 
[BR at this time. It would be expected that such a dramatic 
increase in incidence would lead to an increasing prevalence 
of serological reactors in the population as a whole. This ex- 
pectation is supported by the results of serology on selected 
healthy cattle (Fig 2), and in general diagnostic submissions 
where the latest figures showed 35 per cent of animals and 48 
per cent of herds with evidence of prior exposure to BHV1 in- 
fection. IBR was widespread in mainland Britain and no use- 
ful geographical trends could be discerned. Although IBR 
showed a marked seasonality, with a peak incidence from 
November to February, it did occur throughout the year and 
the peak period for IBR- associated fetopathies was July and 
August, in line with the autumn calving patterns in the cattle 
industry. 
It has been suggested that the explanation for the change in 
[BR incidence was the accidental importation of a virulent 
strain of the virus. This view is supported by molecular genetic 
studies of different isolates (Nettleton 1986, S. Edwards and 
TABLE 4: Summary of sample types used for BHVI isolation and antigen 
detection (cvL case records); the tabulated values are the numbers of 
incidents in which each sample type contributed to the diagnosis 
Sample Virus isolated 
Antigen detected 
(direct immunofluorescence) 
Nasal swab 285 10 
Eye swab 128 3 
Lung 59 6 
Trachea 42 2 
Alimentary tract 18 
Blood 3 
Fetus 12 2 
Vaginal swab 2 
Central nervous system 2 
Others 8 
H. White unpublished observations) and experimental calf in- 
oculations (Msolla and others 1983, S. Edwards unpublished 
observations). The analysis of clinical signs in the case records 
needs to be approached with caution because it was based on 
unsolicited histories, and the absence of a record of a sign 
does not necessarily imply that it was absent from the par- 
ticular incident. The analysis indicates the predominance of 
ocular and upper respiratory signs in IBR incidents. There was 
also evidence for a changing pattern of clinical expression dur- 
ing the decade 1977 to 1986 with a trend away from frank 
tracheitis and mortality, towards a greater involvement of the 
lower respiratory tract and a higher incidence in calves. Ver- 
hoeff and Van Nieuwstadt (1984) observed that in young 
calves BHVI infections tended to be accompanied by pneu- 
monia, whereas in yearlings upper respiratory signs pre- 
dominated. The same authors reported that the severity of 
IBR in Holland had apparently diminished in the 1980s compa- 
red with earlier years (Van Nieuwstadt and Verhoeff 1983). 
The data presented here suggest that BHV1 infection in the 
British cattle population has not yet attained enzootic stability 
following the upsurge in IBR in the 1970s. It may be expected 
that the incidence of clinical disease will continue to decline as 
the population immunity (and seroprevalence) rises towards a 
stable level. This trend may be influenced, both locally and 
generally, by the use of vaccination, by herd health control 
schemes, and by changing patterns of husbandry. 
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A field trial in Belgium to control fox rabies by oral 
immunisation 
B. Brochier, I. Thomas, A. lokem, A. Ginter, J. Kalpers, A. Paquot, F. Costy, 
P.-P. Pastoret 
Veterinary Record (1988) 123, 618 -621 
Campaigns of fox vaccination against rabies were carried out 
in Belgium in September 1986 and June and September 1987. 
The SAD B19 attenuated strain of rabies virus was inserted into 
baits which were distributed over an area of 2100 km2 at a 
density of 11 baits /km2. As recommended by the World Health 
Organisation, the efficacy and the innocuity of the method 
were controlled in the field and in the laboratory. Samples of 
blood and brain and jaw were taken from foxes which were 
shot or found dead in the vaccination area, for the diagnosis of 
rabies, the titration of antirabies antibody and the detection of 
tetracycline marker. In rabid animals, the virus strain was 
characterised by immunofluorescence using monoclonal anti- 
bodies. In September 1987, the uptake of the baits had reached 
72 per cent by 14 days after distribution. Several wild species 
competed with foxes in taking the baits. After the last camp- 
aign, tetracycline was found in 65 per cent of the healthy foxes 
collected and rabies virus neutralising antibodies were detected 
in 77 per cent of them. In 1987, the incidence of rabies dec- 
reased markedly in the vaccination area compared with the 
untreated areas. No vaccine virus was isolated either from 
rabid animals or from 228 small mammals trapped in the 
vaccination area. 
SYLVATIC rabies invaded Belgium in 1966. The epizootic 
moved to the west and the south of the country and reached 
the Meuse and Sambre valleys which appear to constitute a 
natural barrier to the spread of the disease. The evolution of 
the epizootic has been characterised by a succession of peaks 
B. Brochier, DVM, I. Thomas, DVM, A. lokem, A. Ginter, DVM, 
J. Kalpers, A. Paquot, P. -P. Pastoret, DVM, Department of 
Virology, Faculty of Veterinary Medicine, University of Liège, 
45 Rue des Vétérinaires, B -1070, Brussels, Belgium 
F. Costy, DM, Department of Rabies, Pasteur Institute of Bra- 
bant, 28 Rue du Remorqueur, e -1040, Brussels, Belgium 
which, until 1982, had a mean periodicity of four years. How- 
ever, after the severe outbreak in 1982, the expected lull did 
not occur, and in the last five years although the annual num- 
bers of rabies cases have steadily decreased they have re- 
mained abnormally high. It may therefore be assumed that 
rabies persists enzootically behind the leading edge of the in- 
vasion. 
Since 1967, several methods for reducing the fox population 
have been used unsuccessfully. As in most other European 
countries, these control measures were only temporarily ef- 
fective and did not stop the spread of the disease. Other 
methods such as the oral immunisation of foxes against rabies 
needed to be assessed (Baer 1975). Oral administration by the 
FIG 1: Geographical distribution of rabies in Belgium in 1987. 








HIGHLY SENSITIVE ANTIGEN DETECTION PROCEDURES FOR 
THE DIAGNOSIS OF INFECTIOUS BOVINE RHINOTRACHEITIS: 
AMPLIFIED ELISA AND REVERSE PASSIVE HAEMAGGLUTINATION 
S. EDWARDS and G.C. GITAO* 
Central Veterinary Laboratory, New Haw, Weybridge, Surrey (Gt. Britain) 





An International Journal 
ELSEVIER 
ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM 
veterinary microbiology 
An International Journal 
Editors -in- Chief: 
R.H. Johnson, Department of Tropical Veterinary Science, James Cook University, Townsville, Old., 
Australia. 
A.J. Frost, Department of Veterinary Pathology and Public Health, University of Queensland, Brisbane, 
Old., Australia. 
Aims and scope. 
This journal is concerned with microbiological diseases of all animals that are useful to man. This 
includes animals that supply food or other products to mankind (livestock, poultry, game, fish, 
fur -bearing animals), animals living in captivity (in zoos or safari parks) and wild animals when these 
are of interest in the study of interrelationships of diseases in domesticated and wild animals. All 
organisms studied in this subject field, viz. bacteria, mycoplasmas, rickettsia, fungi and viruses, fall 
within the scope of the journal. Studies of antibiotic resistance are also included. Papers of the 
highest quality giving information on pathogenesis, host responses, immunology, epidemiology, 
disease prevention, treatment, control and comparative studies of diseases affecting man and 
animals, as well as laboratory studies of the causal agents of diseases of animals, are published. 
Drug trial publications are acceptable if they contain scientifically valid data. Papers on the taxonomy 
of the organisms concerned do not fall within the scope of the journal. It is intended to give special 
attention to new aspects of veterinary microbiology, arising from the intensification of industrialized 
production systems. 
Submission of articles. 
Manuscripts should be submitted in triplicate to the Editorial Secretariat, Veterinary Microbiology, 
P.O. Box 330, 1000 AH Amsterdam, The Netherlands. 
VETERINARY MICROBIOLOGY HAS NO PAGE CHARGES 
A DETAILED GUIDE TO AUTHORS AND A FREE SAMPLE COPY OF THE JOURNAL 

















































Veterinary Microbiology, 13 (1987) 135 -141 
Elsevier Science Publishers B.V., Amsterdam - Printed in The Netherlands 135 
HIGHLY SENSITIVE ANTIGEN DETECTION PROCEDURES FOR 
THE DIAGNOSIS OF INFECTIOUS BOVINE RHINOTRACHEITIS: 
AMPLIFIED ELISA AND REVERSE PASSIVE HAEMAGGLUTINATION 
S. EDWARDS and G.C. GITAO* 
Central Veterinary Laboratory, New Haw, Weybridge, Surrey (Gt. Britain) 
(Accepted for publication 27 March 1986) 
ABSTRACT 
Edwards, S. and Gitao, G.C., 1987. Highly sensitive antigen detection procedures for 
the diagnosis of infectious bovine rhinotracheitis: amplified ELISA and reverse pas- 
sive haemagglutination. Vet. Microbiol., 13: 135 -141. 
The sensitivity of an enzyme -linked immunosorbent assay (ELISA) for the detec- 
tion of bovid herpesvirus 1 antigen was increased by up to 50 -fold using the biotin - 
avidin interaction to amplify the reaction, when compared with a simple sandwich 
ELISA. An alternative immunoassay, reverse passive haemagglutination (RPHA), had 
a similar sensitivity to the amplified ELISA, and was technically simpler to perform. 
Both the amplified ELISA and the RPHA could detect viral antigen in the nasal secre- 
tions of calves undergoing experimental primary infection with the virus from Day 3 
to Day 7 after inoculation. Neither assay was as sensitive as virus isolation in cell cul- 
ture and they failed to detect antigen in virus -positive samples from the calves from 
8 days after inoculation, and from vaccinated calves undergoing challenge infection. 
INTRODUCTION 
The specific diagnosis of infectious bovine rhinotracheitis (IBR) has 
traditionally been based on the isolation of the causal virus (bovid herpes - 
virus 1; BHV1) in cell culture, together with the detection of an active 
antibody response in the host animal (Gibbs and Rweyemamu, 1977). 
The detection of viral antigen in clinical samples can be a rapid and eco- 
nomical alternative to cell culture. The most widely applied antigen detec- 
tion technique has been immunofluorescence, either on smears of cells 
from the nasal or ocular epithelium (Terpstra, 1979; Nettleton et al., 1983; 
Silim and Elazhary, 1983) or on cryostat sections of tissues collected at 
post mortem (Terpstra, 1979). Immunoenzymatic techniques have been 
described for the labelling of infected cells (Edwards et al., 1983) and for 
*Present address: University of Nairobi, Department of Veterinary Pathology, Nairobi, 
Kenya. 
136 
the detection of soluble antigen in diluted nasal mucus (Faye et al., 1979; 
Nettleton et al., 1982; Collins et al., 1985). 
Edwards et al. (1983) found that none of these three antigen detection 
methods for BHV1 attained the sensitivity of virus isolation in cell culture. 
Guesdon et al. (1979) developed enzyme immunoassays of high sensitivity 
by exploiting the biotin -avidin interaction; the present study describes 
the application of their techniques in an enzyme -linked immunosorbent 
assay (ELISA) for BHV1 antigen and compares it with an alternative em- 
ploying reverse passive haemagglutination (RPHA). 
MATERIALS AND METHODS 
Samples 
The assays were optimised, and their comparative sensitivities assessed, 
using a simple freeze -thaw harvest of BHV1 grown in MDBK cell cultures, 
and with virus from the same harvest purified on a 20 -50% potassium 
tartrate gradient centrifuged at 80 000 X g for 1 h. 
Twenty four calves were experimentally infected with 10' TCIDso of 
a field strain of BHV1 by intranasal inoculation either as a primary infec- 
tion or following vaccination against the virus (Edwards et al., 1986). Cotton 
wool nasal swabs were taken daily from 2 to 10 days after the inoculation, 
and eluted into 3 ml phosphate buffered saline with 0.5% lactalbumen 
hydrolysate and antibiotics. This constituted a dilution factor of approxi- 
mately 1/20 of the nasal mucus. The samples were stored at 70 °C to 
await testing. After clarification by low speed centrifugation the super- 
natant of this extraction medium was tested by the antigen detection assays 
without further treatment or dilution. 
ELISA 
The viral antigen concentration in the sample extraction medium was 
measured by ELISA following three protocols. The simple sandwich (SS) 
method was performed as described by Edwards et al. (1983) using gnoto- 
biotic calf antibody to the virus conjugated directly with peroxidase as 
the detector system. The avidin- biotin ELISAs were developed from those 
of Guesdon et al. (1979). in the labelled avidin- biotin (LAB) system a two - 
stage detection system was used, namely biotinylated antiviral antiserum 
with a 2 :1 molar ratio of biotin:immunoglobulin, followed after washing 
by an avidin -peroxidase conjugate (Sigma type VI) at a dilution of 1/1000. 
The bridged avidin- biotin (BAB) system employed biotinylated antiviral 
antibody at a 4:1 molar ratio of biotin:immunoglobulin, followed after 
washing by avidin (Sigma) 10 pg ml -1 then, after further washes, biotinylated 
horseradish peroxidase (molar ratio 10:1 biotin:peroxidase). For all three 









































antibody, the addition of test samples containing possible viral antigen, 
and the final colour development using o- phenylene diamine as chromogen, 
were as described previously (Edwards et al., 1983). 
The biotinylation of the proteins for the LAB and BAB assays was carried 
out by adding the appropriate quantities of 0.1 M biotin-N- hydroxysuccin- 
imide dissolved in dimethylformamide to a 10 mg ml -' solution of the 
protein in 0.1 M sodium bicarbonate. After reacting for 1 h at room tem- 
perature, the unbound biotin was removed by dialysis against phosphate 
buffered saline pH 7.2. For the optimisation of the assays the most suitable 
degree of biotinylation of each protein and the most appropriate concen- 
tration of each reagent were determined by a series of two -dimensional 
chequerboard titrations using known positive and negative virus samples. 
Each step of the ELISA procedures was incubated for 1 h at 37°C in a 
moist chamber, apart from the substrate which was incubated for 15 min 
at room temperature. 
Controls for each sample in all the ELISAs consisted of parallel tests 
in wells coated with antibody negative to BHV1. To calculate the final 
test results, the optical density value in the control well for each sample 
was subtracted from the value in the test well, thus compensating for varia- 
tion in the non -specific colour reaction obtained with different samples. 
RPHA 
Sheep red blood cells were washed, then treated with chymotrypsin as 
described by Cranage et al. (1985). Anti -viral specific immunoglobulin 
was prepared from gnotobiotic calf antiserum to BHV1 using the caprylic 
acid method (Steinbuch and Audran, 1969). After dialysis against 0.9% 
sodium chloride the antibody was coupled to the enzyme- treated erythro- 
cytes using chromic chloride (Scott et al., 1981). A 1% suspension of the 
coated cells was stabilised by glutaraldehyde treatment (Cranage et al., 
1983a) and kept at 4 °C. The test was carried out by mixing 30 µl of serial 
doubling dilutions of swab extraction media with equal volumes of 1% 
coated red cell suspension in a 96 -well round -bottomed microtitration 
plate. After 2 h at room temperature the haemagglutination reaction in 
each well was graded visually on a scale from 0 (absent) to 4 (complete 
agglutination). The end point was taken as the highest dilution giving a 
reading of . 2. The controls used for each sample were uncoated sheep ery- 
throcytes, and sheep erythrocytes coated with antibody negative to BHV1. 
RESULTS 
The SS ELISA could detect gradient- purified virus at a concentration 
equivalent to 106.° TCID50 m1 -', whereas the amplified ELISAs could detect 
considerably smaller amounts of the same preparation (104.5 TCID50 m1 -' 
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Fig. 1. Comparative sensitivities of three enzyme -linked immunosorbent assay techniques 
and reverse passive haemagglutination for the detection of bovid herpesvirus 1 in cell 
culture fluids. 
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Fig. 2. Virus infectivity, and antigen detected by amplified enzyme -linked immunosor- 
bent assay and reverse passive haemagglutination, in the nasal secretions of a single 
calf following intranasal inoculation of 10' TCIDso bovid herpesvirus 1. 
was equivalent to a detection rate for BAB of 5 ng viral protein per test 
well (100 ng ml -1). The sensitivity of the assays was somewhat lower for 
the crude cell culture harvest of the virus, although the enhanced sensi- 
tivity of the amplified systems was still apparent. The sensitivities of the 
four antigen detection systems are compared in Fig. 1, using the unpurified 
virus preparation. RPHA had a detection limit similar to those of the am- 
plified ELISAs. 



















for the detection of BHV1 antigen in the experimental calf samples. A 
positive result was achieved with only one sample from the vaccinated 
calves undergoing challenge infection. This sample (taken on Day 4 after 
challenge) had an infectivity titre of 106.0 TCID50 ml '. Of the other 79 
vaccinated calf samples, 40 contained infectious virus detectable in cell 
culture and all had titres of X105.5 TCID50 ml-'. 
In the unvaccinated calves undergoing primary challenge with BHV1, 
both antigen detection tests gave positive results for samples with a wide 
range of infectivity titres (103.5- 106'75 TCID50 ml '). The two antigen de- 
tection tests showed a high degree of agreement (r = 0.84) but the corre- 
lation between antigen level and infectivity titre was much lower. Figures 
2 and 3 illustrate the pattern of virus and antigen shedding in the nasal 
secretions of a representative single calf (Fig. 2) and the mean values for 
the group (Fig. 3). The infectivity titre of virus appeared to rise faster 
than the detectable antigen level in the first 3 days after inoculation. There- 
after the curves for the antigen detection tests follow that for the infectivity 
titre except that infectious virus remained detectable at a moderate to 
low level (5105.25 TCID50 ml-') for several days when the antigen detection 
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Fig. 3. Group mean infectivity titres, and antigen level detected by enzyme -linked immu- 
nosorbent assay and reverse passive haemagglutination, in the nasal secretion of 13 
calves following intranasal inoculation of 10' TCIDSO bovid herpesvirus 1. 
DISCUSSION 
BHV1 survives well in clinical samples, and is readily isolated in cell 
culture. No antigen detection technique has yet been described which 
can rival the sensitivity of isolation in cell culture as a method for iden- 
tifying this virus in a sample. Collins et al. (1985), using a carefully opti- 
mised SS ELISA utilising monoclonal antibodies, could detect 105.5 TCID50 
ml -' of BHV1 in nasal swab samples prepared as in the present study. This 
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is similar to the sensitivity of the amplified ELISA and the RPHA presen- 
ted here. Some caution should be exercised in assessing the sensitivity of 
antigen detection techniques in terms of the infectivity titres of virus. 
The results suggest that the amount of detectable antigen is not directly 
related to infectivity, and that in the early days after infection the calves' 
nasal secretions contain a higher proportion of infectious virus to total 
antigen than from Day 4 onwards. A similar trend may be observed in 
the results presented by Collins et al. (1985). Antigen detection methods 
ceased to be useful diagnostic tools from 8 days after the initial infection. 
This has also been reported by other authors using a variety of techniques 
(Terpstra, 1979; Edwards et al., 1983; Collins et al., 1985) although the 
height and duration of positive reactions in antigen detection tests varies 
with the breed and age of calf and the dose and route of virus inoculum 
(Edwards, unpublished observations). 
The infectivity curves of nasal secretions from individual calves (Fig. 2) 
showed a dramatic drop of 100- to 1000 -fold in virus titre over a 2 -day 
period from Day 7 to Day 9 after inoculation. This presumably coincides 
with the onset of the immune response. For antigen detection systems 
to be effective beyond this period, or at any stage in immune animals ex- 
periencing reinfection (e.g. following vaccination), a major increase in assay 
sensitivity will be required. 
All of the available systems are effective during the period of peak virus 
shedding, and success in diagnosis will depend on the selection of animals 
for sampling to coincide with this period. Choice of technique for antigen 
detection will then depend largely on its ease of use in the routine diag- 
nostic laboratory. Although the biotin -avidin reaction was successfully 
used here to increase the sensitivity of ELISA by >20-fold, it was only 
at the expense of technical complexity, with multiple incubations and 
washes, and many opportunities for inadvertent technical error. The RPHA 
was equivalent in sensitivity to the amplified ELISA but much simpler 
to conduct, involving only the addition of coated erythrocytes to the test 
solution, and reading it visually after 1 -2 h. RPHA has been used with 
monoclonal antibodies for herpesvirus antigen detection at a very high 
level of sensitivity (Cranage et al., 1983a,ó). Although problems have been 
reported with RPHA on samples of nasal secretion, due to non -specific 
haemagglutination ( Cranage et al., 1981), this did not arise in the present 
study. This will require further study on samples from cattle with naturally 
occurring respiratory disease to assess its likely importance. 
Despite the limitations of sensitivity, antigen detection techniques are 
being increasingly used in the diagnosis of IBR, with justification on the 
dual grounds of speed and economy. Two techniques described here (am- 
plified BAB ELISA and RPHA) have a sensitivity which is possibly as high 
as can be achieved with this type of technology, can be performed, if nec- 
essary, with simple inexpensive laboratory equipment, and are more ob- 
jective in test evaluation than, for example, immunofluorescence. 
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Experimental infectious bovine rhinotracheitis: comparison of four 
antigen detection methods 
S. EDWARDS, D. CHASEY, H. WHITE 
Central Veterinary Laboratory, New Haw, Weybridge, Surrey 
The duration of detectable viral antigen in nasal 
secretions was studied by four methods in calves 
experimentally infected with infectious bovine rhino - 
tracheitis. Virus isolation in cell culture was the most 
sensitive and was successful for up to 11 days after 
inoculation. Three direct rapid antigen detection 
systems (immunofluorescence, immunoperoxidase 
and enzyme -linked immunosorbent assay [ELISAI) 
were all successful during the pyrexic phase, but less 
useful in the later stages of the disease. Virus isola- 
tion and ELISA remained positive in strongly 
positive samples stored for a week at room tem- 
perature. 
ALTHOUGH bovid herpesvirus 1 (BHV 1) is readily 
isolated in cell culture from most cases of infectious 
bovine rhinotracheitis (IBR) many laboratories lack 
culture facilities and there is a need for alternative 
and more rapid diagnostic methods. This paper 
presents the results of a comparison between three 
rapid antigen detection techniques and virus isolation 
in cell culture, in nasal swab samples from experi- 
mentally infected calves. 
Materials and methods 
A recent (1980) field isolate of BHV 1 was grown 
in primary calf kidney cell culture, harvested by one 
freeze -thaw cycle and stored at -70 °C. Three six- to 
seven -month -old Friesian calves were inoculated 
intranasally with 4 x 108 TCID50 of the virus at the 
fourth cell passage. Three control calves in an 
adjacent but separate pen were inoculated with 
uninfected cell culture harvest. All animals were 
examined daily including rectal temperature 
measurement for seven days before and 14 days after 
inoculation. 
Cotton wool nasal swab samples were taken daily 
and immediately broken off into 3 ml sterile 
phosphate buffered saline (PBS) pH 7.2 in small 
screw capped bottles. These samples were agitated on 
a vortex mixer and the swab removed. The nasal 
n 
secretion suspension was then centrifuged at 500 g 
for five minutes. The supernatant was reserved for 
virus isolation and enzyme -linked immunosorbent 
assay (ELISA). The preparation of cell smears was 
based on the methods of Minnich and Ray (1980) and 
Thomas and Stott (1981). The cell deposit was mixed 
with 1 ml PBS and single drops were spotted onto 
PTFE coated multispot glass slides (C. A. Hendley) 
and evaporated to dryness either rapidly (45 minutes) 
at 37 °C or overnight at 4 °C. The slides were fixed in 
acetone for 10 minutes and rinsed in distilled water 
before labelling by direct immunofluorescence or 
immunoperoxidase techniques. 
The IgG fraction of a gnotobiotic bovine anti- 
serum to BHV 1 was prepared by the method of Reif 
(1969). Immunoglobulin was conjugated with 
fluorescein isothiocyanate by a method based on that 
of Nairn (1976). Horseradish peroxidase (Sigma type 
VI) conjugate was prepared by the sodium periodate 
method of Wilson and Nakane (1978) but was used 
without Sephacryl purification as this had been 
found unnecessary (Chasey 1980). Both conjugates 
were stored as stock preparations at -20 °C after 
dilution with an equal volume of glycerol. 
Smears for immunofluorescence were incubated 
with a one in four dilution of stock conjugate in PBS 
for 30 minutes at 37 °C, washed for 10 minutes in 
each of three changes of PBS and counterstained 
with Evans blue diluted 1 in 100,000 for one minute. 
They were mounted in 50 per cent buffered glycerol 
for microscopic examination under incident ultra- 
violet light. 
Smears for immunoperoxidase labelling were 
reacted with stock conjugate, diluted one in five, for 
30 minutes at room temperature. After rinsing in 
0 1 M phosphate buffer, pH 7.2, they were covered 
with a solution of 3 3' diaminobenzidine (DAB) for 
10 minutes (Chasey 1980), and washed in tap water 
before being lightly counterstained with toluidine 
blue. The smears after rinsing and drying were 
mounted in DPX mountant and examined in bright 
field. Duplicate smears were processed similarly but 
incubated with `inappropriate' conjugates specific 
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for heterologous virus (bovine virus, diarrhoea virus 
or respiratory syncytial virus), and assessment of 
specific IBR labelling was made by comparison. 
The ELISA was performed in microtitre plates 
(M129A; Dynatech) which were coated overnight at 
4 °C with 100 Ml per well of anti -BHV 1 IgG prepara- 
tion, 4 Mg /ml in 50 mM carbonate buffer pH 9.6. 
The plates were washed three times in 0-05 per cent 
Tween 20; 100 Ml aliquots of test sample supernatants 
were added in duplicate to the wells and incubated 
for two hours at 37 °C. After three more washes, 
100 Ml of anti -BHV 1 peroxidase conjugate was added 
at a dilution from stock of 1 in 1000. The conjugate 
diluent was 0.5 M sodium chloride buffered to pH 
7.2 with phosphate, containing 0.05 per cent Tween, 
I mM EDTA, 4 per cent polyethylene glycol 6000 and 
I per cent bovine albumen. The plates were incu- 
bated for one hour at room temperature, washed 
three more times in 0.05 per cent Tween and to each 
well was added 200 1.41 ortho phenylene diamine 
0.4 mg /ml in 0.075 M phosphate citrate buffer pH 
5.0 with 0.01 per cent hydrogen peroxide. The 
colour reaction was stopped after 20 minutes at room 
temperature by the addition of 50 Ml per well 2.5 M 
sulphuric acid. Optical density (OD) was measured at 
492 nm on a Titertek Multiskan photometer. 
For virus isolation, calf kidney secondary cell 
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FIG 1: Duration of BI-IV I detectability for infected animals A, B 
and C, by four techniques; direct immunofluorescence of nasal 
secretion cells (FA), direct immunoperoxidase on nasal secretion 
cells (IPX), enzyme linked immunoassay for soluble antigen in nasal 
secretion (ELISA) and virus isolation with confirmation by immuno- 
peroxidase (VI). Solid bars represent positive results, broken bars 
weak positive 
Eagle's minimum essential medium plus 10 per cent 
fetal calf serum and incubated at 37 °C in 5 per cent 
carbon dioxide atmosphere until confluent mono - 
layers formed. Ten Ml of sample supernatants were 
added in duplicate to wells containing 70 MI of 
medium. The cells were examined daily for four days 
for signs of cytopathic effect. The final identification 
of virus growth was by immunoperoxidase labelling 
of the cells in the microplates. The medium was care- 
fully decanted and the cells fixed with 2 per cent 
formaldehyde in PBS for 15 minutes at 4 °C. The 
plates were rinsed in PBS for five minutes, then 15 
minutes. Twenty -five Ml per well of anti -BHV 1 
peroxidase conjugate was added, diluted 1 in 50 in 
0.5 M sodium chloride plus 1 per cent Tween 80, 
buffered with phosphate to pH 7.6. Plates were 
incubated for 15 minutes at 37 °C then rinsed with 
PBS containing 1 per cent Tween 80 for five minutes, 
then 15 minutes; 25 Ml per well of DAB substrate was 
added for 20 minutes at room temperature, after 
which the wells were emptied and 100 M1 PBS added 
for reading under an inverted microscope. 
Preliminary trials had established the optimal 
concentrations of reagents used in all the immuno- 
assays, and checked the specificity of the reactions. 
Results 
Clinical response 
The three infected animals showed a significant 
rise in rectal temperature above pre -inoculation 
values from the second to sixth (animal A) or seventh 
days (animals B and C). Clinical signs of IBR (nasal 
and ocular discharges and conjunctivitis) appeared 
on the second (animal C) or fourth day (animals A 
and B) and persisted in all animals until the 11th day 
with a slight nasal discharge still present in animal B 
and a mild ocular discharge in animal C up to the 
14th day. Control animals had a normal rectal 
temperature and showed no clinical signs throughout 
the test period. 
Virus detection 
The control animals remained negative to all tests 
throughout the experiment, with the exception of 
four inconclusive results to ELISA (see below). The 
results of the four test systems on nasal swabs from 
infected animals are shown in Fig 1. Readings classed 
as weak positive indicate a result which, taken alone, 
could not be used to establish a definite diagnosis. 
Immunolabelled smears, for example, taken during 
the later stages of infection often contained only one 
or two positive cells. 
The proportion of positive cells in the smears was 
greatest from the second to the sixth days after 
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inoculation (all over 10 per cent, reaching a peak of 
over 50 per cent on the third day). From the seventh 
day this proportion was markedly reduced (1 to 4 per 
cent positive cells) and fell to below 1 per cent in most 
samples thereafter, but even a level of 1 per cent 
positive cells was easily detected especially in fluo- 
rescent labelled smears when non -specific back- 
ground fluorescence was so low as to give a strong 
contrast with specifically labelled cells. 
With immunoperoxidase the interpretation was 
greatly aided by a comparison of the specifically 
labelled and control smears (Fig 2). Endogenous 
peroxi.dase activity was insignificant. 
For the ELISA test the negative baseline level was 
determined from the readings of the control animal 
samples. The mean 013492 for these was 0.13 and the 
95 per cent and 99.9 per cent upper tolerance limits 
using a one tailed t test were 0.21 and 0.28 respec- 
tively. Positive results in Fig 1 are OD readings of at 
least 0.29, and ± values are 0.21 to 0.28. Four of 36 
samples from the control animals fell into this 
inconclusive category. The highest positive values 
were recorded between the second and seventh days 
with an OD range of 0.5 to 1.8. 
(a) 
(b) 
FIG 2: Duplicate nasal smears, lightly counterstained, from an 
infected animal three days after infection, labelled directly with 
immunoperoxidase conjugates specific for BHV 1 (a) and a hetero- 
logous virus (b). x 200 
Chasey, H. White 
The ELISA colour reactions could also be read by 
eye and there was no discrepancy between visual and 
photometer results for positive or negative samples. 
Most of the inconclusive OD values were interpreted 
visually as negative. 
Effects of room temperature storage 
The samples were stored for up to seven days at 
room temperature as either washed cell suspensions 
or as sample supernatants. The effect on cells was 
very variable and, although some samples could still 
be read with confidence by immunofluorescence or 
immunoperoxidase methods after seven days storage, 
the majority were only satisfactory up to three days. 
After this there was a progressive disruption of cell 
architecture and a marked reduction in the number 
of intact cells in the smears. The actual labelling, 
particularly with fluorescent antibody, remained 
strong indicating persistence of the viral antigen, but 
its interpretation became difficult when it could not 
be related to intact cells. 
The effect of seven day storage on ELISA and 
virus isolation results is shown diagrammatically in 
Fig 3. The strong positives remained positive but 
there was a reduction in positive results for both tests 
from the eighth day after inoculation. Gross bacterial 
or fungal contamination of some samples was 
evident after the week at room temperature, but this 
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FIG 3: Effect of room temperature storage on ELISA and virus 
isolation (VI) results for infected animals A, B and C. Continuous 
bars represent positive results and broken bars weak positive. 









































































Antigen detection in experimental IBR 45 
prolonged room. temperature storage in aqueous 
suspension, and if the fluorescent antibody or 
immunoperoxidase techniques are to be used it is 
better to prepare and fix the smears as close to the 
point of origin as possible. Fixed smears can be sent 
without problem through normal mail services. 
The decision as to which test to use. for IBR 
diagnosis will depend on facilities available. Virus 
isolation is to be preferred if possible, although one 
of the rapid antigen detection systems used in parallel 
may enable earlier results to be produced. Provided 
the appropriate antiserum and reagents are available, 
the ELISA requires the least specialised equipment if 
read by eye. Immunofluorescent labelling needs an 
ultraviolet microscope, while immunoperoxidase 
techniques require only simple bright field optics 
and, in addition, produce permanent preparations. 
Slides prepared by either method are easily inter- 
preted by an experienced worker. 
The immunoperoxidase and ELISA results were 
very encouraging although both techniques need to 
be fully proven on clinical samples from field cases of 
IBR. 
Discussion 
All four tests for virus or viral antigen were 
positive from the second to sixth or seventh days 
after inoculation. This coincided with the duration of 
pyrexia in the individual animals. On the first day 
and after the seventh day the most sensitive assay was 
virus isolation, despite the fact that the technique 
employed was designed for ease of application rather 
than maximum sensitivity. Conventional tube 
cultures with repeated passages may well have 
detected virus in the nasal secretions for longer 
periods. The results for immunofluorescence and 
virus isolation are in agreement with those of 
Terpstra (1979). 
None of the three antigen detection systems stood 
out as markedly better than the other two, and any or 
all of them could be developed as diagnostic tests by 
laboratories lacking cell culture facilities. Provided a 
number of animals were sampled in the febrile phase 
of disease, a diagnosis of an outbreak should be 
possible by these means. All the tests can be 
completed within a day of receiving a sample. The 
success of these immunoassays was considered to be 
dependent on the quality of the detector antiserum, 
and previous attempts with non -gnotobiotic sera had 
been less encouraging. The preparation method for 
cell smears was also important in order to obtain 
sufficient cells for labelling. Simple nasal mucus 
smears prepared by wiping the swab tip on a slide 
produced `dirty' preparations with high background 
staining and very few cells for examination. 
The use of polyethylene glycol in the ELISA 
conjugate diluent (Salonen and Vaheri 1981) 
increased the ratio of positive to negative OD by 
increasing the positive readings, and bovine albumen 
further improved the ratio by reducing the negative 
values. 
Delays in transit of samples to the laboratory are a 
common problem and even after one week at room 
temperature virus isolation remained the most 
sensitive test, although its advantage over the ELISA 
was less pronounced. Again acutely infected febrile 
animals were the best source of positive material. The 
relative stability of BHV 1 (Gibbs and Rweyemamu 
1977) is advantageous in overcoming this problem. 
Nasal secretion cells were poorly preserved with 
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A Veterinary Service Scheme for the Rapid 
Diagnosis of Viral Infections in Ruminants, 
using Immunofluorescence 
¡Edwards, MA, VetMB, MSc, MRCVS; H. White, MSc, MIBiol; R.H. Newman and P. Nixon. 
Central Veterinary Laboratory, New Haw, Weybridge, Surrey KT15 3NB 
Summary 
The immunofluorescence technique was developed at the Central Veterinary Labora- 
mry for use as a rapid test for viruses in tissue sections and smears from cases of 
respiratory disease. mucosal disease and abortion in cattle, and border disease in sheep. 
Once reliably established the technique was transferred to Veterinary Investigation 
Centres by means of a training programme and the supply of equipment, conjugates and 
quality control materials. Results obtained in the scheme have demonstrated the 
importance of respiratory syncytial virus and infectious bovine rhinotracheitis virus in 
bovine respiratory disease. Marked seasonal trends for these two infections have also 
been revealed. 
Introduction 
Although applications of immunotluorescence (IF) for the diagnosis of viral infections 
were being reported 30 years ago. Emmons and Riggs commented in 1977 that routine 
use of IF was still surprisingly rare. Among the reasons they suggested were 
non -availability of reliable reagents, inadequate quality control, lack of experienced 
laboratory personnel and lack of confidence in the technique among clinicians. This 
article describes attempts by the Ministry of Agriculture, Fisheries and Food (MAFF) 
veterinary service to address the first three problems in the hope of thereby solving the 
fourth. Particular emphasis was given to the application of the IF technique for 
diagnosis of bovine respiratory diseases. 
At the Central Veterinary Laboratory (CVL) IF has been used for many years in the 
diagnosis of viral infections such as rabies and swine fever. The emergence of infectious 
bovine rhinotracheitis (IBR) as a major disease problem in the late 1970s (Wiseman and 
others, 1978) led to a demand for more specific diagnostic methods, much of which has 
been met by the IF technique (Nettleton and others, 1983). 
A valuable feature of the IF technique is its applicability to agents, such as bovine 
respiratory syncytial virus (RSV) (Thomas and Stott, 1981), which are difficult to 
diagnose by conventional cell culture techniques. A further advantage of IF is its 
rapidity, with test reports being possible within hours of receipt of samples at the 
laboratory. To achieve this, however, it was considered that local testing at Veterinary 
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Investigation Centres (VICs) would be the ideal so as to avoid the inevitable delays in 
shipment to, and reporting from, the specialist central laboratory. 
Year 
Materials and methods 
For the scheme the direct IF method was used for viral antigen detection. Specific 
antisera were prepared by immunising colostrum- deprived calves with live virus by the 
intranasal route, with one or more intranasal booster inoculations being given at four to 
six week intervals, and a final intravenous boost seven days before slaughter and 
bleeding out. Batches of serum were conjugated to fluorescein isothiocyanate (FITC) 9g2 
following the method of Nairn (1976); the conjugates were then lyophilised in 2ml 
aliquots and stored at 4 °C in the dark. Frozen sections of tissue (511m), impression 
smears of lung, and dried smears of washed nasal epithelial cells were fixed in acetone, 
stained with conjugate at a predetermined dilution in phosphate buffered saline pH 7.6 963 
(PBS) for 30 minutes at 37 °C, washed in PBS for 30 minutes, and counterstained with 
Evans' blue. They were then examined by epifluorescent microscopy using a x40 
objective lens. Samples of positive (and negative) control material, prepared from cell 
cultures which had been infected with the respective viruses, were used for comparison, 9g4 
In order to evaluate the method and the reagents, commencing in 1982 all bovine lung 
tissue submitted from VICs to the CVL for virological examination was tested by IF for 
the presence of IBR, RSV. parainfluenza 3 (PI3) and bovine virus diarrhoea (BVD) 
viral antigens. Subsequently the range was extended to include bovine adenovirus 
(subgroup A). In addition, tissues from cases of suspected BVD -mucosal disease and 
ovine border disease were tested for BVD antigen. From bovine abortions, fetal tissues 
were tested for BVD and IBR antigens, and fetal fluids by indirect IF for BVD and IBR 
antibodies. 
The subsequent programme included four main components: (a) training courses held 
at the CVL at which selected staff from all MAFF VICs were given instruction in the 
procedures for IF diagnosis and in the recognition of specific fluorescence patterns 
exhibited by the different viruses; (b) allocation of the necessary resources to VICs to 
up -date their equipment; (c) the preparation at CVL and supply to VICs of the specific 
fluorescent conjugates, and also the positive and negative materials for quality control 
purposes; (d) incorporation of virological IF into the MAFF quality assessment scheme 
in which identical samples are sent to all participating laboratories to test and report 
(Johnson, 1988 *). A summary of tests carried out. and positive diagnoses, was sent 
monthly by VICs to the CVL. where the data were stored and analysed on computer. 
Some results from use of IF diagnosis at VICs were available in 1984 but the scheme was 














Results of IF tests done at the CVL are summarised in Table 1. A comparison of this avest 
antigen detection method with virus isolation in cell culture for lung samples during the ositi 
first two years has been reported previously (Edwards and others, 1984). The success of Augu 
the IF method, particularly for the diagnosis of RSV, led to the decision to decentralise lanua 
viral diagnosis wherever possible and this transfer of work from CVL to VICs accounts nark( 
for the fall in number of tests done at CVL in 1986. liscer 
`r.3(, 
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ble 1. Results of immunofluorescent tests for viral diagnosis on ruminant 
samples at the CVL, 1982 -1986 
in 
;Dr Bovine Respiratory 
Disease 
Nasal 





ic Lungs smears Tissues Fluids 
ie a b a b a b a c a b a b 
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2) I82 293 11(R) 151 18(I) 90 1(B) 46 1(B) 240 12(B) 46 4(B) 
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e, 1(I) 6(I) 
.6 l83 393 8(P) 164 1(R) 226 1(I) 206 6(B) 246 16(B) 70 5(B) 
th 33(R) 1(B) 1(B) 
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:II 2(I) 












- - 285 15(B) 209 20(B) 3 - 
R 
22(1) 
!186 143 4(R) 33 - - - 261 17(B) 46 5(B) 49 6(B) 
Id 1(B) 
ie 
ns .= No. cases (animals) tested: b = no. positive for antigen: c = no. positive for antibody 
to .IBR: P = P13; R = RSV: B = BVD-BD 
offable 2 gives a summary of VIC returns for the two year period 1985 -1986. The first two 
alumns indicate the diagnostic rate on an outbreak basis. The remaining columns 
ie adicate the success rate for individual live animals (e.g. nasal mucus smears) and for 
nadividual animals at post -mortem (smears and frozen sections of tissues). Undue 
sphasis should not be given to the percentage diagnosis rates for categories where the 
as 
atal number of investigations was low. 
is shown in Fig. 1, there was a marked seasonality for IBR and RSV diagnoses with the 
ighest occurrence of both diseases from November to February. Many fewer 
avestigations for respiratory disease were done in the summer but, even so, the 
proportion positive for IBR and RSV was lower. For example, of the 1 409 IBR 
its avestigations in the January to March periods, 237 (17 per cent) were diagnosed as 
re positive compared with only 38 (7 per cent) of the 539 investigations from June to 
of :august. Comparative figures for RSV were 187/1417 (13 per cent) from November to 
se lanuary and 9/373 (2 per cent) from June to August. The seasonal pattern was less 
is narked for PI3 and absent for BVD. No significant geographical differences could be 
Discerned when the data were analysed by VIC of origin. 
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Table 2. Virus diagnosis by immuofluorescence reported by Veterinary 
Investigation Centres in England and Wales, 1985 -86 
100 
80 
Disease outbreaks Live animals PM cases 60 
No. No. No. 
investi- % pos. 
gated 




IBR 4 347 11.8 % 6 721 8.6 % 1 935 5.4 % 
RSV 3 345 9.9 % 4 670 2.1 % 2 035 14.2 % 80 
PI3 3 278 7.1 % 4 668 3.7 % 1 899 6.3 % 
BVD 
Adenovirus 
1 577 6.2 % 
79 10.1 % 
1 656 4.6 % 
467 8.6 % 
830 7.7 %r 
59 13.6 % 
60 
Mucosal disease: BVD 566 28.1 % 360 22.5 % 434 23.3 % 
40 
Abortion 
IBR 186 3.2 % 10 0 183 3.8 %r 20 
BVD 342 5.0 % 44 9.1 % 307 4.9 % 
OVINE 
Respiratory disease 40 
RSV 49 4.1 % 22 4.5 % 26 3.8 %r 
PI3 159 11.9 % 63 6.3 % 121 12.4 % 




This study has shown that a number of important viral infections of ruminants can be 
rapidly identified by direct IF methods for viral antigens. We have shown that the tests 
can be done at VICs without the need for full scale and expensive virus culture facilities. 
An essential component of the scheme, in the absence of commercially available 
reagents, is the central laboratory for the preparation of conjugates and quality control 
materials. Following the decentralisation of the routine testing it is also important to 
ensure that a proportion of samples continue to be referred to the central laboratory in 
order to maintain the expertise and interest of the staff there. 
A particularly noteworthy feature of the work has been the low diagnosis rate for RSV 20 
in live animals, compared with a high rate at post -mortem. RSV is highly pneumotropic 
and the results suggest a need for wider application of lung lavage techniques for ()- 
diagnosis in the live animal (Kimman and others, 1986). Adenovirus conjugates only 
became available latterly and the significance of the virus, and the applicability of IF to 
its detection, remain to be evaluated. Abortion investigations were generally unre- 
warding. 
Preliminary studies were carried out at CVL before the main work began using indirect 
fluorescent labelling for viral antigen detection in bovine respiratory tissue. These gave 




























BVD /Respiratory disease 
BVD /Mucosal disease 
Jan Feb ' Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Month 
figure 1. Seasonal trends in viral infections diagnosed by direct immunofluorescence at 
Veterinary Investigation Centres in England and Wales 1985 -86. 
45 
tNWr 
tal di r+.oblems have been reported by McNulty and Allan (1984) who thought them to be lcFer 
partly due to the quality of anti -species conjugates available commercially. There were 
41,.t) difficulties in using an anti -bovine conjugate on bovine tissues because most of the °it'll, 
hvperimmune anti -viral sera available were prepared in calves. Indirect IF has been 
%uccessfully used in medical virology (Gardner and McQuillin, 1980) and in veterinary 
diets 
diagnosis of IBR using rabbit sera (Nettleton and others, 1983). Because it is pmpt 
economical of viral specific antisera, indirect IF limits the requirement for a range of dectie 
conjugates, but it does require a high degree of quality control checking. 
pm' 
,C. Alternative techniques for antigen detection are available, notably enzyme immuno- 
assays (Nettleton and others, 1982; Edwards and others, 1983; Harmon and others, 
1979; Chao and others, 1979) which have proved especially useful in enteric virus 
diagnosis (Reynolds and others, 1984). Where cellular material is available, however, as 
in respiratory tract samples, immunofluorescence offers the particular advantage of 
enabling microscopical interpretation of the nature and distribution of the fluorescence 
and thus it enhances confidence in the results. The World Health Organization (1981) 
recommended that, whilst enzyme immunoassays should be evaluated further, 
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Establishment of a statistical base for 
use of ELISA in diagnostic serology for 
infectious bovine rhinotracheitis* 
C. Nancy Hebert, t S. Edwards, t Susan Bushnell, t 
P. C. Jonest and C. T. Perryt 
The critical statistical parameters of an enzyme -linked immunosorbent assay were determined 
to enable quantitation of antibody responses in cattle affected with infectious bovine rhino - 
tracheitis. A system of controlling well -to -well variations in optical density reading across a 
microtitre plate was evolved and dose -response assays were carried out to determine the dilution 
of serum which gave the greatest discrimination between acute and convalescent sera from an 
infected animal. Use of a standard serum was studied in further assays. An increase in optical 
density value of 0.15 was set as a diagnostic criterion for a significantly rising antibody response. 
This compared well with the conventional criterion of a fourfold rise in virus neutralizing 
antibody titre. 
INTRODUCTION 
The enzyme -linked immunosorbent assay (ELISA) for the detection of IgG antibodies 
against bovid herpesvirus I (BHV I) in cattle has been shown to correlate with the virus 
neutralization (VN) test, although it can be more sensitive. 1.2,3 The present paper 
describes investigations into some of the variables which affect the ELISA. Differences 
in optical density reading (OD) of wells in various positions on a micro -titre plate were 
first examined. This was followed by a series of experiments designed to study the log 
dose -response curves of standard sera known to have positive antibody titres, and to 
define a statistically significant rise in titre from the acute to the convalescent stage of 
* Received for publication 11 November 1984. 
t Ministry of Agriculture, Fisheries and Food, Central Veterinary Laboratory, New Haw, Weybridge, 
Surrey KT15 3NB, U.K. 
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disease in an individual animal. This rise in OD response could then be compared with 
the rise in titre found in the serum VN test. Finally, results on a large number of low 
antibody titre sera were examined in an attempt to determine a satisfactory positive/ 
negative cut -off point in OD reading. 
MATERIALS AND METHODS 
Virus strain 
Bovid herpesvirus I (Oxford strain) was cultured in either primary calf -kidney or 
MDBK cell monolayers (shown by immunofluorescence to be free of bovine virus 
diarrhoea virus). When the viral cytopathic effect was advanced to the point of 
complete cell detachment the cells were pelleted at 1000 g and washed with phosphate 
buffered saline (PBS). The cell pellet was then suspended in a minimal volume of 0.5% 
Nonidet P40 (BDH) for one hour at 4 °C. The cell debris was removed by centrifugation 
and the supernatant stored in small aliquots at -70 °C as the BHV I antigen. Control 
antigen was prepared by scraping non -infected cells from the culture vessel and 
processing them in parallel with the viral antigen. 
ELISA 
Flexible immunoassay microtitre plates (Falcon 3912, Becton Dickinson) were coated 
in alternate rows with virus and control antigens, 100 p.1 per well, at an appropriate 
dilution (predetermined by chequerboard titration) in 50 mm carbonate /bicarbonate 
buffer, pH 9.6 , overnight at 4 °C. The antigens were removed from the wells by 
decanting or aspiration, and, after washing in PBS or PBS with 0.05% Tween 20 
(PBST), were dried at 37 °C and stored in sealed plastic bags at -20 °C. 
In the assay, sera and conjugate were diluted in 0.5 M sodium chloride buffered to 
pH 7.2 with 0.01 M phosphate, 0.05% Tween 20, 1 mm EDTA and 0.5% ovalbumen. 
This buffer was derived from that of Houwers et al.4 and has been found to be a more 
satisfactory diluent than conventional 0.15 M NaC1 with 0.01 M phosphate and 0.05% 
Tween 20. 
Serum dilutions were incubated in the plates (50 µl /well) for two hours at room 
temperature in a humid chamber. The plates were then washed five times with PBST. 
The conjugate was anti -bovine IgG prepared in rabbits and conjugated to horse- 
radish peroxidase by the periodate method.' This was used at a predetermined dilution 
of 1 /1000 (50 µl per well) and was incubated for one hour at room temperature in the 
humid chamber. After five washes in PBST, orthophenylene diamine (Sigma)6 was 
added, 100 µl per well. The reaction was stopped after 15 min incubation at room 
temperature in the dark by the addition of 25 Al per well of 2.5 M sulphuric acid. The 
OD was read at 492 nm wavelength in a multichannel recorder (Titertek Multiskan, 
Flow Laboratories). 
Virus neutralizing antibody was measured as described by Frerichs et al.' The paired 
sera used for these experiments were from natural outbreaks of bovine respiratory 
disease and had been sent to the laboratory for diagnostic testing. `Standard' sera were 
collected from calves immunized at the laboratory. 
Experiment design and statistical analysis 
Experiment 1. Two replicate plates coated with virus antigen in all wells were filled 
with the same dilution of positive serum (1/100) in all wells in order to study the effect 
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of position on the plate on OD readings. Two -way analyses of variance were carried out 
and results were expressed as standardized differences for rows and columns, that is, 
(Row mean - overall mean) /standard error for row mean, and (Column mean - overall 
mean) /standard error for column mean . 
Experiment 2. Six pairs of acute and convalescent sera were each tested over a range 
of twofold dilutions from 1/50 to 1/6400. In this and all subsequent experiments each 
serum dilution was tested in a block pattern thus: 
T1, T2 
Cl, C2 
where T1 and T2 represent duplicates of the virus positive antigen and Cl and C2 the 
control antigen. Two within -block corrected OD measurements (T1-C1) and (T2 -C2) 
were used as the responses. In this experiment the 12 sera were tested, three on a plate, 
allocated to columns 1-4, 5 -8 and 9 -12, thus filling the 24 'blocks' on the 96 -well 
plate. The log dose -response lines were fitted over the linear portion of the curve for 
each serum and estimates of the response at a dilution of 1/100 were calculated in order 
that convalescent (B) sera could be compared with acute (A) sera. 
Experiment 3. The same sera which were used in Experiment 2, that is, six pairs of 
acute and convalescent sera were tested, but only at a single dilution level, 1/100. Four 
replicate blocks of each serum, six on a plate, were tested, the blocks being randomly 
allocated to the 24 positions. Duplicate plates of each set were prepared. 
Analysis of variance techniques were used to evaluate the results, and to compare 
between -block variability with that found between duplicate responses within blocks. 
The minimum difference in response necessary to demonstrate a significant rise in titre 
from the acute to the convalescent stage of the disease was estimated. 
Experiment 4. Reproducibility was studied further by testing three sera, one known 
to have a moderately strong positive, one a weak positive and the third a negative 
antibody titre. Twenty -four separate dilutions of each serum were tested, each serum 
occupying a plate, again using the block system. Two plates were used on each of four 
days for each serum, making a total of 24 plates in all. 
Experiment 5. The results of tests on 105 pairs of acute and convalescent sera were 
studied using a 1 /100 dilution. The rise in OD response found in Experiment 4 to be 
statistically significant was taken as an indication of a positive increase in titre and 
this was compared with the change in titre in the VN test carried out on the same 
sera. 
Experiment 6. Sera submitted for screening purposes (I. e. determination if negative 
or positive) were examined. Of these, 652 were from cattle herds known to have been 
free of infectious bovine rhinotracheitis (IBR) for many years and therefore true 
negatives, 88 were VN positives,a nd 181 were selected as 'weak positives' having given 
low titre reactions in the VN test. The first groups were tested at 1 /100 and the weak 
positives at 1/100 and 1/50. Of the latter group 119 were retested on a later occasion. 
Throughout these trials occasional aberrant readings occurred. Where these occurred 
in a 'block' of four wells, an estimate of the correct OD value (T -C) was made, 
corresponding to the within -block duplicate. 
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RESULTS 
Experiment 1 
Table 1 shows the standardized differences for rows and columns for the two plates 
tested. Values between -2 and +2 could be due to random variation, but more 
extreme values are likely to reflect genuine differences. These tended to occur in the two 
pairs of end columns of a plate, indicating an 'edge effect', but this was less marked in 
the top and bottom rows. Low and high values tended to occur in adjacent rows and 
columns, giving a clustering effect. Differences between columns are more highly 
significant than those between rows. 
TABLE 1. Identical dilutions in 96 wells on an 8 X 12 microtitre plate. 
Standardized row and column effects for two replicate plates 
Plate 1 Plate 2 
Rows Columns Rows Columns 
A 1.9 1 -6.8 A 3.2 1 -0.5 
B 2.5 2 -3.3 B 0.9 2 -0.6 
C 0-3 3 2.7 C 0-1 3 1-8 
D -2-2 4 2-7 D -1-5 4 2-0 
E -3-0 5 2.0 E -1-3 5 2.1 
F 0.2 6 2-4 F -2-0 6 0.9 
G 0.5 7 2-3 G 0.3 7 -0.4 
H -0.2 8 0 H 0.2 8 2.0 
9 1.0 9 1-2 
10 1.1 10 0-9 
11 1.3 11 -2.6 
12 -5.5 12 -6.8 
P < 0-01 P < 0-001 P < 0.05 P < 0.001 
Replicate 1 Row H, Column 1 was an estimated value since no colour developed in this well. 
Experiment 2 
The log dose -response curves of ten out of the 12 sera were approximately linear over 
the dilution range 1/50 to 1/3200 or 1/50 to 1/6400 (see Table 2 and Fig. 1). All slopes 
were highly significant, and with the exception of the pair 3A and 3B the slope of the 
convalescent serum was considerably higher than that of the acute serum. 
Responses at various dilution levels were estimated from the regression lines in an 
attempt to determine the most clear -cut distinction between acute and convalescent 
sera. A dilution of 1/100 was found to give the optimum range of readings, and at this 
level the difference in mean OD reading for convalescent -acute gave a better 
differentiation than the ratio convalescent /acute, especially with a low -level acute 
serum such as 5A (Table 2). The average difference, omitting 3A and 3B, was 0.70. 
Experiment 3 
Mean corrected OD readings for each of the 12 sera tested are given in Table 3. Mean 
differences between acute and convalescent sera were all very highly significant 
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TABLE 2. Regression of corrected mean optical density reading on log dilution for 
six pairs of sera 
Plate Serum 
Reciprocal 
dilution range* Gradient ± SEt 
Response at 1 /100 dilution 
Estimate B /A$ B -A 
lA 50-3200 0125 ± 0.023 0.17 4.8 0.64 
1 1B 50-3200 0466 ± 0.024 0.81 
2A 50-3200 0089 ± 0.016 0.11 8.6 0.84 
2B 50 -6400 0.524 ± 0.033 0.95 
2 3A 50 -3200 0.454 ± 0.025 0.75 1.1 0.06 
3B 50 -6400 0.478 ± 0.040 0.81 
4A§ 50 -6400 0.170 ± 0.009 0.29 2.6 0.46 
3 4B 50 -6400 0.380 ± 0.026 0.75 
5A 50-400 0.060 ± 0.018 0.03 18.3 0.52 
513 50 -6400 0.328 ± 0.029 0.55 
4 6A 50 -3200 0.095 ± 0.013 0.15 7.9 1.04 
6B 200 -6400 0.626 ± 0.012 1.19 
* Reciprocal dilution range over which log dose -response curve was linear. 
t Gradient ± SE: Regression coefficient and its standard error. 
$ Serum A = acute, B = convalescent. 
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Fig. 1. The log dose -response curves for three pairs of acute (A) and convalescent (B) sera assayed in 
Experiment 2. 
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TABLE 3. Mean optical density readings of six pairs of sera tested at a 
dilution of 1/100 
Mean corrected O.D. values for 4 blocks of 2 replicates 
Serum* 




































* A = Acute, B = convalescent. 
f LSD = Least difference between two means necessary to show significance at the 5% level. 
(P < 0.001) with the exception once more of the low level pair 3A and 3B which did not 
differ significantly in any test. The difference mean corrected of four 
replicate blocks of readings for each serum required to show a difference which is 
significant at the 5% level averaged at 0.113. If only a single block of duplicates per 
serum was used, the difference necessary for significance would be 0.226. 
The variance (F) ratios of the difference between blocks of the same serum in different 
areas of the plate to that between duplicates within blocks was significant for each of the 
four plates tested (Table 4). 
Experiment 4 
Mean corrected OD readings for each of the three sera tested are shown in Table 5. 
Each value represents the mean of 24 separately prepared dilutions allocated to the blocks 
of four wells on a plate. The day -to -day variation was greater than that between plates 
tested on the same day. Overall, there was a clear -cut distinction between the three 
sera. The upper 99% tolerance limit (one- sided) for the negative serum 1 was 0.06, 
while for serum 2 there was a chance of only 1/1000 of obtaining a reading lower than 
0.16. 
TABLE 4. Variability between blocks /within blocks of sera 
Pattern 1 Pattern 2 
Plate 1 Plate 2 Plate 3 Plate 4 
F ratio (18, 24 DF) 7.80 2.28 2.03 13.43 
Significance (P) <0.001 <0.05 0.05 < 0.001 
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TABLE 5. Mean optical density (OD) readings of 24 separate dilutions 
per plate for each of three sera 
Serum 1 Serum 2 
Negative Weak positive 
Serum 3 
Medium positive 
Day Plate 1 Plate 2 Plate 1 Plate 2 Plate 1 Plate 2 
1 0.027 0.050*** 0.254 0.216*** 0.685 0.698 
2 0.027 0.020 0.292 0262 ** 0.672 0.596 ** 
3 0.010 0.013 0.275 0.333 * ** 0.762 0.746 
4 0.016 0.012 0.238 0.247 0.739 0.723 
SEM of 
24 values 0.0032 0.0066 0.0112 
Overall mean OD 0.022 0.265 0.703 
LSDt (5% level) 0.043 0.090 0.152 
LSDt (1% level) 0.057 0.119 0.200 
95% C.L.$ of a 
single result ± 0.031 ± 0.064 ± 0.108 
Significant difference between plates, ** = P < 0.01, * ** = P < 0.001. 
t LSD = least difference necessary for significance between individual dilutions within a plate. 
$ C.L. = Confidence limit. 
Experiment .5 
From the findings in Experiment 4 it would appear that a change in corrected OD 
reading of 0.15 can be accepted as statistically significant (Table 5), and if the rise from 
the acute to the convalescent stage in a pair of sera reached this level in the present 
experiment it was interpretated as positive. The criterion for a significant rise in 
seroneutralization (VN) titre (loge) was taken as 2.0 (i.e. a fourfold rise in titre), and on 
this basis 87 of the 105 sera examined (83 %) gave a positive result to both tests, while 
16 were negative to both. The remaining two sera were negative to the VN test but 
positive in the ELISA. In one of these the rise in OD only just reached a value of 0- 15, 
while in the other it was 0.46, but this animal was from a group experiencing an IBR 
outbreak in which other animals sampled showed a rising titre by both tests. 
Experiment 6 
Sera with known weak positive antibody titres. The distribution of corrected OD 
readings on the 119 sera which were tested twice was very similar and the results have 
therefore been pooled to give a group of 300 tests, of which 107 had a titre of less than 
1/4 in the VN test (Table 6). Both distributions were positively skew with considerable 
overlap. 
Sera with known positive or negative antibody titres. Tests on 88 sera all giving positive 
results in the VN test gave a mean OD response of 1.21, with an SE of ± 0.045. The 
lower 95% tolerance limit (one -tailed) was 0.51. According to this sample, there is a 
chance of less than 1/1000 of obtaining a reading of less than 0.10 in a sample with a 
strongly positive titre. Of the total of 652 known negative sera, 157 had zero OD 
readings giving an apparently positively skew distribution. In fact, the distribution is 
probably normal, with many of the zero readings having a numerically negative value. 
No readings exceeded 0.10. 
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TABLE 6. Distribution of corrected optical density (OD) readings of 
sera assessed as positive or negative according to the virus neutralization 
test 
300 weak positive sera 
740 sera 
652 Known negatives 88 VN positives 
OD VN < 4 VN > 4 OD VN (-ve) OD VN (+ve) 
0 31 6 0.00 157 0.10 -0.19 5 
0.01 -0.04 35 9 0.01 68 0.20 -0.29 2 
0.05 -0.09 24 7 0-02 75 0.30 -0.39 0 
0.10-0.14 10 26 0.03 74 0.40-0.49 2 
0.15 -0.19 3 33 0-04 64 0-50-0-59 1 
0.20 -0.24 2 21 0.05 67 0.60-0.69 2 
0.25 -0.29 0 17 0-06 58 0.70 -0.79 4 
0.30 -0.39 2 33 0.07 53 0.80 -0.89 1 
0.40-0.49 18 0-08 35 0.90 -0.99 2 
0.50 -0.59 11 0.09 1 1.00 -1.09 3 
0.60 -0.69 4 1.10 -1.19 9 
0.70 -0.79 1 1-20-1-29 7 
0.80-0.89 3 1.30 -1.39 15 
0.90-0.99 1 1-50- 1-59y 12 
1.00 -1.09 0 1.60 -1.69 7 
1.10 -1.19 1 1.70 -1.79 2 
1.20 -1.29 0 
1.30 -1.39 2 
Total 107 193 652 88 
DISCUSSION 
It has been shown by a number of workers that variations in optical density readings 
occur between wells in different positions on a micro -titre plate. Kricka et al.8 
examined plates of various types using four separate assay procedures. They demon- 
strated that higher absorbance values frequently occurred round the edges of the plate 
than in the centre, possibly due to a birefringence effect, and that high, medium and 
low readings tended to occur in clusters in adjacent rows and columns. In Experiment 1 
of the present trial, and in other studies at this laboratory, similar effects have been 
observed, and it was found that differences between columns were almost always 
greater than those between rows. The pattern is not necessarily the same when two 
plates are tested consecutively with the same dilutions, nor is the overall mean level of 
absorbance the same on both plates. There is a tendency for low (or high) row and 
column means to be grouped together giving a clustering effect. The greater range in 
the standardized column effects indicates that these differ more significantly than do 
the row effects. 
That the block system considerably reduces variability is shown in the present 
experiments where differences between blocks in different areas of a plate are 
consistently, and generally statistically significantly higher than intra -block variation. 
When designing an experiment it is usually advisable to assign the sera under test to 
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these 24 blocks of four wells each in a systematic pattern (although this can still be 
'random') taking into account the likelihood that higher absorbance will probably 
occur round the edges of the plate particularly in the first two and last two columns. 
In designing the layout of sera on the plate it is also important to consider technical 
aspects of the addition of the solutions and to follow a straightforward pattern which 
will avoid errors of technique. 
Despite some deviations from linearity it has been shown that it is possible to fit 
regression lines to sera over a range spanning more than 100 -fold difference in dilution. 
This is of use in assessing the potency of test sera in relation to a standard of known 
potency. Since day -to -day variations between assays are almost always greater than 
those between plates tested on the same day, the standard should be included at three or 
more dilution levels at least once in each day's assay. This will serve as a working quality 
control check. Care should of course be taken when expressing OD readings in terms of 
the standard where these fall in the area of low slope at either end of the sigmoidal 
curve. 
The greater the activity of the serum the steeper will be the slope of the log 
dose -response curve, and significant deviations from parallelism of the curve may 
occur, as pointed out by de Savigny & Voller.9 It has been shown' that ELISA 
results, whether expressed as OD values or as end -point titres, are affected by both the 
concentration of antibodies in the serum and their affinity, and that the effects of 
affinity vary at different serum dilutions in the assay. Tests at a single serum dilution 
tend to measure high affinity antibodies whereas end -point titres relate to a larger range 
of affinities. These factors may account for the differences in slope of the dilution curves 
for different sera in the present study. Despite the lack of parallelism, the use of a single 
test dilution to compare sera from the same animal can be justified in that the change in 
slope will tend to enhance differences between acute and convalescent sera and thus 
improve the test's value for quantitative diagnositc assay. 
The log dose -response curve was used to assess the optimum dilution at which field 
sera should be tested in order to give optical density readings the majority of which, 
after correction for the corresponding control values, will fall within the range 
0.10 -1.90. In our experiments this dilution was found to be 1/100, since this gave the 
greatest differentiation between convalescent and acute sera. A dilution of 1/200 would 
also have given a satisfactory range of readings, but the difference convalescent - acute 
was less consistent than the ratio convalescent /acute. In practical terms a ratio is less 
satisfactory than a difference since it can be seriously misleading if the acute serum (the 
denominator) has a very low value. Ratios are, however, widely used to determine a 
positive response to the presence of antibodies and de Savigny & Voller9 have put 
forward a number of other approaches to estimate relative 'antibody activity'. They 
concluded that no system was ideal. 
When low titre sera were being tested as in Experiment 6 it was found that a dilution 
of 1/50 was more satisfactory than one of 1 /100, and this is recommended for use in a 
screening test where a high proportion of negative values is expected. 
When the paired sera were tested by both the ELISA and the VN test, there were 
only two discrepancies out of a total of 105 pairs of samples. Of these, one had a rise in 
OD which was just significant but it had a static VN titre. This may possibly be 
accounted for by a test error in the VN (which was not repeated) or by the fact that the 
two tests do not necessarily measure the same antibodies. 
The occasional 'aberrant' OD values recorded in individual wells are thought to be 
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associated with technical errors in performance of the test. This view was reinforced by 
the observation that the frequency of such aberrant values decreased as operators became 
more familiar with the technical procedures. In routine diagnostic testing they will be 
detected by a discrepancy between the replicates within a block and such samples would 
be retested. 
Actual corrected OD readings for the 72 sera can be defined as positive or negative by 
reference to the VN titre. This confirms earlier findings, namely, that the distribution 
of positive readings is very wide with occasional zero or very low values, and also that 
there is a tendency to positive skewness particularly in the distribution of negative 
readings. This fact was also noted by de Savigny & Voller,9 who suggested that 
non -parametric methods should be used in defining an upper limit for negative sera. 
Some of the high reading `negative' sera may be weak positives detected only by the 
ELISA with its greater sensitivity as described by Bolton et al.' Inevitably there is an 
overlap between the distribution of OD values for negative and positive sera and some 
sera will remain indeterminate. 
However, from the results in the final experiment it appears that, while sera with 
weak positive antibody titres can give very low OD readings, for a true negative serum 
there is a probability of less than 1/500 that the readings will exceed 0.10. In 
Experiment 6 there was one such value, which was omitted from the calculations since 
it was an outlier. 
Although the VN test is widely accepted as the reference method for assessment of 
BHVI antibodies, it is also recognised that it suffers from interference by non -antibody 
neutralizing factors in some sera. 13'14 It is suggested that such factors may account for 
some of the discrepant readings, particularly where weak positive VN sera were 
negative by ELISA. In such cases the ELISA may be the more accurate test. 
Although some authors have recommended highly purified antigens for ELISA"3 
others have achieved satisfactory results with a crude antigen.15,16 The unpurified 
antigen used in the present experiments is very simply prepared with basic laboratory 
facilities and has performed well with experimental and field sera. 
Non -specific reactivity, detected by high OD with the control antigen, is a problem 
with some field sera which have been handled or stored. The block testing system used 
here, incorporating control antigen, will detect such sera and will still allow assessment 
of virus specific antibodies except in the occasional samples with very high control readings. 
The use of ELISA in quantitative diagnostic serology for IBR has been established, 
and a critical level determined for significant rises in OD (0.15) between acute and 
convalescent sera tested simultaneously at a single dilution of 1 /100. For screening of 
sera in conjunction with IBR control schemes, testing prior to export, etc., the 
maximum sensitivity was achieved at 1/50 serum dilution, with a calculated OD of 
0.10 as the positive /negative cut -off point. 
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